%PDF-1.3
%‚„œ”
1 0 obj
<<
/Length 9023
>>
stream
/GS0 gs
q
0 0.701 595 793 re
W n
1 g
0 793.701 0 0 re
f
Q
/GS0 gs
/GS2 gs
0 0 0 0 k
42.744 18.126 25.512 15.007 re
f
q
BT
/F0 1 Tf
8 0 0 8 42.7441 19.8606 Tm
0 Tr
0 0 0 1 k
(77)Tj
ET
0 0 0 0 k
42.52 51.024 510.236 439.37 re
f
BT
/F1 1 Tf
8.5 0 0 8.5 42.5197 483.9609 Tm
0 0 0 1 k
-0.0002 Tc
(Resumen)Tj
ET
BT
/F2 1 Tf
8.5 0 0 8.5 53.8583 464.9609 Tm
-0.0001 Tc
0.0739 Tw
(El metotrexato a dosis elevadas est\207 incluido en las pautas de)Tj
-1.33395 -1.11765 TD
0.2122 Tw
(los tratamientos quimioter\207picos de numerosas neoplasias. Las)Tj
0.1055 Tw
(concentraciones plasm\207ticas de metotrexato son consideradas el)'
0 -1.11764 TD
0.126 Tw
(mejor valor predictivo de su toxicidad. La monitorizaci\227n de las)Tj
0 -1.11765 TD
0.0133 Tw
(concentraciones plasm\207ticas de metotrexato es una pr\207ctica habi)Tj
28.04665 0 TD
0 Tc
(-)Tj
-28.04665 -1.11765 TD
-0.0001 Tc
0.0774 Tw
(tual para identificar pacientes de riesgo, ajustar la dosis de \207cido)Tj
0 -1.11764 TD
0.1767 Tw
(fol\222nico y establecer medidas correctoras. El metotrexato es un)Tj
0 -1.11765 TD
-0.0242 Tw
(\207cido d\216bil que se elimina v\222a renal, por lo que cualquier alteraci\227n)Tj
T*
0 Tc
-0.009 Tw
(de la misma produce un elentecimiento en su eliminaci\227n. Se des-)Tj
0 -1.11764 TD
-0.0001 Tc
0.1114 Tw
(cribe un caso de toxicidad grave por metotrexato, debido a una)Tj
0 -1.11765 TD
-0.0162 Tw
(insuficiencia renal en un paciente con linfoma no Hodgkin tratado)Tj
0.2549 Tw
(con metotrexato a dosis de 1 g/m)'
4.25 0 0 4.25 180.6006 363.6484 Tm
0 Tc
(2)Tj
8.5 0 0 8.5 183.1499 360.4609 Tm
-0.0001 Tc
(. Las medidas correctoras)Tj
-16.54473 -1.11764 TD
0.0771 Tw
(incluyen el rescate con \207cido fol\222nico, la administraci\227n de resin)Tj
28.04665 0 TD
0 Tc
(-)Tj
-28.04665 -1.11765 TD
-0.0001 Tc
0.1818 Tw
(colestiramina, la hidrataci\227n y alcalinizaci\227n urinaria, el control)Tj
0 Tw
(del pH urinario y las t\216cnicas de eliminaci\227n extracorp\227rea.)'
ET
BT
/F1 1 Tf
8.5 0 0 8.5 42.5197 312.9609 Tm
(Palabras clave:)Tj
ET
BT
/F2 1 Tf
8.5 0 0 8.5 112.8813 312.9609 Tm
(Metotrexato. Intoxicaci\227n. Monitorizaci\227n.)Tj
ET
BT
/F1 1 Tf
8.5 0 0 8.5 42.5197 274.9609 Tm
(Summary)Tj
ET
BT
/F2 1 Tf
8.5 0 0 8.5 53.8583 255.9609 Tm
-0.0001 Tw
(High-dose methotrexate is included in chemotherapy regimens)Tj
-1.33395 -1.11764 TD
0.2118 Tw
(used to treat a number of malignant neoplasms. Methotrexate)Tj
0 -1.11765 TD
0.242 Tw
(plasma concentration is considered the best toxicity predictor.)Tj
0 -1.11764 TD
0 Tc
0.036 Tw
(Monitoring methotrexate plasma concentrations is standard prac-)Tj
-0.0001 Tc
0.0875 Tw
(tice in the identification of at-risk patients, the titration of folinic)'
0 -1.11765 TD
0 Tc
0.039 Tw
(acid doses, and the establishment of corrective measures. Metho-)Tj
0 -1.11764 TD
0.057 Tw
(trexate is a kidney-cleared weak acid, and renal function  impair-)Tj
-0.0001 Tc
-0.023 Tw
(ment may retard methotrexate clearance. A case of severe metho)'
28.04665 0.00001 TD
0 Tc
(-)Tj
-28.04665 -1.11766 TD
-0.0001 Tc
0.0438 Tw
(trexate-induced toxicity secondary to renal failure is reported in a)Tj
0 -1.11764 TD
0.0756 Tw
(patient with non-Hodgkin\325s lymphoma receiving methotrexate at)Tj
-0.0002 Tc
-0.0126 Tw
(a dose of 1 g/m)'
4.25 0 0 4.25 101.7412 164.1484 Tm
0 Tc
(2)Tj
8.5 0 0 8.5 104.2906 160.9609 Tm
-0.0001 Tc
(. Corrective measures included folinic acid rescue)Tj
24.41417 38 TD
0.029 Tw
(therapy, cholestyramine resin administration, hydration and urine)Tj
0 -1.11765 TD
0.0322 Tw
(alkalinization, urine pH monitoring, and extracorporeal clearance)Tj
0 -1.11764 TD
(techniques.)Tj
ET
BT
/F1 1 Tf
8.5 0 0 8.5 311.811 445.9609 Tm
-0.0002 Tc
0 Tw
(Key words:)Tj
ET
BT
/F2 1 Tf
8.5 0 0 8.5 362.9667 445.9609 Tm
0 Tc
(Methotrexate. Toxicity. Monitoring.)Tj
ET
0 J 0 j 0.4 i 10 M []0 d 0.667 w 
0 0 0 1 K
311.811 434.128 m
552.756 434.128 l
S
311.811 432.794 m
552.756 432.794 l
S
BT
/F3 1 Tf
10.5 0 0 10.5 311.811 390.4609 Tm
-0.0002 Tc
(INTRODUCCI\356N)Tj
ET
BT
/F0 1 Tf
10.5 0 0 10.5 323.1496 367.4609 Tm
-0.0001 Tc
0.6498 Tw
(Las concentraciones plasm\207ticas de metotrexato)Tj
-1.07986 -1.09524 TD
0.0014 Tw
((MTX) suponen el mejor valor predictivo de su toxicidad)Tj
T*
0 Tc
-0.016 Tw
(y probablemente tambi\216n de su eficacia (1-3). La monito-)Tj
-0.0001 Tc
0.2956 Tw
(rizaci\227n del MTX, una pr\207ctica cl\222nica habitual para)'
-0.0087 Tw
(identificar pacientes de riesgo, ajustar dosis de \207cido fol\222)'
22.61437 0 TD
0 Tc
(-)Tj
-22.61437 -1.09524 TD
-0.0001 Tc
0.1449 Tw
(nico y establecer otras medidas correctoras, ha logrado)Tj
-0.0224 Tw
(reducir la incidencia de efectos adversos graves, as\222 como)'
0 -1.09523 TD
-0.0191 Tw
(del n\234mero de muertes debidas a altas concentraciones de)Tj
0 -1.09524 TD
0 Tw
(MTX (1,2).)Tj
1.07986 -1.09524 TD
-0.0063 Tw
(El MTX es un \207cido d\216bil que se elimina por v\222a renal,)Tj
-1.07986 -1.09523 TD
-0.0023 Tw
(mediante filtraci\227n glomerular y secreci\227n tubular activa.)Tj
0 -1.09524 TD
0.2032 Tw
(Cualquier alteraci\227n de la funci\227n renal se traduce en)Tj
0.5082 Tw
(concentraciones plasm\207ticas por encima de valores)'
0 -1.09523 TD
0.1454 Tw
(umbrales durante m\207s tiempo, aumentando la gravedad)Tj
0 -1.09524 TD
-0.0086 Tw
(de los efectos adversos. La hidrataci\227n y la alcalinizaci\227n)Tj
T*
0 Tc
0.017 Tw
(urinaria previene la precipitaci\227n del MTX y de su meta-)Tj
0 -1.09523 TD
-0.0001 Tc
0.025 Tw
(bolito 7-hidroxi-MTX en los t\234bulos renales, favorecien)Tj
22.61437 0.00001 TD
0 Tc
(-)Tj
-22.61437 -1.09525 TD
-0.0001 Tc
0 Tw
(do su eliminaci\227n renal (3,4).)Tj
1.07986 -1.09524 TD
0.1609 Tw
(El \207cido fol\222nico antagoniza la acci\227n citot\227xica del)Tj
-1.07986 -1.09523 TD
0.0499 Tw
(MTX a varios niveles: a\) por inhibici\227n competitiva con)Tj
0 -1.09524 TD
0 Tc
0.059 Tw
(el MTX por la entrada dentro de la c\216lula; b\) por dismi-)Tj
0 -1.09523 TD
-0.0001 Tc
0.0846 Tw
(nuci\227n de la poliglutamaci\227n del MTX por competici\227n)Tj
0 -1.09524 TD
0 Tc
0.05 Tw
(por la enzima folilpoliglutamato sintetasa; y c\) por com-)Tj
-0.0001 Tc
-0.0115 Tw
(petici\227n directa por la dihidrofolato reductasa, desplazan)'
22.61436 0.00001 TD
0 Tc
(-)Tj
-22.61436 -1.09524 TD
-0.0001 Tc
0 Tw
(do al MTX de su sitio de uni\227n (5). )Tj
1.07986 -1.09524 TD
0.0618 Tw
(La administraci\227n de sales biliares, carb\227n activado y)Tj
-1.07986 -1.09524 TD
0.405 Tw
(resincolestiramina, tiene por objeto secuestrar en el)Tj
0 -1.09523 TD
0 Tc
0.014 Tw
(lumen gastrointestinal el MTX procedente del ciclo ente-)Tj
ET
BT
/F4 1 Tf
18 0 0 18 44.0294 668.0061 Tm
0.001 Tc
0 Tw
[(Manejo de la intoxicaci\227n por metotr)19(exato: a pr)18(op\227sito de un caso)]TJ
ET
BT
/F0 1 Tf
12 0 0 12 98.1759 635.0061 Tm
-0.0001 Tc
(M. J. FERN\347NDEZ MEG\352A, M. AL\356S ALMI\204ANA)Tj
6 0 0 6 361.4434 639.0686 Tm
0 Tc
(1)Tj
12 0 0 12 364.4434 635.0061 Tm
-0.0001 Tc
(, M. J. TEROL CASTERA)Tj
6 0 0 6 494.0997 639.0686 Tm
0 Tc
(2)Tj
ET
BT
/F5 1 Tf
10.5 0 0 10.5 107.6547 610.5061 Tm
[(Servicio de Farmacia. Hospital V)74(ir)36(gen de la Luz. Cuenca. )]TJ
5.25 0 0 5.25 353.7689 614.0686 Tm
(1)Tj
10.5 0 0 10.5 356.3939 610.5061 Tm
-0.0001 Tc
(Hospital General de Castell\227n.)Tj
5.25 0 0 5.25 129.2379 602.5686 Tm
0 Tc
(2)Tj
10.5 0 0 10.5 131.8629 599.0061 Tm
[(Servicio de Hematolog\222a y Oncolog\222a. Hospital Cl\222nico Universitario. V)111(alencia )]TJ
ET
BT
/F2 1 Tf
7 0 0 7 42.5197 758.048 Tm
-0.0002 Tc
(1130-6343/2004/28/5/371)Tj
0 -0.99999 TD
0 Tc
(F)Tj
5.25 0 0 5.25 46.4384 751.048 Tm
-0.0001 Tc
(ARMACIA)Tj
7 0 0 7 73.1041 751.048 Tm
0 Tc
(H)Tj
5.25 0 0 5.25 78.7027 751.048 Tm
-0.0001 Tc
(OSPITALARIA)Tj
7 0 0 7 42.5197 744.048 Tm
-0.0002 Tc
(Copyright \251 2004 )Tj
8.45751 0.00001 TD
0 Tc
(A)Tj
5.25 0 0 5.25 106.7621 744.048 Tm
-0.0001 Tc
(R\347N)Tj
7 0 0 7 120.0952 744.048 Tm
0 Tc
(E)Tj
5.25 0 0 5.25 124.2942 744.048 Tm
-0.0001 Tc
(DICIONES)Tj
7 0 0 7 149.0689 744.048 Tm
-0.0002 Tc
(, S. L)Tj
2.39893 0.00001 TD
0 Tc
(.)Tj
ET
0 0 0 0 k
42.52 57.701 240.945 86.932 re
f
0.5 w 
42.52 104.189 m
283.465 104.189 l
S
BT
/F5 1 Tf
8 0 0 8 42.5197 95.4354 Tm
0 0 0 1 k
-0.0001 Tc
(Recibido: )Tj
ET
BT
/F0 1 Tf
8 0 0 8 75.6154 95.4354 Tm
(24-11-2003)Tj
ET
BT
/F5 1 Tf
8 0 0 8 42.5197 86.4354 Tm
(Aceptado: )Tj
ET
BT
/F0 1 Tf
8 0 0 8 77.3927 86.4354 Tm
(21-01-2004)Tj
ET
BT
/F5 1 Tf
8 0 0 8 42.5197 68.4354 Tm
0.0578 Tw
(Correspondencia: )Tj
ET
BT
/F0 1 Tf
8 0 0 8 103.1888 68.4354 Tm
(M. J. Fern\207ndez Meg\222a. Servicio de Farmacia. Hospital)Tj
-7.58364 -1.125 TD
0 Tw
(Virgen de la Luz. Hermandad Donantes de Sangre, 1. 16002 Cuenca.)Tj
ET
BT
/F2 1 Tf
7 0 0 7 492.2203 760.3819 Tm
0 Tc
(F)Tj
5.25 0 0 5.25 496.139 760.3819 Tm
-0.0001 Tc
(ARM)Tj
7 0 0 7 510.1014 760.3819 Tm
0 Tc
(H)Tj
5.25 0 0 5.25 515.7 760.3819 Tm
-0.0002 Tc
(OSP)Tj
7 0 0 7 528.4012 760.3819 Tm
-0.0001 Tc
((Madrid))Tj
-11.99562 -1 TD
0 Tc
[(Vol. 28. N.\241)-300(5, pp. 371-374, 2004)]TJ
ET
0 0 0 0.2 k
437.297 738.942 115.459 11.13 re
f
BT
/F3 1 Tf
7 0 0 7 443.3769 742.54 Tm
0 0 0 1 k
-0.0001 Tc
(COMUNICACIONES CORTAS)Tj
ET
Q
endstream
endobj
2 0 obj
<<
/SA false
/OPM 1
/Type/ExtGState
/OP false
>>
endobj
3 0 obj
<<
/SA false
/OPM 1
/Type/ExtGState
/OP true
>>
endobj
4 0 obj
<<
/FunctionType 4
/Length 16
/Range[0 1 0 1 0 1 0 1]
/Domain[0 1]
>>
stream
{ dup dup dup }
endstream
endobj
5 0 obj
<<
/Length 8927
/Resources<</Font<</F18 6 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS1 7 0 R/GS3 8 0 R>>>>
/BBox[-1.49209 -0.50943 1.25112 3.25218]
/Subtype/Form
/OPI<</2.0<<
/Type/OPI
/F(ANTONIO:  REVISTAS:FARMACIA HOSP. :FARM HOSPITAL 28-5:09. M.J. Fern\207ndez:Fig. 1)
/Overprint false
/CropRect[0 0 217 211]
/IncludedImageQuality 1
/Size[217 211]
/Inks/full_color
/Version 2
>>
>>
/Type/XObject
/FormType 1
/Name/Fm1
/Matrix[1 0 0 1 0 0]
>>
stream
/GS1 gs
0 J 0 j 0.4 i 3.8637 M []0 d 0.0023 w 
0 0 0 1 K
0.1597 0.9824 m
0.1597 0.4485 l
0.9754 0.4485 l
S
0.2672 0.4477 m
0.2672 0.4354 l
S
0.376 0.4477 m
0.376 0.4354 l
S
0.4838 0.4477 m
0.4838 0.4354 l
S
0.5926 0.4477 m
0.5926 0.4354 l
S
0.7013 0.4477 m
0.7013 0.4354 l
S
0.8092 0.4477 m
0.8092 0.4354 l
S
0.9161 0.4477 m
0.9161 0.4354 l
S
0.1597 0.4477 m
0.1597 0.4354 l
S
/GS3 gs
BT
/F18 1 Tf
0.03687 0 0 0.03791 0.0808 0.9645 Tm
0 0 0 1 k
0 Tc
(100)Tj
0.55588 -2.775 TD
(10)Tj
0.55589 -2.77499 TD
(1)Tj
-0.83377 -2.77501 TD
(0,1)Tj
-0.55588 -2.775 TD
(0,01)Tj
-0.55589 -2.775 TD
(0,001)Tj
2.55876 -1.11785 TD
(0)Tj
2.46751 -0.00715 TD
[(200)-1262(400)-1254(600)-1410(800)-761(1.000)-358(1.200)-506(1.400)]TJ
4.62223 -1.53284 TD
(Horas postinfusi\227n)Tj
0 0.03791 -0.03687 0 0.0382 0.5668 Tm
(log (MTX) (mcM))Tj
ET
/GS1 gs
0.7953 0.6045 m
0.7511 0.5884 l
0.5631 0.5884 l
0.5133 0.559 l
0.4856 0.5884 l
0.4055 0.5884 l
0.3787 0.6074 l
0.3658 0.6074 l
0.3529 0.6216 l
0.3262 0.6216 l
0.2562 0.6842 l
0.2386 0.688 l
0.2202 0.7136 l
0.2018 0.8159 l
0.187 0.8576 l
0.1695 0.8965 l
0.1668 0.9211 l
0.1594 0.9458 l
S
0.7875 0.5999 m
0.7914 0.6069 l
0.7953 0.6139 l
0.7993 0.6069 l
0.8032 0.5999 l
0.7953 0.5999 l
f
0.7875 0.5999 m
0.7914 0.6069 l
0.7953 0.6139 l
0.7993 0.6069 l
0.8032 0.5999 l
0.7953 0.5999 l
s
0.7377 0.58 m
0.7416 0.587 l
0.7456 0.594 l
0.7495 0.587 l
0.7534 0.58 l
0.7456 0.58 l
f
0.7377 0.58 m
0.7416 0.587 l
0.7456 0.594 l
0.7495 0.587 l
0.7534 0.58 l
0.7456 0.58 l
s
0.6861 0.579 m
0.69 0.586 l
0.6939 0.593 l
0.6979 0.586 l
0.7018 0.579 l
0.6939 0.579 l
f
0.6861 0.579 m
0.69 0.586 l
0.6939 0.593 l
0.6979 0.586 l
0.7018 0.579 l
0.6939 0.579 l
s
0.5543 0.58 m
0.5582 0.587 l
0.5621 0.594 l
0.5661 0.587 l
0.57 0.58 l
0.5621 0.58 l
f
0.5543 0.58 m
0.5582 0.587 l
0.5621 0.594 l
0.5661 0.587 l
0.57 0.58 l
0.5621 0.58 l
s
0.5045 0.5525 m
0.5084 0.5595 l
0.5124 0.5665 l
0.5163 0.5595 l
0.5202 0.5525 l
0.5124 0.5525 l
f
0.5045 0.5525 m
0.5084 0.5595 l
0.5124 0.5665 l
0.5163 0.5595 l
0.5202 0.5525 l
0.5124 0.5525 l
s
0.4769 0.5809 m
0.4808 0.5879 l
0.4847 0.5949 l
0.4887 0.5879 l
0.4926 0.5809 l
0.4847 0.5809 l
f
0.4769 0.5809 m
0.4808 0.5879 l
0.4847 0.5949 l
0.4887 0.5879 l
0.4926 0.5809 l
0.4847 0.5809 l
s
0.4621 0.58 m
0.4661 0.587 l
0.47 0.594 l
0.4739 0.587 l
0.4778 0.58 l
0.47 0.58 l
f
0.4621 0.58 m
0.4661 0.587 l
0.47 0.594 l
0.4739 0.587 l
0.4778 0.58 l
0.47 0.58 l
s
0.4234 0.58 m
0.4273 0.587 l
0.4313 0.594 l
0.4352 0.587 l
0.4391 0.58 l
0.4313 0.58 l
f
0.4234 0.58 m
0.4273 0.587 l
0.4313 0.594 l
0.4352 0.587 l
0.4391 0.58 l
0.4313 0.58 l
s
0.4114 0.58 m
0.4154 0.587 l
0.4193 0.594 l
0.4232 0.587 l
0.4272 0.58 l
0.4193 0.58 l
f
0.4114 0.58 m
0.4154 0.587 l
0.4193 0.594 l
0.4232 0.587 l
0.4272 0.58 l
0.4193 0.58 l
s
0.3985 0.58 m
0.4025 0.587 l
0.4064 0.594 l
0.4103 0.587 l
0.4142 0.58 l
0.4064 0.58 l
f
0.3985 0.58 m
0.4025 0.587 l
0.4064 0.594 l
0.4103 0.587 l
0.4142 0.58 l
0.4064 0.58 l
s
0.3709 0.5999 m
0.3748 0.6069 l
0.3787 0.6139 l
0.3827 0.6069 l
0.3866 0.5999 l
0.3787 0.5999 l
f
0.3709 0.5999 m
0.3748 0.6069 l
0.3787 0.6139 l
0.3827 0.6069 l
0.3866 0.5999 l
0.3787 0.5999 l
s
0.358 0.5999 m
0.3619 0.6069 l
0.3658 0.6139 l
0.3698 0.6069 l
0.3737 0.5999 l
0.3658 0.5999 l
f
0.358 0.5999 m
0.3619 0.6069 l
0.3658 0.6139 l
0.3698 0.6069 l
0.3737 0.5999 l
0.3658 0.5999 l
s
0.346 0.6122 m
0.3499 0.6192 l
0.3539 0.6262 l
0.3578 0.6192 l
0.3617 0.6122 l
0.3539 0.6122 l
f
0.346 0.6122 m
0.3499 0.6192 l
0.3539 0.6262 l
0.3578 0.6192 l
0.3617 0.6122 l
0.3539 0.6122 l
s
0.334 0.6113 m
0.3379 0.6183 l
0.3419 0.6253 l
0.3458 0.6183 l
0.3497 0.6113 l
0.3419 0.6113 l
f
0.334 0.6113 m
0.3379 0.6183 l
0.3419 0.6253 l
0.3458 0.6183 l
0.3497 0.6113 l
0.3419 0.6113 l
s
0.3211 0.6122 m
0.325 0.6192 l
0.329 0.6262 l
0.3329 0.6192 l
0.3368 0.6122 l
0.329 0.6122 l
f
0.3211 0.6122 m
0.325 0.6192 l
0.329 0.6262 l
0.3329 0.6192 l
0.3368 0.6122 l
0.329 0.6122 l
s
0.3054 0.6236 m
0.3094 0.6306 l
0.3133 0.6376 l
0.3172 0.6306 l
0.3212 0.6236 l
0.3133 0.6236 l
f
0.3054 0.6236 m
0.3094 0.6306 l
0.3133 0.6376 l
0.3172 0.6306 l
0.3212 0.6236 l
0.3133 0.6236 l
s
0.2935 0.6454 m
0.2974 0.6524 l
0.3013 0.6594 l
0.3052 0.6524 l
0.3092 0.6454 l
0.3013 0.6454 l
f
0.2935 0.6454 m
0.2974 0.6524 l
0.3013 0.6594 l
0.3052 0.6524 l
0.3092 0.6454 l
0.3013 0.6454 l
s
0.2806 0.6568 m
0.2845 0.6638 l
0.2884 0.6708 l
0.2923 0.6638 l
0.2963 0.6568 l
0.2884 0.6568 l
f
0.2806 0.6568 m
0.2845 0.6638 l
0.2884 0.6708 l
0.2923 0.6638 l
0.2963 0.6568 l
0.2884 0.6568 l
s
0.2677 0.6643 m
0.2716 0.6713 l
0.2755 0.6783 l
0.2794 0.6713 l
0.2834 0.6643 l
0.2755 0.6643 l
f
0.2677 0.6643 m
0.2716 0.6713 l
0.2755 0.6783 l
0.2794 0.6713 l
0.2834 0.6643 l
0.2755 0.6643 l
s
0.2418 0.6814 m
0.2458 0.6884 l
0.2497 0.6954 l
0.2536 0.6884 l
0.2576 0.6814 l
0.2497 0.6814 l
f
0.2418 0.6814 m
0.2458 0.6884 l
0.2497 0.6954 l
0.2536 0.6884 l
0.2576 0.6814 l
0.2497 0.6814 l
s
0.2317 0.6814 m
0.2356 0.6884 l
0.2396 0.6954 l
0.2435 0.6884 l
0.2474 0.6814 l
0.2396 0.6814 l
f
0.2317 0.6814 m
0.2356 0.6884 l
0.2396 0.6954 l
0.2435 0.6884 l
0.2474 0.6814 l
0.2396 0.6814 l
s
0.2114 0.7089 m
0.2154 0.7159 l
0.2193 0.7229 l
0.2232 0.7159 l
0.2272 0.7089 l
0.2193 0.7089 l
f
0.2114 0.7089 m
0.2154 0.7159 l
0.2193 0.7229 l
0.2232 0.7159 l
0.2272 0.7089 l
0.2193 0.7089 l
s
0.2068 0.7449 m
0.2108 0.7519 l
0.2147 0.7589 l
0.2186 0.7519 l
0.2225 0.7449 l
0.2147 0.7449 l
f
0.2068 0.7449 m
0.2108 0.7519 l
0.2147 0.7589 l
0.2186 0.7519 l
0.2225 0.7449 l
0.2147 0.7449 l
s
0.2031 0.7601 m
0.2071 0.7671 l
0.211 0.7741 l
0.2149 0.7671 l
0.2189 0.7601 l
0.211 0.7601 l
f
0.2031 0.7601 m
0.2071 0.7671 l
0.211 0.7741 l
0.2149 0.7671 l
0.2189 0.7601 l
0.211 0.7601 l
s
0.1893 0.8188 m
0.1932 0.8258 l
0.1972 0.8328 l
0.2011 0.8258 l
0.205 0.8188 l
0.1972 0.8188 l
f
0.1893 0.8188 m
0.1932 0.8258 l
0.1972 0.8328 l
0.2011 0.8258 l
0.205 0.8188 l
0.1972 0.8188 l
s
0.1838 0.8397 m
0.1877 0.8467 l
0.1916 0.8537 l
0.1956 0.8467 l
0.1995 0.8397 l
0.1916 0.8397 l
f
0.1838 0.8397 m
0.1877 0.8467 l
0.1916 0.8537 l
0.1956 0.8467 l
0.1995 0.8397 l
0.1916 0.8397 l
s
0.1773 0.8577 m
0.1813 0.8647 l
0.1852 0.8717 l
0.1891 0.8647 l
0.193 0.8577 l
0.1852 0.8577 l
f
0.1773 0.8577 m
0.1813 0.8647 l
0.1852 0.8717 l
0.1891 0.8647 l
0.193 0.8577 l
0.1852 0.8577 l
s
0.169 0.8643 m
0.173 0.8713 l
0.1769 0.8783 l
0.1808 0.8713 l
0.1848 0.8643 l
0.1769 0.8643 l
f
0.169 0.8643 m
0.173 0.8713 l
0.1769 0.8783 l
0.1808 0.8713 l
0.1848 0.8643 l
0.1769 0.8643 l
s
0.1626 0.8786 m
0.1665 0.8856 l
0.1704 0.8926 l
0.1744 0.8856 l
0.1783 0.8786 l
0.1704 0.8786 l
f
0.1626 0.8786 m
0.1665 0.8856 l
0.1704 0.8926 l
0.1744 0.8856 l
0.1783 0.8786 l
0.1704 0.8786 l
s
0.1552 0.9174 m
0.1591 0.9244 l
0.1631 0.9314 l
0.167 0.9244 l
0.1709 0.9174 l
0.1631 0.9174 l
f
0.1552 0.9174 m
0.1591 0.9244 l
0.1631 0.9314 l
0.167 0.9244 l
0.1709 0.9174 l
0.1631 0.9174 l
s
0.1488 0.9402 m
0.1527 0.9472 l
0.1566 0.9542 l
0.1605 0.9472 l
0.1645 0.9402 l
0.1566 0.9402 l
f
0.1488 0.9402 m
0.1527 0.9472 l
0.1566 0.9542 l
0.1605 0.9472 l
0.1645 0.9402 l
0.1566 0.9402 l
s
BT
/F18 1 Tf
0.02496 0 0 0.02566 0.0142 0.264 Tm
[(Tiempo)-643(C)]TJ
0.01872 0 0 0.01925 0.1259 0.2595 Tm
(MTX)Tj
0.02496 0 0 0.02566 0.1834 0.2615 Tm
[(Tiempo)-1450(C)]TJ
0.01872 0 0 0.01925 0.3153 0.2595 Tm
(MTX)Tj
0.02496 0 0 0.02566 0.3863 0.2615 Tm
[(Tiempo)-1667(C)]TJ
0.01872 0 0 0.01925 0.5236 0.2595 Tm
(MTX)Tj
0.02496 0 0 0.02566 0.6032 0.2615 Tm
[(Tiempo)-1493(C)]TJ
0.01872 0 0 0.01925 0.7362 0.2595 Tm
(MTX)Tj
0.02496 0 0 0.02566 0.8129 0.2615 Tm
[(Tiempo)-1222(C)]TJ
0.01872 0 0 0.01925 0.9391 0.2595 Tm
(MTX)Tj
0.02496 0 0 0.02566 0.0341 0.2263 Tm
[(0,16)-1592(48)-2360(72)-2588(3,49)-2206(240)-2527(0,10)-2551(408)-2353(0,03)-2436(744)-2082(0,02)]TJ
0.69482 -1.36932 TD
[(6)-2287(29)-2360(96)-2588(0,98)-2206(264)-2527(0,08)-2551(456)-2353(0,02)-2436(984)-2082(0,02)]TJ
-0.27795 -1.36932 TD
[(12)-2009(29)-2082(102)-2032(0,72*)-1928(288)-2527(0,05)-2551(480)-2353(0,02)-2019(1.080)-1665(0,02)]TJ
T*
[(24)-1314(13,09)-1387(112)-2032(0,33*)-1928(312)-2527(0,04)-2551(504)-2353(0,02)-2019(1.176)-1665(0,03)]TJ
0 -1.36934 TD
[(36)-1592(9,58)-1665(150)-2032(0,18*)-1928(336)-2527(0,04)-2551(576)-2353(0,02)]TJ
0 -1.36932 TD
[(48)-1592(7,79)-1665(168)-2310(0,18)-2206(360)-2527(0,04)-2551(600)-2353(0,02)]TJ
0 -1.36934 TD
[(60)-1592(5,35)-1665(216)-2310(0,12)-2206(384)-2527(0,03)-2551(648)-2353(0,01)]TJ
ET
0.0045 0.0057 0.9899 0.2882 re
s
0.0014 w 
0.0027 0.254 m
0.9962 0.254 l
S
0.0027 0.218 m
0.9962 0.218 l
S
0.0027 0.182 m
0.9962 0.182 l
S
0.0027 0.1479 m
0.9962 0.1479 l
S
0.0027 0.1138 m
0.9962 0.1138 l
S
0.0027 0.0777 m
0.9962 0.0777 l
S
0.0027 0.0436 m
0.9962 0.0436 l
S
0.0986 0.2939 m
0.0986 0.0057 l
S
0.176 0.2939 m
0.176 0.0057 l
S
0.2737 0.2939 m
0.2737 0.0057 l
S
0.3714 0.2939 m
0.3714 0.0057 l
S
0.4801 0.2939 m
0.4801 0.0057 l
S
0.5833 0.2939 m
0.5833 0.0057 l
S
0.6939 0.2939 m
0.6939 0.0057 l
S
0.7935 0.2939 m
0.7935 0.0057 l
S
0.9004 0.2939 m
0.9004 0.0057 l
S
endstream
endobj
9 0 obj
<<
/Length 50
/Resources<</ProcSet[/PDF]/ExtGState<</GS1 7 0 R>>/XObject<</Fm1 5 0 R>>>>
/BBox[0 0 595.27594 793.70093]
/Subtype/Form
/OPI<</1.3<<
/Type/OPI
/F(ANTONIO:  REVISTAS:FARMACIA HOSP. :FARM HOSPITAL 28-5:09. M.J. Fern\207ndez:Fig. 1)
/Position[323.78299 106.789 323.78299 317.789 540.78302 317.789 540.78302 106.789]
/CropFixed[0 0 217 211]
/CropRect[0 0 217 211]
/Size[217 211]
/Version 1.3
>>
>>
/Type/XObject
/FormType 1
/Name/Fm0
/Matrix[1 0 0 1 0 0]
>>
stream
/GS1 gs
q
217 0 0 211 323.783 107.49 cm
/Fm1 Do
Q
endstream
endobj
10 0 obj
<<
/Length 10869
>>
stream
/GS0 gs
q
0 0.701 595 793 re
W n
1 g
0 793.701 0 0 re
f
Q
/GS0 gs
/GS2 gs
0 0 0 0 k
42.52 51.024 510.236 657.638 re
f
q
BT
/F0 1 Tf
10.5 0 0 10.5 42.5197 701.4813 Tm
0 Tr
0 0 0 1 k
0.217 Tw
(rohep\207tico, para, de este modo, incrementar el aclara-)Tj
0 -1.09524 TD
-0.0001 Tc
0 Tw
(miento total del MTX (6).)Tj
1.07987 -1.09523 TD
0.0818 Tw
(Las t\216cnicas de eliminaci\227n extracorp\227rea pueden ser)Tj
-1.07987 -1.09524 TD
0.1187 Tw
(\234tiles tanto en el tratamiento del fallo renal, como para)Tj
T*
0 Tc
0.068 Tw
(las intoxicaciones de MTX. La hemoperfusi\227n es la t\216c-)Tj
0 -1.09523 TD
0.141 Tw
(nica m\207s efectiva para conseguir reducir las concentra-)Tj
0 -1.09524 TD
-0.0001 Tc
0.2715 Tw
(ciones plasm\207ticas del f\207rmaco. La hemodi\207lisis y la)Tj
0 -1.09523 TD
0.1524 Tw
(hemofiltraci\227n son t\216cnicas habitualmente utilizadas en)Tj
0 -1.09524 TD
0.1266 Tw
(el tratamiento del fallo renal asociado a la intoxicaci\227n)Tj
0 Tw
(por MTX (4,7).)'
1.07987 -1.09523 TD
0 Tc
0.066 Tw
(Los principales efectos adversos del MTX son mielo-)Tj
-1.07987 -1.09524 TD
-0.012 Tw
(supresi\227n, afectando a todas las series celulares, la insufi-)Tj
0 -1.09523 TD
-0.0001 Tc
-0.0111 Tw
(ciencia renal por da\226o en los t\234bulos renales, la mucositis)Tj
T*
0 Tc
0.016 Tw
(de todo el tracto gastrointestinal y las alteraciones neuro-)Tj
0 -1.09524 TD
-0.012 Tw
(l\227gicas sobre todo cuando se administra MTX v\222a intrate-)Tj
0 -1.09523 TD
-0.0001 Tc
0 Tw
(cal (3,4).)Tj
ET
BT
/F3 1 Tf
10.5 0 0 10.5 42.5197 494.4814 Tm
-0.0002 Tc
(CASO CL\352NICO)Tj
ET
BT
/F0 1 Tf
10.5 0 0 10.5 53.8583 471.4813 Tm
-0.0001 Tc
0.0266 Tw
(Se trata de un paciente de 69 a\226os, de 79,5 kg de peso)Tj
-1.07987 -1.09524 TD
0.2371 Tw
(y altura de 1,65 m, diagnosticado de linfoma )Tj
ET
BT
/F5 1 Tf
10.5 0 0 10.5 252.5467 459.9813 Tm
(natural)Tj
-20.00257 -1.09524 TD
-0.0002 Tc
(killer)Tj
ET
BT
/F0 1 Tf
10.5 0 0 10.5 67.7056 448.4813 Tm
-0.0001 Tc
0.0386 Tw
(con factores de mal pron\227stico \(edad, )Tj
ET
BT
/F16 1 Tf
10.5 0 0 10.5 230.1827 448.4813 Tm
0 Tc
(b)Tj
ET
BT
/F0 1 Tf
5.25 0 0 5.25 235.9454 446.3814 Tm
(2)Tj
10.5 0 0 10.5 238.5704 448.4813 Tm
0 Tw
(-microglo-)Tj
-18.6715 -1.09524 TD
-0.0001 Tc
0.212 Tw
(bulina, estadio IV con afectaci\227n pulmonar\). El \234nico)Tj
-0.0109 Tw
(antecedente de inter\216s es una diabetes mellitus tipo II. No)'
0 Tw
(existe infiltraci\227n de m\216dula \227sea. )'
1.07987 -1.09524 TD
-0.0051 Tc
0.0644 Tw
(El d\222a +1 se inici\227 el tratamiento con MTX a dosis de)Tj
-1.07987 -1.09524 TD
(1g/m)Tj
5.25 0 0 5.25 63.8943 394.5438 Tm
0 Tc
(2)Tj
10.5 0 0 10.5 70.0184 390.9813 Tm
-0.0051 Tc
0.0907 Tw
(en perfusi\227n de 24 horas, 200 mg/m)Tj
5.25 0 0 5.25 225.286 394.5438 Tm
0 Tc
(2)Tj
10.5 0 0 10.5 231.4101 390.9813 Tm
-0.0051 Tc
(en una infu)Tj
4.62481 0 TD
0 Tc
(-)Tj
-22.61437 -1.09524 TD
-0.0051 Tc
0.0564 Tw
(si\227n corta de 2 horas y el resto \(800 mg/m)Tj
5.25 0 0 5.25 222.6291 383.0438 Tm
0 Tc
(2)Tj
10.5 0 0 10.5 225.2279 379.4813 Tm
-0.0051 Tc
(\) en 22 horas.)Tj
-17.40078 -1.09524 TD
0.0425 Tw
(La dosis total fue de 1.980 mg. El d\222a +3 el paciente pre)Tj
22.61437 0 TD
0 Tc
(-)Tj
-22.61437 -1.09524 TD
-0.0051 Tc
0.2538 Tw
(sent\227 nefrotoxicidad, con retraso en la eliminaci\227n de)Tj
0.0158 Tw
(MTX, bioqu\222micamente expresado por un valor de creati)'
22.61435 0 TD
0 Tc
(-)Tj
-22.61435 -1.09524 TD
-0.005 Tc
0.054 Tw
(nina plasm\207tica de 2,6 mg/dl, que corresponde a un acla-)Tj
-0.0051 Tc
0.148 Tw
(ramiento de creatinina de 27 ml/h, seg\234n la f\227rmula de)'
-0.0012 Tw
(Cockroft-Gault. El pH urinario present\227 valores inferiores)'
0.0556 Tw
(a 7. La concentraci\227n plasm\207tica de MTX a 12 horas y a)'
0 -1.09523 TD
-0.0195 Tw
(las 24 horas postinfusi\227n fue de 29,00 mcM y 13,09 mcM,)Tj
0 -1.09525 TD
0.0529 Tw
(respectivamente. Se inici\227 una hiperhidrataci\227n vigorosa,)Tj
0 -1.09523 TD
-0.005 Tc
0.114 Tw
(alcalinizaci\227n urinaria con la administraci\227n de bicarbo-)Tj
0 -1.09524 TD
-0.0051 Tc
0.0783 Tw
(nato s\227dico para facilitar la eliminaci\227n renal de MTX y)Tj
T*
0.015 Tc
0.004 Tw
[(un control estricto del pH urinario \(T)70(abla I\). La Unidad)]TJ
0 -1.09523 TD
0.0149 Tc
0.3176 Tw
(de Farmacocin\216tica del Servicio de Farmacia reco-)Tj
0 -1.09524 TD
-0.005 Tc
0.085 Tw
[(m)-20(e)-20(n)-20(d)-15<97>-15( )-15(aumentar la dosis de rescate con \207cido fol\222nico a)]TJ
-0.0051 Tc
-0.0023 Tw
(100 mg/m)'
5.25 0 0 5.25 84.9527 210.5438 Tm
0 Tc
(2)Tj
10.5 0 0 10.5 87.5515 206.9813 Tm
-0.0051 Tc
(/3 h y la administraci\227n de resincolestiramina a)Tj
-4.28874 -1.09523 TD
-0.0192 Tw
(dosis de 4 g/6 h. La pauta de fol\222nico se fue adaptando a lo)Tj
0 -1.09524 TD
-0.005 Tc
0.003 Tw
[(lar)18(go del tratamiento \(T)69(abla I\). El d\222a +5 ante la persisten-)]TJ
T*
-0.02 Tw
(cia de concentraciones elevadas de MTX se decidi\227 some-)Tj
0 -1.09523 TD
-0.0051 Tc
0 Tw
(ter al paciente a t\216cnicas de eliminaci\227n extracorp\227rea.)Tj
1.07987 -1.09524 TD
-0.0001 Tc
0.0259 Tw
(La evoluci\227n temporal de las concentraciones plasm\207)Tj
21.53449 0.00001 TD
0 Tc
(-)Tj
-22.61435 -1.09525 TD
-0.0001 Tc
0.0266 Tw
(ticas de MTX se muestra en la figura 1. En la figura 2 se)Tj
0 -1.09523 TD
0 Tc
-0.019 Tw
(muestran los valores de creatinina s\216rica durante el episo-)Tj
0 -1.09524 TD
-0.0001 Tc
0.0318 Tw
(dio. El pH urinario se midi\227 en cada turno de enfermer\222a)Tj
0.0289 Tw
((Fig. 3), administr\207ndose un bolo de 20 meq bicarbonato)'
0 -1.09523 TD
0 Tw
(s\227dico si el pH es inferior a 7.)Tj
1.07987 -1.09524 TD
-0.02 Tc
-0.021 Tw
(Los par\207metros farmacocin\216ticos del MTX se han obteni-)Tj
-1.07987 -1.09524 TD
-0.0201 Tc
0.0444 Tw
(do con el programa )Tj
ET
BT
/F5 1 Tf
10.5 0 0 10.5 124.3596 68.9813 Tm
(Pharmacokinetics Systems Abbottbase)Tj
5.25 0 0 5.25 279.4759 72.5438 Tm
0 Tc
<A8>Tj
ET
BT
/F0 1 Tf
10.5 0 0 10.5 42.5197 57.4813 Tm
-0.0202 Tc
(\(PKS)Tj
5.25 0 0 5.25 64.4281 61.0438 Tm
0 Tc
<A8>Tj
10.5 0 0 10.5 68.3119 57.4813 Tm
-0.0201 Tc
0.0418 Tw
(\), mostrando los siguientes valores: )Tj
ET
BT
/F16 1 Tf
10.5 0 0 10.5 213.7762 57.4813 Tm
0 Tc
(a)Tj
ET
BT
/F0 1 Tf
10.5 0 0 10.5 220.1902 57.4813 Tm
-0.0202 Tc
(\(h)Tj
5.25 0 0 5.25 228.5143 61.0438 Tm
(-1)Tj
10.5 0 0 10.5 232.6764 57.4813 Tm
-0.02 Tc
(\)= 0,0309; )Tj
ET
BT
/F16 1 Tf
10.5 0 0 10.5 277.7018 57.4813 Tm
0 Tc
(b)Tj
ET
BT
/F0 1 Tf
8 0 0 8 42.5197 744.001 Tm
(372)Tj
7 0 0 7 245.8385 744.001 Tm
-0.0001 Tc
0 Tw
(M. J. FERN\347NDEZ MEG\352A ET AL.)Tj
35.37494 0.00001 TD
0 Tc
(F)Tj
5.25 0 0 5.25 497.3545 744.001 Tm
-0.0001 Tc
(ARM)Tj
7 0 0 7 511.0631 744.001 Tm
0 Tc
(H)Tj
5.25 0 0 5.25 516.1166 744.001 Tm
-0.0001 Tc
(OSP)Tj
7 0 0 7 527.4937 744.001 Tm
-0.0002 Tc
((Madrid))Tj
ET
0 0 0 0 k
527.244 18.126 25.512 16.673 re
f
BT
/F0 1 Tf
8 0 0 8 544.7559 19.8606 Tm
0 0 0 1 k
0 Tc
(78)Tj
ET
0 0 0 0 k
311.811 338.354 240.945 370.308 re
f
BT
/F17 1 Tf
8.5 0 0 8.5 336.4291 702.2866 Tm
0 0 0 1 k
-0.0002 Tc
(Tabla I.)Tj
ET
BT
/F18 1 Tf
8.5 0 0 8.5 367.6048 702.2866 Tm
-0.0001 Tc
(Plan terap\216utico seguido tras el retraso en la)Tj
ET
0 J 0 j 0.4 i 10 M []0 d 0.5 w 
0 0 0 1 K
311.811 687.785 m
552.756 687.785 l
S
BT
/F18 1 Tf
8.5 0 0 8.5 395.456 692.2866 Tm
(eliminaci\227n del MTX)Tj
ET
BT
/F19 1 Tf
7.65 0 0 8.5 311.811 677.2866 Tm
(Hiperhidrataci\227n vigorosa y alcalinizaci\227n urinaria)Tj
ET
BT
/F18 1 Tf
7.65 0 0 8.5 315.8936 667.2866 Tm
-0.0223 Tc
(Suero glucosado 5% 1.000 cc + 500 meq bicarbonato s\227dico en 1 h)Tj
0.02223 -1.17647 TD
-0.0001 Tc
(En las 4 h siguientes)Tj
1.1118 -1.17647 TD
(500 meq bicarbonato s\227dico)Tj
(Suero glucosado 5% 500 cc + 10 meq ClK)'
(Suero fisiol\227gico 500 cc + 10 meq ClK)'
(Manitol 10% 500 cc + 10 meq ClK)'
-1.12848 -1.17647 TD
-0.017 Tc
-0.021 Tw
[(S)9(uero fisiol\227gico 4.000 cc + 500 meq bicarbonato s\227dico + 100 meq ClK en)]TJ
0.47384 -1.17647 TD
-0.0168 Tc
0 Tw
(24 h d\222a +3)Tj
-0.47384 -1.17647 TD
-0.017 Tc
-0.021 Tw
[(S)9(uero fisiol\227gico 3.000 cc + 500 meq bicarbonato s\227dico + 100 meq ClK en)]TJ
0.47384 -1.17647 TD
-0.0168 Tc
0 Tw
(24 h d\222a +4 y +5)Tj
-0.47384 -1.17647 TD
-0.017 Tc
-0.021 Tw
[(S)9(uero fisiol\227gico 2.000 cc + 500 meq bicarbonato s\227dico + 120 meq ClK en)]TJ
0.47384 -1.17647 TD
-0.0168 Tc
0 Tw
(24 h a partir del d\222a +6)Tj
-0.45717 -1.17647 TD
0 Tc
0.192 Tw
[(B)1(icarbonato s\227dico 850 mg 2 caps/8 h. Si pH urinario < 7)]TJ
ET
BT
/F20 1 Tf
7.65 0 0 8.5 519.1106 547.2866 Tm
<DD>Tj
ET
BT
/F18 1 Tf
7.65 0 0 8.5 526.2114 547.2866 Tm
-0.0001 Tc
0.1916 Tw
(20 meq)Tj
-26.91509 -1.17647 TD
0 Tw
(bicarbonato s\227dico iv en )Tj
ET
BT
/F19 1 Tf
7.65 0 0 8.5 401.9074 537.2866 Tm
(bolus)Tj
-11.77731 -1.88236 TD
(Rescate con \207cido fol\222nico)Tj
ET
BT
/F18 1 Tf
7.65 0 0 8.5 316.0637 511.2866 Tm
0 Tc
0.02 Tw
[(P)10(auta habitual \(60 mg iv de \207cido fol\222nico a las 12 h tras el fin de la per-)]TJ
0.48984 -1.17647 TD
-0.0001 Tc
0 Tw
(fusi\227n + 15 mg/6 h 8 dosis\))Tj
-0.48984 -1.17647 TD
(165 mg/3 h iv d\222a +3)Tj
(200 mg/3 h iv del d\222a +4 al +14)'
(15 mg/6h iv desde el d\222a +15 al +23)'
ET
BT
/F19 1 Tf
7.65 0 0 8.5 311.811 455.2866 Tm
(Diur\216ticos)Tj
ET
BT
/F18 1 Tf
7.65 0 0 8.5 316.0637 445.2866 Tm
(Seguril 20 mg iv en desayuno y comida del d\222a +4 al +13)Tj
0 -1.17647 TD
(Seguril 40 mg iv extra en cena seg\234n diuresis)Tj
ET
BT
/F19 1 Tf
7.65 0 0 8.5 311.811 419.2866 Tm
(Inhibici\227n del ciclo enterohep\207tico)Tj
ET
BT
/F18 1 Tf
7.65 0 0 8.5 316.0637 409.2866 Tm
(Resincolestiramina 4 g/6 h desde el d\222a +3 al +25)Tj
ET
BT
/F19 1 Tf
7.65 0 0 8.5 311.811 393.2866 Tm
(T\216cnicas de eliminaci\227n extracorp\227rea)Tj
ET
BT
/F18 1 Tf
7.65 0 0 8.5 316.0637 383.2866 Tm
0 Tc
[(H)14(emofiltraci\227n 2,5 l + hemodi\207lisis 3 h desde el d\222a +5 al +9 (5 sesiones))]TJ
ET
BT
/F19 1 Tf
7.65 0 0 8.5 311.811 367.2866 Tm
-0.0001 Tc
0.1304 Tw
(Monitorizaci\227n farmacocin\216tica)Tj
ET
BT
/F18 1 Tf
7.65 0 0 8.5 418.3156 367.2866 Tm
(del MTX hasta alcanzar concentraciones)Tj
ET
1 w 
311.811 352.535 m
552.756 352.535 l
S
BT
/F18 1 Tf
7.65 0 0 8.5 311.811 357.2866 Tm
0 Tw
(plasm\207ticas seguras)Tj
ET
/GS0 gs
0 0 0 0 k
312.061 101.373 240.445 223.235 re
f
q
312.061 101.373 240.445 223.235 re
W n
/GS1 gs
/Fm0 Do
Q
/GS2 gs
0.5 w 
312.061 101.373 240.445 223.235 re
s
311.811 56.024 240.945 36.182 re
f
BT
/F18 1 Tf
8 0 0 8 311.811 86.2057 Tm
0 0 0 1 k
-0.0002 Tc
0.2607 Tw
(Fig. 1.- )Tj
ET
BT
/F19 1 Tf
8 0 0 8 341.7562 86.2057 Tm
-0.0001 Tc
(Evoluci\227n de la concentraci\227n plasm\207tica  de metotrexato)Tj
-3.74315 -1.1875 TD
0.0707 Tw
(durante el ingreso del paciente. Concentraciones plasm\207ticas de MTX)Tj
-0.0002 Tc
0.1423 Tw
(en mcM \(C)'
4 0 0 4 351.4139 65.6057 Tm
-0.0001 Tc
(MTX)Tj
8 0 0 8 359.4129 67.2057 Tm
0 Tc
0.142 Tw
(\) a los distintos tiempos  de muestreo \(horas postinfu-)Tj
-5.95024 -1.1875 TD
-0.0001 Tc
0 Tw
(si\227n\). *Muestras plasm\207ticas obtenidas tras la di\207lisis.)Tj
ET
Q
endstream
endobj
7 0 obj
<<
/SA true
/OPM 1
/Type/ExtGState
/OP false
>>
endobj
8 0 obj
<<
/SA true
/OPM 1
/Type/ExtGState
/OP true
>>
endobj
11 0 obj
<<
/Length 5930
/Resources<</Font<</F21 12 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS1 7 0 R/GS3 8 0 R>>>>
/BBox[-0.23091 -3.19338 2.43849 1.55932]
/Subtype/Form
/OPI<</2.0<<
/Type/OPI
/F(ANTONIO:  REVISTAS:FARMACIA HOSP. :FARM HOSPITAL 28-5:09. M.J. Fern\207ndez:Fig. 2)
/Overprint false
/CropRect[0 0 223 167]
/IncludedImageQuality 1
/Size[223 167]
/Inks/full_color
/Version 2
>>
>>
/Type/XObject
/FormType 1
/Name/Fm3
/Matrix[1 0 0 1 0 0]
>>
stream
/GS1 gs
0 J 0 j 0.4 i 3.8637 M []0 d 0.0026 w 
0 0 0 1 K
0.1332 0.9695 m
0.1332 0.1415 l
0.975 0.1415 l
S
0.1602 0.3165 m
0.2152 0.6382 l
0.246 0.6364 l
0.2742 0.7357 l
0.3037 0.7391 l
0.3575 0.6193 l
0.3869 0.5064 l
0.4407 0.621 l
0.4715 0.5252 l
0.4984 0.5526 l
0.5279 0.5988 l
0.6124 0.479 l
0.6406 0.5235 l
0.6688 0.491 l
0.6957 0.4072 l
0.7252 0.4277 l
0.8059 0.4517 l
0.8354 0.4021 l
0.8584 0.4226 l
S
0.9228 0.1404 m
0.9228 0.1248 l
S
/GS3 gs
BT
/F21 1 Tf
0.03587 0 0 0.0479 0.1232 0.0847 Tm
0 0 0 1 k
(0)Tj
ET
/GS1 gs
0.1529 0.3015 m
0.1567 0.3103 l
0.1605 0.3192 l
0.1644 0.3103 l
0.1682 0.3015 l
0.1605 0.3015 l
f
0.1529 0.3015 m
0.1567 0.3103 l
0.1605 0.3192 l
0.1644 0.3103 l
0.1682 0.3015 l
0.1605 0.3015 l
s
0.9739 0.1404 m
0.9739 0.1248 l
S
0.8663 0.1404 m
0.8663 0.1248 l
S
0.8098 0.1404 m
0.8098 0.1248 l
S
0.7515 0.1404 m
0.7515 0.1248 l
S
0.6977 0.1404 m
0.6977 0.1248 l
S
0.6394 0.1404 m
0.6394 0.1248 l
S
0.5865 0.1404 m
0.5865 0.1248 l
S
0.5282 0.1404 m
0.5282 0.1248 l
S
0.473 0.1404 m
0.473 0.1248 l
S
0.4156 0.1404 m
0.4156 0.1248 l
S
0.3591 0.1404 m
0.3591 0.1248 l
S
0.3017 0.1404 m
0.3017 0.1248 l
S
0.2488 0.1404 m
0.2488 0.1248 l
S
0.1914 0.1404 m
0.1914 0.1248 l
S
0.1332 0.1404 m
0.1332 0.1248 l
S
/GS3 gs
BT
/F21 1 Tf
0.03587 0 0 0.0479 0.1813 0.0847 Tm
[(2)-1021(4)-929(6)-1057(8)-754(10)-481(12)-399(14)-552(16)-335(18)-531(20)-436(22)-503(24)-432(26)-415(28)-327(30)]TJ
ET
/GS1 gs
0.1324 0.1413 m
0.1207 0.1413 l
S
0.1324 0.256 m
0.1207 0.256 l
S
0.1324 0.3771 m
0.1207 0.3771 l
S
0.1324 0.4969 m
0.1207 0.4969 l
S
0.1324 0.6164 m
0.1207 0.6164 l
S
0.1324 0.7364 m
0.1207 0.7364 l
S
0.1324 0.8562 m
0.1207 0.8562 l
S
0.1324 0.9677 m
0.1207 0.9677 l
S
/GS3 gs
BT
/F21 1 Tf
0.03587 0 0 0.0479 0.0932 0.9553 Tm
(4)Tj
-0.83373 -2.47501 TD
(3,5)Tj
0.83373 -2.475 TD
(3)Tj
-0.83373 -2.47499 TD
(2,5)Tj
0.83373 -2.47501 TD
(2)Tj
-0.83373 -2.47499 TD
(1,5)Tj
0.83373 -2.47501 TD
(1)Tj
-0.83373 -2.475 TD
(0,5)Tj
10.55369 -2.18779 TD
(D\222a de ingreso)Tj
0 0.0479 -0.03587 0 0.0349 0.2655 Tm
(Creatinina plasm\207tica (mg/dl))Tj
ET
/GS1 gs
0.2103 0.632 m
0.2141 0.6409 l
0.2179 0.6497 l
0.2218 0.6409 l
0.2256 0.632 l
0.2179 0.632 l
f
0.2103 0.632 m
0.2141 0.6409 l
0.2179 0.6497 l
0.2218 0.6409 l
0.2256 0.632 l
0.2179 0.632 l
s
0.239 0.6344 m
0.2428 0.6433 l
0.2466 0.6521 l
0.2505 0.6433 l
0.2543 0.6344 l
0.2466 0.6344 l
f
0.239 0.6344 m
0.2428 0.6433 l
0.2466 0.6521 l
0.2505 0.6433 l
0.2543 0.6344 l
0.2466 0.6344 l
s
0.2641 0.7266 m
0.2679 0.7355 l
0.2718 0.7443 l
0.2756 0.7355 l
0.2794 0.7266 l
0.2718 0.7266 l
f
0.2641 0.7266 m
0.2679 0.7355 l
0.2718 0.7443 l
0.2756 0.7355 l
0.2794 0.7266 l
0.2718 0.7266 l
s
0.2964 0.729 m
0.3002 0.7379 l
0.304 0.7467 l
0.3079 0.7379 l
0.3117 0.729 l
0.304 0.729 l
f
0.2964 0.729 m
0.3002 0.7379 l
0.304 0.7467 l
0.3079 0.7379 l
0.3117 0.729 l
0.304 0.729 l
s
0.3502 0.6093 m
0.354 0.6181 l
0.3579 0.627 l
0.3617 0.6181 l
0.3655 0.6093 l
0.3579 0.6093 l
f
0.3502 0.6093 m
0.354 0.6181 l
0.3579 0.627 l
0.3617 0.6181 l
0.3655 0.6093 l
0.3579 0.6093 l
s
0.3789 0.4979 m
0.3827 0.5068 l
0.3866 0.5156 l
0.3904 0.5068 l
0.3942 0.4979 l
0.3866 0.4979 l
f
0.3789 0.4979 m
0.3827 0.5068 l
0.3866 0.5156 l
0.3904 0.5068 l
0.3942 0.4979 l
0.3866 0.4979 l
s
0.4363 0.6069 m
0.4401 0.6157 l
0.444 0.6246 l
0.4478 0.6157 l
0.4516 0.6069 l
0.444 0.6069 l
f
0.4363 0.6069 m
0.4401 0.6157 l
0.444 0.6246 l
0.4478 0.6157 l
0.4516 0.6069 l
0.444 0.6069 l
s
0.4632 0.5171 m
0.467 0.5259 l
0.4709 0.5348 l
0.4747 0.5259 l
0.4785 0.5171 l
0.4709 0.5171 l
f
0.4632 0.5171 m
0.467 0.5259 l
0.4709 0.5348 l
0.4747 0.5259 l
0.4785 0.5171 l
0.4709 0.5171 l
s
0.491 0.5422 m
0.4948 0.5511 l
0.4987 0.5599 l
0.5025 0.5511 l
0.5063 0.5422 l
0.4987 0.5422 l
f
0.491 0.5422 m
0.4948 0.5511 l
0.4987 0.5599 l
0.5025 0.5511 l
0.5063 0.5422 l
0.4987 0.5422 l
s
0.5197 0.5877 m
0.5235 0.5966 l
0.5274 0.6054 l
0.5312 0.5966 l
0.535 0.5877 l
0.5274 0.5877 l
f
0.5197 0.5877 m
0.5235 0.5966 l
0.5274 0.6054 l
0.5312 0.5966 l
0.535 0.5877 l
0.5274 0.5877 l
s
0.5744 0.5159 m
0.5783 0.5247 l
0.5821 0.5336 l
0.5859 0.5247 l
0.5897 0.5159 l
0.5821 0.5159 l
f
0.5744 0.5159 m
0.5783 0.5247 l
0.5821 0.5336 l
0.5859 0.5247 l
0.5897 0.5159 l
0.5821 0.5159 l
s
0.6049 0.4716 m
0.6087 0.4804 l
0.6126 0.4892 l
0.6164 0.4804 l
0.6202 0.4716 l
0.6126 0.4716 l
f
0.6049 0.4716 m
0.6087 0.4804 l
0.6126 0.4892 l
0.6164 0.4804 l
0.6202 0.4716 l
0.6126 0.4716 l
s
0.6345 0.5147 m
0.6383 0.5235 l
0.6422 0.5324 l
0.646 0.5235 l
0.6498 0.5147 l
0.6422 0.5147 l
f
0.6345 0.5147 m
0.6383 0.5235 l
0.6422 0.5324 l
0.646 0.5235 l
0.6498 0.5147 l
0.6422 0.5147 l
s
0.6596 0.4871 m
0.6635 0.496 l
0.6673 0.5048 l
0.6711 0.496 l
0.6749 0.4871 l
0.6673 0.4871 l
f
0.6596 0.4871 m
0.6635 0.496 l
0.6673 0.5048 l
0.6711 0.496 l
0.6749 0.4871 l
0.6673 0.4871 l
s
0.6874 0.4033 m
0.6913 0.4121 l
0.6951 0.421 l
0.6989 0.4121 l
0.7027 0.4033 l
0.6951 0.4033 l
f
0.6874 0.4033 m
0.6913 0.4121 l
0.6951 0.421 l
0.6989 0.4121 l
0.7027 0.4033 l
0.6951 0.4033 l
s
0.7161 0.4177 m
0.72 0.4265 l
0.7238 0.4354 l
0.7276 0.4265 l
0.7314 0.4177 l
0.7238 0.4177 l
f
0.7161 0.4177 m
0.72 0.4265 l
0.7238 0.4354 l
0.7276 0.4265 l
0.7314 0.4177 l
0.7238 0.4177 l
s
0.7726 0.4428 m
0.7765 0.4517 l
0.7803 0.4605 l
0.7841 0.4517 l
0.7879 0.4428 l
0.7803 0.4428 l
f
0.7726 0.4428 m
0.7765 0.4517 l
0.7803 0.4605 l
0.7841 0.4517 l
0.7879 0.4428 l
0.7803 0.4428 l
s
0.7968 0.444 m
0.8007 0.4529 l
0.8045 0.4617 l
0.8083 0.4529 l
0.8121 0.444 l
0.8045 0.444 l
f
0.7968 0.444 m
0.8007 0.4529 l
0.8045 0.4617 l
0.8083 0.4529 l
0.8121 0.444 l
0.8045 0.444 l
s
0.8273 0.3973 m
0.8312 0.4062 l
0.835 0.415 l
0.8388 0.4062 l
0.8426 0.3973 l
0.835 0.3973 l
f
0.8273 0.3973 m
0.8312 0.4062 l
0.835 0.415 l
0.8388 0.4062 l
0.8426 0.3973 l
0.835 0.3973 l
s
0.8551 0.4177 m
0.859 0.4265 l
0.8628 0.4354 l
0.8666 0.4265 l
0.8704 0.4177 l
0.8628 0.4177 l
f
0.8551 0.4177 m
0.859 0.4265 l
0.8628 0.4354 l
0.8666 0.4265 l
0.8704 0.4177 l
0.8628 0.4177 l
s
endstream
endobj
13 0 obj
<<
/Length 51
/Resources<</ProcSet[/PDF]/ExtGState<</GS1 7 0 R>>/XObject<</Fm3 11 0 R>>>>
/BBox[0 0 595.27594 793.70093]
/Subtype/Form
/OPI<</1.3<<
/Type/OPI
/F(ANTONIO:  REVISTAS:FARMACIA HOSP. :FARM HOSPITAL 28-5:09. M.J. Fern\207ndez:Fig. 2)
/Position[51.492 532.59302 51.492 699.59302 274.492 699.59302 274.492 532.59302]
/CropFixed[0 0 223 167]
/CropRect[0 0 223 167]
/Size[223 167]
/Version 1.3
>>
>>
/Type/XObject
/FormType 1
/Name/Fm2
/Matrix[1 0 0 1 0 0]
>>
stream
/GS1 gs
q
223 0 0 167 51.492 533.2939 cm
/Fm3 Do
Q
endstream
endobj
14 0 obj
<<
/Length 5127
/Resources<</Font<</F18 6 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS1 7 0 R/GS3 8 0 R>>>>
/BBox[-0.20559 -2.7787 2.37136 3.72705]
/Subtype/Form
/OPI<</2.0<<
/Type/OPI
/F(ANTONIO:  REVISTAS:FARMACIA HOSP. :FARM HOSPITAL 28-5:09. M.J. Fern\207ndez:Fig. 3)
/Overprint false
/CropRect[0 0 231 122]
/IncludedImageQuality 1
/Size[231 122]
/Inks/full_color
/Version 2
>>
>>
/Type/XObject
/FormType 1
/Name/Fm5
/Matrix[1 0 0 1 0 0]
>>
stream
/GS1 gs
0 J 0 j 0.4 i 3.8637 M []0 d 0.003 w 
0 0 0 1 K
0.2006 0.3852 m
0.2006 0.4809 l
0.2771 0.4809 l
0.2771 0.3825 l
0.355 0.3825 l
0.355 0.6803 l
0.4343 0.5765 l
0.4343 0.6803 l
0.5902 0.6803 l
0.6667 0.5765 l
0.6667 0.877 l
0.7431 0.6776 l
0.7431 0.8661 l
0.824 0.6776 l
S
0.4329 0.5792 m
0.4329 0.4754 l
S
/GS3 gs
BT
/F18 1 Tf
0.03463 0 0 0.06557 0.4465 0.028 Tm
0 0 0 1 k
0 Tc
(D\222a de ingreso)Tj
ET
/GS1 gs
0.5017 0.6642 m
0.5054 0.6763 l
0.5091 0.6884 l
0.5128 0.6763 l
0.5165 0.6642 l
0.5091 0.6642 l
f
0.5017 0.6642 m
0.5054 0.6763 l
0.5091 0.6884 l
0.5128 0.6763 l
0.5165 0.6642 l
0.5091 0.6642 l
s
0.5825 0.6696 m
0.5862 0.6817 l
0.5899 0.6938 l
0.5936 0.6817 l
0.5973 0.6696 l
0.5899 0.6696 l
f
0.5825 0.6696 m
0.5862 0.6817 l
0.5899 0.6938 l
0.5936 0.6817 l
0.5973 0.6696 l
0.5899 0.6696 l
s
0.659 0.5685 m
0.6627 0.5806 l
0.6664 0.5927 l
0.6701 0.5806 l
0.6738 0.5685 l
0.6664 0.5685 l
f
0.659 0.5685 m
0.6627 0.5806 l
0.6664 0.5927 l
0.6701 0.5806 l
0.6738 0.5685 l
0.6664 0.5685 l
s
0.659 0.8663 m
0.6627 0.8784 l
0.6664 0.8906 l
0.6701 0.8784 l
0.6738 0.8663 l
0.6664 0.8663 l
f
0.659 0.8663 m
0.6627 0.8784 l
0.6664 0.8906 l
0.6701 0.8784 l
0.6738 0.8663 l
0.6664 0.8663 l
s
0.7348 0.6696 m
0.7385 0.6817 l
0.7422 0.6938 l
0.7459 0.6817 l
0.7496 0.6696 l
0.7422 0.6696 l
f
0.7348 0.6696 m
0.7385 0.6817 l
0.7422 0.6938 l
0.7459 0.6817 l
0.7496 0.6696 l
0.7422 0.6696 l
s
0.7369 0.8527 m
0.7406 0.8648 l
0.7443 0.8769 l
0.748 0.8648 l
0.7517 0.8527 l
0.7443 0.8527 l
f
0.7369 0.8527 m
0.7406 0.8648 l
0.7443 0.8769 l
0.748 0.8648 l
0.7517 0.8527 l
0.7443 0.8527 l
s
0.8149 0.6669 m
0.8186 0.679 l
0.8223 0.6911 l
0.8259 0.679 l
0.8296 0.6669 l
0.8223 0.6669 l
f
0.8149 0.6669 m
0.8186 0.679 l
0.8223 0.6911 l
0.8259 0.679 l
0.8296 0.6669 l
0.8223 0.6669 l
s
0.4253 0.4674 m
0.429 0.4795 l
0.4326 0.4917 l
0.4363 0.4795 l
0.44 0.4674 l
0.4326 0.4674 l
f
0.4253 0.4674 m
0.429 0.4795 l
0.4326 0.4917 l
0.4363 0.4795 l
0.44 0.4674 l
0.4326 0.4674 l
s
0.4274 0.5685 m
0.4311 0.5806 l
0.4348 0.5927 l
0.4385 0.5806 l
0.4422 0.5685 l
0.4348 0.5685 l
f
0.4274 0.5685 m
0.4311 0.5806 l
0.4348 0.5927 l
0.4385 0.5806 l
0.4422 0.5685 l
0.4348 0.5685 l
s
0.4267 0.6669 m
0.4304 0.679 l
0.4341 0.6911 l
0.4378 0.679 l
0.4415 0.6669 l
0.4341 0.6669 l
f
0.4267 0.6669 m
0.4304 0.679 l
0.4341 0.6911 l
0.4378 0.679 l
0.4415 0.6669 l
0.4341 0.6669 l
s
0.3459 0.6669 m
0.3496 0.679 l
0.3533 0.6911 l
0.357 0.679 l
0.3607 0.6669 l
0.3533 0.6669 l
f
0.3459 0.6669 m
0.3496 0.679 l
0.3533 0.6911 l
0.357 0.679 l
0.3607 0.6669 l
0.3533 0.6669 l
s
0.3473 0.5658 m
0.351 0.5779 l
0.3547 0.59 l
0.3584 0.5779 l
0.3621 0.5658 l
0.3547 0.5658 l
f
0.3473 0.5658 m
0.351 0.5779 l
0.3547 0.59 l
0.3584 0.5779 l
0.3621 0.5658 l
0.3547 0.5658 l
s
0.3473 0.4674 m
0.351 0.4795 l
0.3547 0.4917 l
0.3584 0.4795 l
0.3621 0.4674 l
0.3547 0.4674 l
f
0.3473 0.4674 m
0.351 0.4795 l
0.3547 0.4917 l
0.3584 0.4795 l
0.3621 0.4674 l
0.3547 0.4674 l
s
0.3481 0.3732 m
0.3518 0.3853 l
0.3554 0.3974 l
0.3591 0.3853 l
0.3628 0.3732 l
0.3554 0.3732 l
f
0.3481 0.3732 m
0.3518 0.3853 l
0.3554 0.3974 l
0.3591 0.3853 l
0.3628 0.3732 l
0.3554 0.3732 l
s
0.2701 0.3732 m
0.2738 0.3853 l
0.2775 0.3974 l
0.2812 0.3853 l
0.2849 0.3732 l
0.2775 0.3732 l
f
0.2701 0.3732 m
0.2738 0.3853 l
0.2775 0.3974 l
0.2812 0.3853 l
0.2849 0.3732 l
0.2775 0.3732 l
s
0.2694 0.4702 m
0.2731 0.4823 l
0.2768 0.4944 l
0.2805 0.4823 l
0.2842 0.4702 l
0.2768 0.4702 l
f
0.2694 0.4702 m
0.2731 0.4823 l
0.2768 0.4944 l
0.2805 0.4823 l
0.2842 0.4702 l
0.2768 0.4702 l
s
0.1929 0.3732 m
0.1966 0.3853 l
0.2003 0.3974 l
0.204 0.3853 l
0.2077 0.3732 l
0.2003 0.3732 l
f
0.1929 0.3732 m
0.1966 0.3853 l
0.2003 0.3974 l
0.204 0.3853 l
0.2077 0.3732 l
0.2003 0.3732 l
s
0.1929 0.4743 m
0.1966 0.4864 l
0.2003 0.4985 l
0.204 0.4864 l
0.2077 0.4743 l
0.2003 0.4743 l
f
0.1929 0.4743 m
0.1966 0.4864 l
0.2003 0.4985 l
0.204 0.4864 l
0.2077 0.4743 l
0.2003 0.4743 l
s
/GS3 gs
BT
/F18 1 Tf
0 0.06557 -0.03463 0 0.0321 0.4199 Tm
(pH urinario)Tj
0.03463 0 0 0.06557 0.1137 0.1049 Tm
[(0)-1650(1)-1680(2)-1713(3)-1618(4)-1696(5)-1806(6)-1681(7)-1603(8)-1691(9)-1471(10)-1034(11)]TJ
-0.99453 12.71046 TD
(9)Tj
-0.83375 -1.475 TD
(8,5)Tj
0.83375 -1.475 TD
(8)Tj
-0.83375 -1.47501 TD
(7,5)Tj
0.83375 -1.475 TD
(7)Tj
-0.83375 -1.47501 TD
(6,5)Tj
0.83375 -1.47498 TD
(6)Tj
-0.83375 -1.47504 TD
(5,5)Tj
0.83375 -1.475 TD
(5)Tj
ET
/GS1 gs
0.124 0.9675 m
0.124 0.1887 l
0.9769 0.1887 l
S
0.2775 0.1892 m
0.2775 0.1679 l
S
0.1231 0.1888 m
0.1119 0.1888 l
S
0.2002 0.1892 m
0.2002 0.1679 l
S
0.1239 0.1892 m
0.1239 0.1679 l
S
0.3565 0.1892 m
0.3565 0.1679 l
S
0.4328 0.1892 m
0.4328 0.1679 l
S
0.5108 0.1892 m
0.5108 0.1679 l
S
0.5898 0.1892 m
0.5898 0.1679 l
S
0.6671 0.1892 m
0.6671 0.1679 l
S
0.7429 0.1892 m
0.7429 0.1679 l
S
0.823 0.1892 m
0.823 0.1679 l
S
0.8998 0.1892 m
0.8998 0.1679 l
S
0.9756 0.1892 m
0.9756 0.1679 l
S
0.1231 0.2826 m
0.1119 0.2826 l
S
0.1231 0.3779 m
0.1119 0.3779 l
S
0.1231 0.4804 m
0.1119 0.4804 l
S
0.1231 0.5746 m
0.1119 0.5746 l
S
0.1231 0.6771 m
0.1119 0.6771 l
S
0.1231 0.7724 m
0.1119 0.7724 l
S
0.1231 0.8738 m
0.1119 0.8738 l
S
0.1231 0.9653 m
0.1119 0.9653 l
S
endstream
endobj
15 0 obj
<<
/Length 50
/Resources<</ProcSet[/PDF]/ExtGState<</GS1 7 0 R>>/XObject<</Fm5 14 0 R>>>>
/BBox[0 0 595.27594 793.70093]
/Subtype/Form
/OPI<</1.3<<
/Type/OPI
/F(ANTONIO:  REVISTAS:FARMACIA HOSP. :FARM HOSPITAL 28-5:09. M.J. Fern\207ndez:Fig. 3)
/Position[47.492 338.29999 47.492 460.29999 278.492 460.29999 278.492 338.29999]
/CropFixed[0 0 231 122]
/CropRect[0 0 231 122]
/Size[231 122]
/Version 1.3
>>
>>
/Type/XObject
/FormType 1
/Name/Fm4
/Matrix[1 0 0 1 0 0]
>>
stream
/GS1 gs
q
231 0 0 122 47.492 339.001 cm
/Fm5 Do
Q
endstream
endobj
16 0 obj
<<
/Length 11770
>>
stream
/GS0 gs
q
0 0.701 595 793 re
W n
1 g
0 793.701 0 0 re
f
Q
/GS0 gs
/GS2 gs
0 0 0 0 k
42.52 51.024 510.236 657.638 re
f
q
BT
/F0 1 Tf
10.5 0 0 10.5 42.5197 253.6037 Tm
0 Tr
0 0 0 1 k
-0.0202 Tc
(\(h)Tj
5.25 0 0 5.25 50.8438 257.1662 Tm
(-1)Tj
10.5 0 0 10.5 55.0058 253.6037 Tm
-0.0201 Tc
0.1719 Tw
(\)= 0,001; K)Tj
5.25 0 0 5.25 105.0941 251.5037 Tm
-0.02 Tc
(12 )Tj
10.5 0 0 10.5 112.244 253.6037 Tm
-0.0202 Tc
(\(h)Tj
5.25 0 0 5.25 120.5681 257.1662 Tm
(-1)Tj
10.5 0 0 10.5 124.7302 253.6037 Tm
-0.02 Tc
(\)= 0,0008; K)Tj
5.25 0 0 5.25 179.8584 251.5037 Tm
(21 )Tj
10.5 0 0 10.5 187.0084 253.6037 Tm
-0.0202 Tc
(\(h)Tj
5.25 0 0 5.25 195.3325 257.1662 Tm
(-1)Tj
10.5 0 0 10.5 199.4946 253.6037 Tm
-0.02 Tc
(\)= 0,0013; K)Tj
5.25 0 0 5.25 254.6228 251.5037 Tm
(13 )Tj
10.5 0 0 10.5 261.7728 253.6037 Tm
-0.0202 Tc
(\(h)Tj
5.25 0 0 5.25 270.0969 257.1662 Tm
(-1)Tj
10.5 0 0 10.5 274.259 253.6037 Tm
-0.0203 Tc
(\)=)Tj
-22.07041 -1.09524 TD
-0.0201 Tc
0 Tw
(0,0301; Vc (l/kg)= 1,39; Cl (l/kg.h)= 0,041; t)Tj
5.25 0 0 5.25 222.305 240.0037 Tm
(1/2)Tj
ET
BT
/F16 1 Tf
5.25 0 0 5.25 228.6986 240.0037 Tm
0 Tc
(b)Tj
ET
BT
/F0 1 Tf
10.5 0 0 10.5 233.89 242.1037 Tm
-0.0201 Tc
((h)= 537.)Tj
-17.14588 -1.09523 TD
-0.0101 Tc
0.0564 Tw
(El d\222a +6 el paciente present\227 anemia grado 4 seg\234n la)Tj
-1.07987 -1.09524 TD
0.0011 Tw
(escala de la OMS. Ante el riesgo de retrasar la eliminaci\227n)Tj
-0.0131 Tw
(de MTX se decidi\227 posponer la transfusi\227n de concentrado)'
0 -1.09523 TD
-0.01 Tc
0.004 Tw
(de hemat\222es (CH). El d\222a +7 se transfundieron CH por per-)Tj
0 -1.09524 TD
-0.0101 Tc
-0.0176 Tw
(sistencia y empeoramiento de la anemia. Desde el d\222a +8 al)Tj
T*
-0.01 Tc
-0.014 Tw
[(+13 el paciente present\227 aplasia medular)40(, precisando trans-)]TJ
0 -1.09523 TD
-0.0101 Tc
0.0653 Tw
(fusi\227n de plaquetas, CH y administraci\227n de G-CSF \(fac)Tj
22.61436 0.00001 TD
0 Tc
(-)Tj
-22.61436 -1.09525 TD
-0.0101 Tc
0.1617 Tw
(tor estimulante de colonias de granulocitos\) hasta el d\222a)Tj
0 -1.09524 TD
-0.01 Tc
0.009 Tw
(+18. Se traslad\227 al paciente a una habitaci\227n de aislamien-)Tj
0 -1.09523 TD
-0.0101 Tc
0.298 Tw
(to, procedimiento utilizado en la sala de Hematolog\222a)Tj
0 -1.09524 TD
0.0786 Tw
(cuando las cifras de neutr\227filos descienden por debajo de)Tj
T*
-0.01 Tc
0.109 Tw
(500/mcl. El paciente present\227 edemas en miembros infe-)Tj
0 -1.09523 TD
-0.0101 Tc
0.0521 Tw
(riores, manos y cara desde el d\222a +2 al d\222a +10 a pesar de)Tj
0 -1.09524 TD
0.2509 Tw
(forzar la diuresis con furosemida. El d\222a +12 apareci\227)Tj
-0.0205 Tw
(mucositis grado 1-2 y fiebre de 38,2 \274C \(desde el d\222a +12 al)'
0 -1.09523 TD
-0.01 Tc
0.058 Tw
(+18\), por lo que se inici\227 tratamiento antibi\227tico con imi-)Tj
25.64679 61.27405 TD
0.086 Tw
(penem. El d\222a +19 el paciente sufri\227 un cuadro confusio-)Tj
0 -1.09524 TD
0.041 Tw
(nal, con p\216rdida de conciencia, crisis convulsivas precedi-)Tj
0 -1.09523 TD
-0.0101 Tc
0.0207 Tw
(das de espasmos abdominales e hipoton\222a generalizada sin)Tj
0 -1.09524 TD
0.028 Tw
(relajaci\227n de esf\222nteres, que cedi\227 de forma espont\207nea en)Tj
0.0614 Tw
(5-10 minutos. Este cuadro se repiti\227 en tres ocasiones. Se)'
0 -1.09523 TD
-0.01 Tc
0.036 Tw
(propusieron como posibles causas de este cuadro una vas-)Tj
0 -1.09524 TD
-0.0101 Tc
0.0794 Tw
(culitis por el linfoma, toxicidad por imipenem. Se realiz\227)Tj
0 -1.09523 TD
-0.01 Tc
0.06 Tw
[(una T)80(AC cerebral que no mostr\227 alteraciones. Se retir\227 el)]TJ
0 -1.09524 TD
-0.012 Tw
[(imipenem y se inici\227 tratamiento con una dosis de car)18(ga de)]TJ
T*
0.006 Tw
(fenito\222na de 1.000 mg, seguido de 300 mg al d\222a. Se moni-)Tj
0 -1.09523 TD
-0.0101 Tc
-0.0026 Tw
(torizaron las concentraciones plasm\207ticas de fenito\222na para)Tj
0 -1.09524 TD
0.3703 Tw
(asegurar concentraciones eficaces dentro del intervalo)Tj
0.1422 Tw
(terap\216utico. Como consecuencia se ajust\227 la posolog\222a a)'
0 -1.09523 TD
-0.01 Tc
0.008 Tw
(400 mg/d\222a de fenito\222na. Se realiz\227 una RMN que no mos-)Tj
0 -1.09524 TD
-0.0101 Tc
0.0372 Tw
(tr\227 focalidad neurol\227gica. El electroencefalograma mostr\227)Tj
0 -1.09523 TD
-0.01 Tc
0.169 Tw
[(sufrimiento temporal derecho y)65(, tras punci\227n lumbar)40(, se)]TJ
0 -1.09525 TD
0.127 Tw
(descart\227 afectaci\227n microbiana. El paciente tambi\216n pre-)Tj
0 -1.09523 TD
-0.0101 Tc
-0.004 Tw
(sent\227 un cuadro cerebeloso con desorientaci\227n, dismetr\222a e)Tj
0.1411 Tw
(inestabilidad en la marcha. Ambos cuadros neurol\227gicos)'
0 -1.09524 TD
-0.0151 Tc
0.1068 Tw
(desaparecieron en pocos d\222as con el tratamiento con feni-)Tj
T*
-0.01 Tc
-0.021 Tw
[(t)5(o)5(\222na. El paciente fue dado de alta el d\222a +29, tras recupera-)]TJ
-0.0101 Tc
0.092 Tw
(ci\227n hematol\227gica hasta un recuento de 6.800 leucocitos,)'
-0.01 Tc
(4.000/)'
ET
BT
/F16 1 Tf
10.5 0 0 10.5 337.7236 448.4813 Tm
0 Tc
(m)Tj
ET
BT
/F0 1 Tf
10.5 0 0 10.5 343.6684 448.4813 Tm
-0.0101 Tc
0.7454 Tw
(l neutr\227filos, 9,8 g/dl de hemoglobina y)Tj
-3.03403 -1.09524 TD
0.0099 Tc
(136.000/mm)Tj
5.25 0 0 5.25 366.2372 440.5438 Tm
0 Tc
(3)Tj
10.5 0 0 10.5 373.2355 436.9813 Tm
0.0099 Tc
0.1515 Tw
(plaquetas, y mejor\222a de la funci\227n renal)Tj
-5.84995 -1.09524 TD
-0.0251 Tc
0.003 Tw
((Cr= 1,7 mg/dl). Posteriormente, el paciente sigui\227 con el es-)Tj
0.0145 Tw
(quema HyperCV)'
6.36366 0 TD
(AD, aunque s\227lo se le administraron prime)Tj
16.25073 0 TD
0 Tc
(-)Tj
-22.61438 -1.09525 TD
-0.025 Tc
0 Tw
[(ras partes. T)35(ras los 6 ciclos obtuvo respuesta completa. )]TJ
ET
BT
/F3 1 Tf
10.5 0 0 10.5 311.811 367.9813 Tm
-0.0002 Tc
(COMENT)Tj
4.5603 0 TD
-0.0001 Tc
(ARIO)Tj
ET
BT
/F0 1 Tf
10.5 0 0 10.5 323.1496 344.9813 Tm
0 Tc
(V)Tj
0.59609 0 TD
-0.0151 Tc
0.0515 Tw
(arios autores han relacionado concentraciones plasm\207)Tj
20.93843 0 TD
0 Tc
(-)Tj
-22.61438 -1.09525 TD
-0.0151 Tc
-0.019 Tw
(ticas de MTX mayores de 1 )Tj
ET
BT
/F16 1 Tf
10.5 0 0 10.5 425.4731 333.4813 Tm
0 Tc
(m)Tj
ET
BT
/F0 1 Tf
10.5 0 0 10.5 431.3654 333.4813 Tm
-0.0151 Tc
(M a las 42 h desde el inicio de)Tj
-11.38613 -1.09524 TD
-0.015 Tc
0.061 Tw
(la infusi\227n con un mayor riesgo de toxicidad gastrointesti-)Tj
0 -1.09523 TD
-0.0151 Tc
-0.0103 Tw
(nal y medular (1,8,9). El paciente muestra, 48 h despu\216s del)Tj
0 -1.09524 TD
0.1236 Tw
(inicio de la infusi\227n (C24 h postifusi\227n), concentraciones)Tj
0 -1.09523 TD
-0.015 Tc
-0.0208 Tw
(de 13,09 )Tj
ET
BT
/F16 1 Tf
10.5 0 0 10.5 348.7417 287.4814 Tm
0 Tc
(m)Tj
ET
BT
/F0 1 Tf
10.5 0 0 10.5 354.634 287.4814 Tm
-0.0151 Tc
(M. Por su parte, Borsi et al indican que la exposi)Tj
18.53596 0.00001 TD
0 Tc
(-)Tj
-22.61434 -1.09525 TD
-0.0151 Tc
0.0197 Tw
(ci\227n a concentraciones plasm\207ticas de MTX por encima de)Tj
0 -1.09523 TD
-0.015 Tc
0.0323 Tw
(0,05 )Tj
ET
BT
/F16 1 Tf
10.5 0 0 10.5 332.3626 264.4813 Tm
0 Tc
(m)Tj
ET
BT
/F0 1 Tf
10.5 0 0 10.5 338.2549 264.4813 Tm
-0.0151 Tc
(M a las 48 h postinfusi\227n, se asocia con un aumento)Tj
-2.51847 -1.09524 TD
0.1042 Tw
(de toxicidad (5). En este caso la concentraci\227n a las 48 h)Tj
0.0344 Tw
(postinfusi\227n fue de 7,79 )'
ET
BT
/F16 1 Tf
10.5 0 0 10.5 413.4206 241.4813 Tm
0 Tc
(m)Tj
ET
BT
/F0 1 Tf
10.5 0 0 10.5 419.3129 241.4813 Tm
-0.0151 Tc
(M. Hasta las 288 horas (12 d\222as))Tj
-10.23827 -1.09523 TD
0.2256 Tw
(postinfusi\227n no se alcanzan concentraciones plasm\207ticas)Tj
0 -1.09524 TD
-0.0158 Tw
(seguras \(menores de 0,05 )Tj
ET
BT
/F16 1 Tf
10.5 0 0 10.5 416.5375 218.4813 Tm
0 Tc
(m)Tj
ET
BT
/F0 1 Tf
10.5 0 0 10.5 422.4298 218.4813 Tm
-0.0151 Tc
(M\). La concentraci\227n umbral de)Tj
-10.53512 -1.09524 TD
0.1969 Tw
(toxicidad en las c\216lulas renales es aproximadamente 2,2)Tj
0 -1.09523 TD
0.0213 Tw
(mcM cuando el pH urinario es de 5,7 y de 22 )Tj
ET
BT
/F16 1 Tf
10.5 0 0 10.5 499.7843 195.4813 Tm
0 Tc
(m)Tj
ET
BT
/F0 1 Tf
10.5 0 0 10.5 505.6766 195.4813 Tm
-0.015 Tc
(M a pH 6,9)Tj
-18.46339 -1.09524 TD
-0.0151 Tc
0.0296 Tw
((4). Nuestro paciente present\227 concentraciones plasm\207ticas)Tj
0.0776 Tw
(de MTX superiores a 22 )'
ET
BT
/F16 1 Tf
10.5 0 0 10.5 416.9304 172.4813 Tm
0 Tc
(m)Tj
ET
BT
/F0 1 Tf
10.5 0 0 10.5 422.8227 172.4813 Tm
-0.0151 Tc
(M durante 2 d\222as y mayores de)Tj
-10.57254 -1.09523 TD
-0.015 Tc
0.0012 Tw
(2,2 )Tj
ET
BT
/F16 1 Tf
10.5 0 0 10.5 326.9441 160.9813 Tm
0 Tc
(m)Tj
ET
BT
/F0 1 Tf
10.5 0 0 10.5 332.8365 160.9813 Tm
-0.0151 Tc
(M durante 4 d\222as. En los primeros d\222as posteriores a la)Tj
-2.00242 -1.09524 TD
0.0015 Tw
(administraci\227n de MTX el pH se situ\227 por debajo de 7. Los)Tj
0.2661 Tw
(par\207metros farmacocin\216ticos del MTX en este ciclo de)'
0 -1.09523 TD
-0.015 Tc
0.011 Tw
(administraci\227n muestran un claro enlentecimiento de la eli-)Tj
0 -1.09524 TD
-0.0151 Tc
0.2222 Tw
(minaci\227n. Si se comparan estos valores con los valores)Tj
T*
-0.015 Tc
0.074 Tw
(medios de un grupo de pacientes de caracter\222sticas simila-)Tj
0 -1.09523 TD
-0.0151 Tc
0.0167 Tw
(res, se comprueba el retraso en la eliminaci\227n renal del f\207r)Tj
22.61435 0.00001 TD
0 Tc
(-)Tj
-22.61435 -1.09525 TD
-0.0151 Tc
-0.008 Tw
(maco y su acumulaci\227n: )Tj
ET
BT
/F16 1 Tf
10.5 0 0 10.5 412.2351 80.4813 Tm
0 Tc
(a)Tj
ET
BT
/F0 1 Tf
10.5 0 0 10.5 418.7016 80.4813 Tm
-0.0152 Tc
(\(h)Tj
5.25 0 0 5.25 427.1306 84.0438 Tm
(-1)Tj
10.5 0 0 10.5 431.3451 80.4813 Tm
-0.0151 Tc
(\)= 0,38; )Tj
ET
BT
/F16 1 Tf
10.5 0 0 10.5 465.7177 80.4813 Tm
0 Tc
(b)Tj
ET
BT
/F0 1 Tf
10.5 0 0 10.5 471.3229 80.4813 Tm
-0.0152 Tc
(\(h)Tj
5.25 0 0 5.25 479.7519 84.0438 Tm
(-1)Tj
10.5 0 0 10.5 483.9664 80.4813 Tm
-0.0151 Tc
(\)= 0,07; K)Tj
5.25 0 0 5.25 525.7616 78.3814 Tm
-0.015 Tc
(12)Tj
10.5 0 0 10.5 530.8541 80.4813 Tm
-0.0152 Tc
(\(h)Tj
5.25 0 0 5.25 539.2832 84.0438 Tm
(-1)Tj
10.5 0 0 10.5 543.4977 80.4813 Tm
-0.0153 Tc
(\)=)Tj
-22.06539 -1.09524 TD
-0.015 Tc
0.5615 Tw
(0,02; K)Tj
5.25 0 0 5.25 348.1022 66.8814 Tm
(21)Tj
10.5 0 0 10.5 353.1947 68.9813 Tm
-0.0152 Tc
(\(h)Tj
5.25 0 0 5.25 361.6237 72.5438 Tm
(-1)Tj
10.5 0 0 10.5 365.8382 68.9813 Tm
-0.0151 Tc
(\)= 0,09; K)Tj
5.25 0 0 5.25 419.5938 66.8814 Tm
-0.015 Tc
(13)Tj
10.5 0 0 10.5 424.6863 68.9813 Tm
-0.0152 Tc
(\(h)Tj
5.25 0 0 5.25 433.1153 72.5438 Tm
(-1)Tj
10.5 0 0 10.5 437.3298 68.9813 Tm
-0.0151 Tc
(\)= 0,34; Vc\(l/kg\)= 0,53;)Tj
-11.95417 -1.09523 TD
0 Tw
(Cl(l/kg.h)= 0,16; t)Tj
5.25 0 0 5.25 385.3178 55.3814 Tm
(1/2)Tj
ET
BT
/F16 1 Tf
5.25 0 0 5.25 391.7901 55.3814 Tm
0 Tc
(b)Tj
ET
BT
/F0 1 Tf
10.5 0 0 10.5 394.5927 57.4813 Tm
-0.015 Tc
[(\(h\)= 16,24 \(1)37(1\).)]TJ
7 0 0 7 42.5197 744.001 Tm
0 Tc
(Vol. 28. N.)Tj
4.47167 0.00001 TD
[<A1>-250(5, 2004)-9573(MANEJO DE LA INTOXICACI\356N POR METOTREXATO: A PROP\356SITO DE UN CASO)]TJ
8 0 0 8 540.7559 744.001 Tm
(373)Tj
ET
0 0 0 0 k
42.744 18.126 25.512 15.007 re
f
BT
/F0 1 Tf
8 0 0 8 42.7441 19.8606 Tm
0 0 0 1 k
(79)Tj
ET
/GS0 gs
0 0 0 0 k
42.77 525.1771 240.445 183.235 re
f
q
42.77 525.1771 240.445 183.235 re
W n
/GS1 gs
/Fm2 Do
Q
/GS2 gs
0 J 0 j 0.4 i 10 M []0 d 0.5 w 
0 0 0 1 K
42.77 525.1771 240.445 183.235 re
s
42.52 479.828 240.945 36.181 re
f
BT
/F18 1 Tf
8 0 0 8 42.5197 510.0095 Tm
0 0 0 1 k
-0.0002 Tc
0.0075 Tw
(Fig. 2.- )Tj
ET
BT
/F19 1 Tf
8 0 0 8 68.4137 510.0095 Tm
-0.0001 Tc
(Evoluci\227n de la concentraci\227n plasm\207tica de creatinina durante)Tj
-3.23675 -1.1875 TD
0 Tw
(el ingreso del paciente.)Tj
ET
/GS0 gs
0 0 0 0 k
42.77 321.133 240.445 157.735 re
f
q
42.77 321.133 240.445 157.735 re
W n
/GS1 gs
/Fm4 Do
Q
/GS2 gs
42.77 321.133 240.445 157.735 re
s
42.52 275.784 240.945 36.182 re
f
BT
/F18 1 Tf
8 0 0 8 42.5197 305.9659 Tm
0 0 0 1 k
-0.0002 Tc
0.1471 Tw
(Fig. 3.- )Tj
ET
BT
/F19 1 Tf
8 0 0 8 70.6468 305.9659 Tm
-0.0001 Tc
(Medidas del pH urinario durante el ingreso del paciente \(en)Tj
-3.51589 -1.1875 TD
0 Tw
(algunos d\222as se registraron varias medidas\).)Tj
ET
Q
endstream
endobj
17 0 obj
<<
/Length 10779
>>
stream
/GS0 gs
q
0 0.701 595 793 re
W n
1 g
0 793.701 0 0 re
f
Q
/GS0 gs
/GS2 gs
0 0 0 0 k
42.52 365.039 510.236 343.623 re
f
q
BT
/F0 1 Tf
10.5 0 0 10.5 53.8583 701.4813 Tm
0 Tr
0 0 0 1 k
0.013 Tw
(Entre las causas de este enlentecimiento en la elimina-)Tj
-1.07987 -1.09524 TD
-0.0001 Tc
0.0601 Tw
(ci\227n del MTX cabe, por una parte, una cierta disfunci\227n)Tj
0 -1.09523 TD
0 Tc
-0.023 Tw
(renal, ya que el paciente present\227 un valor basal de creati-)Tj
0 -1.09524 TD
-0.0001 Tc
0.0014 Tw
(nina plasm\207tica de 1,2 mg/dl, ligeramente por encima del)Tj
0.2357 Tw
(valor de normalidad. Adicionalmente, se plantea si la)'
0 -1.09523 TD
-0.0117 Tw
(hidrataci\227n y la alcalinizaci\227n fueron suficientes. Cuando)Tj
0 -1.09524 TD
0.116 Tw
(existe aciduria o deshidrataci\227n, el MTX y su principal)Tj
0 -1.09523 TD
0 Tc
0.185 Tw
(metabolito 7-hidroxi-MTX, de menor solubilidad, pue-)Tj
0 -1.09524 TD
-0.0001 Tc
-0.0142 Tw
(den precipitar a nivel de los t\234bulos renales provocando o)Tj
0.0817 Tw
(acentuando el da\226o renal. Adem\207s el pH \207cido favorece)'
0 -1.09523 TD
0 Tc
0.038 Tw
(la reabsorci\227n de las formas no ionizadas del MTX, pro-)Tj
0 -1.09524 TD
0.018 Tw
(longando su acci\227n citot\227xica. El paciente present\227 valo-)Tj
0 -1.09523 TD
-0.0001 Tc
0.0429 Tw
(res de pH urinario menor de 7 en varias mediciones. Por)Tj
0.0508 Tw
(\234ltimo, son factores agravantes la edad del paciente y su)'
0 -1.09524 TD
0 Tw
(enfermedad de base, la diabetes mellitus tipo II. )Tj
1.07987 -1.09523 TD
0 Tc
0.102 Tw
(Los tratamientos con MTX a dosis altas pueden oca-)Tj
-1.07987 -1.09525 TD
-0.024 Tw
[(sionar cuadros de toxicidad graves que alar)18(gan la estancia)]TJ
0 -1.09523 TD
-0.0001 Tc
0.1881 Tw
(hospitalaria e incluso pueden comprometer la vida del)Tj
-0.0012 Tw
(paciente. En el caso que se presenta, la estancia fue de 25)'
0 -1.09524 TD
0.1689 Tw
(d\222as. El paciente debe ser monitorizado estrechamente,)Tj
T*
0 Tc
-0.008 Tw
(obteni\216ndose el valor basal de la tasa de filtraci\227n glome-)Tj
-0.0001 Tc
0.1927 Tw
(rular y la concentraci\227n plasm\207tica de creatinina, para)'
0.1096 Tw
(poder detectar a los pacientes con riesgo de sufrir da\226o)'
T*
0 Tc
0.038 Tw
(renal (4). Una rigurosa hidrataci\227n, alcalinizaci\227n y con-)Tj
T*
-0.014 Tw
(trol del pH urinario son necesarios para asegurar una ade-)Tj
-0.0001 Tc
0 Tw
(cuada eliminaci\227n renal del MTX.)'
1.07987 -1.09524 TD
0.3255 Tw
(La monitorizaci\227n rutinaria de las concentraciones)Tj
-1.07987 -1.09524 TD
0.22 Tw
(plasm\207ticas de MTX contin\234a siendo necesaria por la)Tj
0.2201 Tw
(amplia variabilidad en la eliminaci\227n de este f\207rmaco)'
0.3378 Tw
(entre los distintos pacientes, e incluso en el mismo)'
25.64679 31.7619 TD
0 Tc
0.2 Tw
(paciente en distintos ciclos. Diversos autores han pro-)Tj
0 -1.09524 TD
-0.0001 Tc
0.0134 Tw
(puesto la utilizaci\227n de m\216todos de estimaci\227n bayesiana)Tj
0 -1.09523 TD
0.1882 Tw
(con un n\234mero reducido de muestras plasm\207ticas para)Tj
0 -1.09524 TD
0.3216 Tw
(definir los par\207metros farmacocin\216ticos del MTX, la)Tj
T*
0 Tc
-0.005 Tw
(exposici\227n sist\216mica al f\207rmaco y la detecci\227n de pacien-)Tj
0 -1.09523 TD
-0.0001 Tc
0.1618 Tw
(tes con retraso en la eliminaci\227n del MTX (10-12). El)Tj
0 -1.09524 TD
0.0377 Tw
(plan terap\216utico seguido en este paciente para minimizar)Tj
0 -1.09523 TD
0 Tc
0.161 Tw
(los efectos citot\227xicos del MTX y facilitar su elimina-)Tj
0 -1.09524 TD
0.043 Tw
(ci\227n, es similar al descrito por otros autores en la biblio-)Tj
-0.0001 Tc
0.0122 Tw
(graf\222a, incluyendo en superrescate con \207cido fol\222nico y la)'
0 -1.09523 TD
0.2472 Tw
(administraci\227n de resincolesteramina, que secuestra el)Tj
0 -1.09524 TD
0 Tc
0.029 Tw
(MTX excretada por la bilis e impide su reabsorci\227n inte-)Tj
0 -1.09523 TD
-0.0001 Tc
0.5759 Tw
(rrumpiendo de este modo el ciclo enterohep\207tico)Tj
T*
0 Tc
0.067 Tw
((5,7,13,14). Estas medidas tuvieron que ser complemen-)Tj
0 -1.09524 TD
-0.0001 Tc
0.0672 Tw
(tadas con procedimientos de depuraci\227n extracorp\227rea y)Tj
0 -1.09523 TD
0.3803 Tw
(otras medidas terap\216uticas de soporte \(transfusiones,)Tj
0 -1.09525 TD
0 Tc
0.038 Tw
(antibi\227ticos, etc.\) para corregir el severo cuadro yatrog\216-)Tj
0 -1.09523 TD
-0.0001 Tc
0 Tw
(nico provocado por el MTX. )Tj
1.07986 -1.09523 TD
0.1645 Tw
(En conclusi\227n, cuando se administran dosis altas de)Tj
-1.07986 -1.09524 TD
0.1824 Tw
(MTX se debe evaluar la funci\227n renal para identificar)Tj
0.017 Tw
(pacientes de riesgo de sufrir retraso en la eliminaci\227n del)'
-0.0226 Tw
(MTX. Adem\207s se debe mantener una hidrataci\227n y alcali)'
22.61437 0 TD
0 Tc
(-)Tj
-22.61437 -1.09524 TD
0.054 Tw
(nizaci\227n adecuados antes, durante y despu\216s de la admi-)Tj
-0.0001 Tc
0.023 Tw
(nistraci\227n del MTX. Una vez instaurado el da\226o renal, la)'
0.0436 Tw
(administraci\227n de \207cido fol\222nico y de resincolestiramina,)'
0.2413 Tw
(que interfiere en el ciclo enterohep\207tico del MTX, la)'
0.252 Tw
(hidrataci\227n y alcalinizaci\227n urinaria y las t\216cnicas de)'
0.0674 Tw
(hemodi\207lisis, son efectivas en el abordaje de una intoxi)'
22.61439 0 TD
0 Tc
(-)Tj
-22.61439 -1.09524 TD
-0.0001 Tc
0.1278 Tw
(caci\227n por MTX debida a un retraso en su eliminaci\227n)Tj
(renal.)'
8 0 0 8 42.5197 744.001 Tm
0 Tc
(374)Tj
7 0 0 7 245.8385 744.001 Tm
-0.0001 Tc
0 Tw
(M. J. FERN\347NDEZ MEG\352A ET AL.)Tj
35.37494 0.00001 TD
0 Tc
(F)Tj
5.25 0 0 5.25 497.3545 744.001 Tm
-0.0001 Tc
(ARM)Tj
7 0 0 7 511.0631 744.001 Tm
0 Tc
(H)Tj
5.25 0 0 5.25 516.1166 744.001 Tm
-0.0001 Tc
(OSP)Tj
7 0 0 7 527.4937 744.001 Tm
-0.0002 Tc
((Madrid))Tj
ET
0 0 0 0 k
527.244 18.126 25.512 16.673 re
f
BT
/F0 1 Tf
8 0 0 8 544.7559 19.8606 Tm
0 0 0 1 k
0 Tc
(80)Tj
ET
0 J 0 j 0.4 i 10 M []0 d 0.5 w 
0 0 0 1 K
42.52 283.284 m
552.756 283.284 l
S
BT
/F3 1 Tf
10.5 0 0 10.5 42.5197 289.2036 Tm
-0.0002 Tc
(Bibliograf\222a)Tj
ET
0 0 0 0 k
42.52 52.566 510.236 217.2771 re
f
BT
/F0 1 Tf
8 0 0 8 46.5197 264.3726 Tm
0 0 0 1 k
0 Tc
0.118 Tw
[(1.)-1000(Relling MV, Fairclough D, Ayers D, Crom R, Rodman JH, Ching-)]TJ
1.80315 -1.12124 TD
0.082 Tw
(Hon Pui, et al. Patient characteristics associated with high-risk met-)Tj
0 -1.12125 TD
-0.0001 Tc
-0.0105 Tw
(hotrexate concentrations and toxicicy. J Clin Oncol 1994; 8: 1667-72.)Tj
-1.80315 -1.12125 TD
0 Tc
-0.006 Tw
[(2.)-1000(Wall AM, Gajjar A, Link A, Mahmoud H, Pui CH, Relling MV. Indi-)]TJ
1.80315 -1.12125 TD
-0.0001 Tc
0.0129 Tw
(vidualized methotrexate dosing in children with relapsed acute lymp)Tj
27.4822 -0.00001 TD
0 Tc
(-)Tj
-27.4822 -1.12124 TD
-0.0001 Tc
0 Tw
(hoblastic leukemia. Leukemia 2000; 14 (2): 221-5.)Tj
-1.80315 -1.12125 TD
-0.025 Tc
-0.023 Tw
[(3)-25(.)-1025(Winter\325s ME. Basic Clinical Pharmacokinetics. 3\273 ed. San Francisco 1996. )]TJ
T*
0 Tc
0 Tw
[(4.)-1000(DrugDex)]TJ
4 0 0 4 90.2834 204.3014 Tm
<A8>Tj
8 0 0 8 96.3204 201.5826 Tm
-0.0001 Tc
0.1248 Tw
(Information System. Micromedex Inc. Denver, Colorado)Tj
-4.42194 -1.12125 TD
0 Tw
(2000. Drug Evaluation Methotrexate.)Tj
-1.80315 -1.12125 TD
0 Tc
0.037 Tw
[(5.)-1000(Borsi JD, Sagen E, Romslo I, Moe PJ. Rescue after intermediate and)]TJ
1.80315 -1.12125 TD
-0.0001 Tc
0.1196 Tw
(high-dose methotrexate: background, rationale and current practice.)Tj
0 Tw
(Pediatric Hematology and Oncology 1990; 7: 374-63.)'
-1.80315 -1.12125 TD
0 Tc
0.031 Tw
[(6.)-1000(Peris F. Estudio farmacocin\216tico de la interacci\227n metotrexato-coles-)]TJ
1.80315 -1.12125 TD
0.12 Tw
(tiramina. Implicaciones terap\216uticas. [tesis doctoral] Valencia: Uni-)Tj
-0.0001 Tc
0 Tw
(versidad de Valencia. Facultad de Farmacia, 1995.)'
-1.80315 -1.12125 TD
0 Tc
-0.012 Tw
[(7.)-1000(Kepka L, De Lassence A, Ribrag V, Gachot B, Blot F, Theodore C, et)]TJ
1.80315 -1.12125 TD
-0.0001 Tc
0.0116 Tw
(al. Succesful rescue in a patient with high dose methotrexate-induced)Tj
0.0238 Tw
(nephrotoxicity and acute renal failure. Leuk Lymphoma 1998; 29 \(1-)'
0 Tw
(2\): 205-9.)'
-1.80315 -1.12125 TD
0 Tc
(8.)Tj
1.75 0.00001 TD
-0.0001 Tc
0.024 Tw
(Odoul F, Le Guellec C, Lamagnere JP, Breilh D, Saux MC, Paintaud)Tj
0.05315 -1.12126 TD
0 Tc
0.055 Tw
(G, et al. Prediction of methotrexate elimination after high dose infu-)Tj
0 -1.12125 TD
0.058 Tw
(sion in children with acute lymphoblastic leukaemia using a popula-)Tj
-0.0001 Tc
0.1422 Tw
(tion pharmacokinetic approach. (Abstract) Fundam Clin Pharmacol)'
0 Tw
(1999; 13 (5): 495-604.)'
31.85826 25.78874 TD
0 Tc
0.013 Tw
[(9.)-1000(Raude E, Oellerich M, Weinel P, Freund M, Shrappe M, Riehm H, et)]TJ
1.80315 -1.12124 TD
-0.0001 Tc
0.0544 Tw
(al. High-dose methotrexate: pharmacokinetics in children and young)Tj
0 -1.12125 TD
0.0821 Tw
(adults. International Journal of Clinical Pharmacology, Therapy and)Tj
0 Tc
0 Tw
(Toxicology 1988; 7: 364-70.)'
-2.30315 -1.12125 TD
(10.)Tj
2.25 -0.00001 TD
-0.0001 Tc
-0.0136 Tw
(Rousseau A, Sabot C, Delepine N, Delepine G, Debord J, Lachatre G,)Tj
0.05315 -1.12124 TD
0.0786 Tw
(et al. Bayesian estimation of methotrexate pharmacokinetic parame)Tj
27.48221 0.00001 TD
0 Tc
(-)Tj
-27.48221 -1.12126 TD
-0.014 Tw
(ters and area under the curve in children and young adults with locali-)Tj
0 -1.12125 TD
-0.0001 Tc
0 Tw
(sed osteosarcoma. Clin Pharmacokinet 2002; 41 (13): 1095-104.)Tj
-2.30315 -1.12125 TD
0 Tc
0.116 Tw
[(11.)-1000(Monjanel-Mouterde S, Lejeune C, Ciccolini J, Merite N, Hadjaj D,)]TJ
2.30315 -1.12125 TD
-0.0001 Tc
0.01 Tw
(Bonnier P, et al. Bayesian population model of methotrexate to guide)Tj
0.0467 Tw
(dosage adjustments for folate rescue in patients with breast cancer. J)'
0 Tw
(Clin Pharm Ther 2002; 27 (3): 189-95.)'
-2.30315 -1.12125 TD
0.025 Tc
0.035 Tw
[(1)25(2)25(.)-975(Fern\207ndez Meg\222a MJ, Al\227s Almi\226ana M, Ezquer Borr\207s J. Moni)-1(-)]TJ
2.30315 -1.12125 TD
0.0249 Tc
0.2923 Tw
(torizaci\227n farmacocin\216tica del metotrexato en infusi\227n de 24)Tj
0.1288 Tw
(horas en poblaci\227n adulta afectada de linfoma no Hodgkin. [en)'
(prensa].)'
-2.30315 -1.12125 TD
0 Tc
0.091 Tw
[(13.)-1000(Widemann BC, Balis PM, Murphy RF, Sorensen JM, Montello MJ,)]TJ
2.30315 -1.12125 TD
-0.0001 Tc
0.1296 Tw
(O\325Brien M, et al. Carboxypeptidasa-G2, thymidine, and leucovorin)Tj
0.0073 Tw
(rescue in cancer patients with methtrexate-induced renal dysfunction.)'
0 Tw
(J Clin Oncol 1997; 15 (5): 2125-34.)'
-2.30315 -1.12125 TD
0 Tc
-0.018 Tw
[(14.)-1000(Van den Bongard HJ, Mathjt RA, Boogerd W, Schornagel JH, Soesan)]TJ
2.30315 -1.12125 TD
0.03 Tw
(M, Schellens JH, et al. Successful rescue with leucovorin and thymi-)Tj
-0.0001 Tc
0.005 Tw
(dine in a patient with high-dose methotrexate induced acute renal fai)'
27.48221 0.00001 TD
0 Tc
(-)Tj
-27.48221 -1.12126 TD
-0.0001 Tc
0 Tw
(lure. Cancer Chemother Pharmacol 2001; 47 (6): 537-40.)Tj
ET
Q
endstream
endobj
18 0 obj
<<
/Nums[0<</S/D>>]
>>
endobj
19 0 obj
<<
/Type/Encoding
/BaseEncoding/MacRomanEncoding
/Differences[32/space 40/parenleft/parenright 43/plus/comma/hyphen/period/slash/zero/one/two/three/four/five/six/seven/eight/nine/colon/semicolon 61/equal 65/A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P 82/R/S/T/U/V/W/X 90/Z/bracketleft 93/bracketright 97/a/b/c/d/e/f/g/h/i/j/k/l/m/n/o/p/q/r/s/t/u/v/w/x/y/z 132/Ntilde 135/aacute 142/eacute 146/iacute 150/ntilde/oacute 156/uacute 161/degree 168/registered 187/ordfeminine/ordmasculine 213/quoteright 231/Aacute 234/Iacute 238/Oacute]
>>
endobj
20 0 obj
<<
/Length 9559
/Subtype/Type1C
/Length1 9559
>>
stream
  ETVMSD+Times-Roman   @¯ ¯¯¯¯˚<˚n˙|˙
 ãã
 ãã   ˚   ˜  ¨¨  %6 }àç002.000Copyright © 1994-1997 Stream Technologies Inc. All Rights Reserved.
 Turku is a trademark of Stream Technologies Inc.Turku RomanTurku  W   - B T  D P O F U S J Q M N » E Y 	 . 5 9 
 V K W Z C œ G     [ ÿ  ” I H ﬁ  & R $     + ' 3 / ´ % ; ( ∂ " ª 4 * ∫ 0  ) 7  ◊  L    6 1 , •  è # ° X 8  ã < > Y   / uíì‡%ö¯D±ö“Ñ=µ>|Ê2«		r	›
>
∂°˛7N»Ê%ó—;©sY÷C¨Ë!}Î3°w
n≠$ãÏtÓ%“)å˜S∏wÊkñ±7ùóiå» g ¢!:!Ÿ""Å"™"‘˚*ôv¯Ë‘ü¯@¯T˘ö¸|_`%úÉ≤Ã¢õ¡ã˜m˚Z¸ËÃdã≤dû˘ûÓ∞¯Ë˜Bs˚
Siz˚I0Åè∞¯n”òò’èü˚ßw’áò~C¸QpC~~Aáw¯≠˚bñvåƒ¯§∞„˜6›x¯O≥•{tÖà}rÖóª˜W˜`π˚ 1CYNrûw¢¢°†°òáòãò®™ü∑π¶lWNOuBqWg]kxjãZãN∑`…ã∏ã∏¢¬Ω∏Tëùx∑™ßõ≠ß˚0ﬂsàÄÉx{yb{sfo≠π»∫µ˜±˚ôÇ°êv¯Zwí¢æ»˜:—ú˜˜ªt´M∞ Ànú|§ã©Ø≠®∂≈Æd6úõ¨á˜ÉÜáâÖÜÑåéÖúôcçs:QXDO™e·Z≈j≠xùqãn_koYEiØÚs{\˚/òîíêéîìïäàñúÅ¥§á•Ÿ ƒ”˚bÅ”¯®§◊¯0˜(}ì`HapQã1K›˜ƒ‘ÿ≤ñÇcóëwïkö|£ã¶ûù•¡E∫<˚+!˚!˚⁄/˜ﬂ∆∫˜¿˚*Ç¶¯4ß®‰˜ö‰¯i˜~˜0È˚˚0+˚˚Á'˜˜ÍÛ˜2h˚^FA8O˜˜*ÁºÃ–ﬂ«*˚˚*†v¯)¬åw⁄‹:ﬂ˜Eﬂ‘¯xõ]}õº˜yË^ƒB[p|ID€¨ÑçYxà@tyéôëåì¶ì{[˚ãS}z\â{˜göYê{ò≠˜≠Ãª√õî¨ª£kJ˚eN}xZà{˚bÅ–˜o´˜Ø§–F“˜cÒÙ¯<˜1{ìW<dpJã.Pﬁ˜Ö˜À˜P…&˚7(˚&˚ —6˜	ÎÕø˜ΩÏ˚˜-˚cŸöÆØ«∆•m7ó¸Åø¯´–ﬂ˜™Õ~ñvrzÅtãg|¶ ˜≥´&˜ñâéÖU<midpÑÜâàãÖãáåâéãø˚¬5©b…∏≤§æ¨˚—†v¯`w†w÷ﬂ–˜‚¯+¨wühblsH]â‰∞ÜéJqwÑMu{éöìåï§ï{_˚éYÇÉNÅ{˜ÉõKvùƒ˜súò§ûûôòôìîíìáÉîx†ìáõ°õû•¸†v¯^w˜$◊8ﬂ˜E˘ßt¢opttop°tßß¢¢¶÷˝õËKèÅñ”˜˜ÜèWwZyVy|é©åãì¶î{_˚{CÅGà{˚*˚Vv˜a´¯«åw’ﬂ˜v‡Ï¯i˜à˜F‰*R_sVaâç‘‹ÖéTvää4m{åóéãó´ëÅ[¸gUÑÑMÑ{˜ÖõAå}ó…˜0m´©≤˜Ê˜˜$6f˚YAArmóûs}óÇóï˜äÏØìª™∫’º>˚¸†vÏﬂ˜îõMå~ó√¯ÁáéHwvÖEy{åôíãó∞ìÄY¸pV{}Ná{˜†v¯-øåw·ﬂ˜Lﬂ˜Kﬁ‹˘ôõRåïª˜c˜d∆=SXpSU≈xk§SbvÇXFÜáÉÜÅÉ÷ºÉéZyåã1pyéõêåñ§ïx^˚íV}}Sâ{˜rõYyô∞˜Øéïïóï‹£®´ó™ª°iC˚mU~Sà{˜sõSå|ú»˜ê∏´™ú∫¡ûn9˚gSÑÉPÑ{˚bñvåƒ¯§∞„§˜r6›ƒ˜œ˘ú}ôz|}Ñ||˚'˚)≥˜.Ïûóîôãú¸˝t¯O≥•{tÖà}rÖóª˜W˜`π˚ 1CYNrûw¢¢°†°òáòãò®™ü∑π¶lWNOuBqWg]kxjãZãN∑`…ã∏ã∏¢¬Ω¥Tëùx∑™ßõ≠ß˚0ﬂsàÄÉt{yb{sfo≠π»∫µ˜±˚*Åø¯ß¶·˜wﬂ¯µõÉÇäãáfÇó∏¯ÀÜéUx|á=v{åòëãêØìÇa˚0¨crïb˚.˚˚˚◊2˜¿µ†∂™çNêàŸßoÅÎ≠˚+»m^l_9Sﬁ˜˜æ◊‘¬ª\U˚*†v¯Wwú¯b¯sõhçyòn∑˚˜Xﬂ˜û¶ßõ≠åö˚3}¨áíá}~uU?~üèÖs≥x™Ñöãìãõïë´çô˚b}µäêá∞SÍ˚%˚˚9pd}Ålä{˜%õnÄêóìêóô°€˜‹˚õsãäãÄ{ÄÑrá{˚—˚1v˘Íwª‡˜ƒ˚6˚·Z˜˜l˜[∂Ò˜ÓÇõ˚@˚@˚ã˚L˚µ#Î%≤aßt≤t˜Éãû˘ûˆ∑¯ú˘ÔüFçyù–¯Q”ôô‘éü˚[˚o¸é˚{¯é˚Zw›Üò~D¸+&|x;Ñw˜}ü@éx•Ì¯$ç˜é¸∑ô˜ê¯Œç¸V9Ä~<Üwdãû¯Ì∂ü°˜gÒ˜|v¯„¯ÅÑ˜>¸ƒÑ˚>§˜°†õ˜¡¸í@~8àw˜∫ü8é~ó÷¯í¡˜†{˚°”ãû˘ûï˘H‡˘RüWêwòe¬˚S˜¶˜%˜K≈’§öÃèü˚Äw≈àñÜr|É}kd˚˚`∆CÓ~¶ã¢£öë»ü˚¡w–Ö¢w„˚˜˚5˚0˚U;)~ÅWÜw˜}‡ûVçsñå°åúò§∞∏˜˜(Í˚!´\ùgã}‡uwÉSäw˚—˚1v˘Íw˜\‡˜±˜ä˜aÛ+Òdµo¢d¢{˜5º˚˚l˚[`%˚(î{˜@˜÷˜ã˜L˚*Åƒ¯(w—ﬂ˜Fﬂ=ŸË¯rØôYäñ∫˜Ï˚2{ÀáïÇY˚ÅràÄÉÅuy^wlcjÆµ˜€˚%{ªàò~[˚è;∫Y◊Ø±õ¶¶Ë∑∂9çàŸßîéæô¸˚Xv˘7w˜$Á8ﬂ˜U˘ßt¢pottop¢tß¶¢¢¶Ëå˝¯^ÜèXwXyWy|é©åãì¶î{_¸!Äjg}ÇêóÄ≥iÜéwwwywk≤t¬˜∆÷˜"˚*ív¯ewû¯\¯o¯Gõ˚{´äöÄv|Çoy]=˚[%˜îÜòáúãíúòî¨çõ˚W{üäïÜó§s˜˚ø£NéÇòeîãíãèíù∑˜˜‘¶Œíî©ç˚*˚m¯Àwô¯`¯n¯Iô˚}ØàóÑzÑéîqB<˚q˚˜êÇûãíãñúííΩëô˚a}®ÜóÑîw˜˚ä¶PÆJ|tpG{rt|z||wuùloxzpk™r¥“µº˜*ƒ˜/¯-ñ©ôò°é˚*Å´¯Àœﬂ˜w‰¯h˜á˜?Ë$SWlXpâ˜¡Üéa{U{[~{åïíãèÆîÅc¸úm„i⁄˜Ú˜˜!2b˚	]L5[\££˜ê∂µ¨ƒ◊ø;˚˚bÅ–˜o´˜Ø§–F“¿˜rGÒ√˜œ˘ú}ôz|}Ñ||˚'˚)≥˜.Ïûóîôãú¸˝Ú¯<˜1{ìW<dpJã.Pﬁ˜Ö˜À˜P…&˚7(˚&˚ —6˜	ÎÕø˜ΩÍ˚˜-˚cŸöÆØ«∆•m7ó˚—†v¯7´˜_®Úﬂ7ﬁ¯˘´\ßU˚QA˚2ä:k‹˚œBÅÄBá{˜òõ:çñ÷˜œ˜´Ë˚˜∆ùß≤†îÖoük°îÑú¢ûû¢˚*†v˜i·¯ö=åyñ∫¯ÌÇç˚G0~•ïúíúèîã¢ï}j¸m\yÄ=ä|˚—†v˜UÀ≤˜ä˜±˜UÀ˚äK˚*}Ø¯Á∆˜—⁄g“–¯C˜lÍkπ+∑‡œπ§∞≈⁄K¬/,MX˚döá≥÷∏´ ãÃ∏^L^r_cnpwvÅWyû¡¶Üz™–ªp®XO8QICqvì†h£cÇéys}~ug∑v÷˜1˜Î˜Ä˜—˜˜I∑™r§mlrrlm§r™©§§©˚bã©¯©¶¯¯6˜yèv*|~/ã˚˜¢¯*ö˚Ôà˚ú’ïôö»˜˚ù¸*|¯˚*Ç¶¯4ß®‰∆˜rx‰ﬂ˜œ˘ú}ôz|}Ñ||˚'˚)≥˜.Ïûóîôãú¸#˝Ë¯i˜~˜0È˚˚0+˚˚Á'˜˜ÍÛ˜2h˚^FA8O˜˜*ÁºÃ–ﬂ«*˚õv£v√˜ †˜Xñøh≤\jrskl¢wØ`ôêéãîïêáÅäâiogVgïxŒ≠∏»ƒ¸†v¯bwÃ˜r˚Uﬂo ˜œ˘ú}ôz|}Ñ||˚'˚)≥˜.Ïûóîôãú˚≥˝–˜êõKèÅñ”˜˜ÜèXyWxXx|é©åãì¶î{_˚{CÅGà{˚*†v¯+¡”ﬂ˜Nﬂ¯zõXêÇó–˜[ˆa¿9R_rQ`â˜¬Öè\{òè kzåìëãè∞ìÇa¸kFÇUÜ{˜kõTç~úŒ˜Öπµ´ù±∫¶eF˚ZGÄ}Rá{˚*˚nƒ˜&÷@‘Ê§˜k≤êßß–nﬁ˜EŸ•®›¿¯i¯≤?u~çìwù]têm*AE-L§h–gCKyvtuö|≤{æ¿FZnfgTÿ`Ô˜˜ŸÊ ]¥@é˚êTçsïãùîòûôòóòôìîúêÜ®ÁœÕ‰®áû|∞P˚Snf_›¿MaÃÌ»¶Æªƒ∏B.Û˚ﬁR?b˚ﬁ¿3M©µ£ïú≤π¨Ñéõâ§àªâ¿âà°Äãi˚*Åƒ¯(w—ﬂ°˜rIﬂ=Ÿﬁ˜œ˘ú}ôz|}Ñ||˚'˚)≥˜.Ïûóîôãú¸"˝‰¯rØôYäñ∫˜Ï˚2{ËÀáïÇY˚ÅràÄÉÅuy^wlcjÆµ˜€˚%{ªàò~[˚è;∫Y◊Ø±õ¶¶‰∑∂9çàŸßîéæô˚*ã◊¯§‘˜Â·¯n˜~êmdÜpPã˚Ñ˜=˜D‚Ê≥⁄ã⁄Ì:Ÿ&˚HK˚lüÜØÍ≤Ø”ã›ƒP6?\*95˚F˚P~¯dã±eû˜»µb¥˜ì≤xûÓ˜ú¢¨¢´Ä¯Ë˜>o˚ ^]s˚7#Åè≤˜å˜.âﬂäñÇö6¢˜|t6|Å8˚.˜q®êêß˜˜û~0ù§á˜#¸•WÄw’áò~C¸QC~~Aáw¯Ø˚*˚Vv˜a…¯ß£‡˜|ﬂ¯|˚kõ]çzö¥¯ÍÜêNgU™|ê_ã˚,˚˚&˚Õ4Ï¿¿§ªπçä˚NT|~AÑ{‰˜ÎkÑ~t~srÖs>W◊˜˜	¡Ÿ‹Õ™kFú}∑¯Ov˜M≤ß˜˘˜yú=AOp5ã˚+,˜˜K˜SÂ˜	˜(ˆ“N˚∞°Ç˜tvÉu|wåÅå{éxíbôYìaã˚Zã˚!˚#ã˚]ã˚f˜˚˜_ã˜ã˜ øæ◊˚*†v˜;À¯Qw˜∑⁄>ÿË¯k˜;À&¯Q_˚Œ¸QK˜≠˚;ÿ˜;<À˚Ñ˜Ç˜Èç¸Ä˜˜ç˜‹˜˜T¯)©r§mlrrml§r™©§§™˚˝™r§mlrrlm§r™©§§©¸õv£v˜Û˜€˜ ˚˜h˜T¯)©r§lmrrml§r©™§§™∞ß¸øh≤\jrskl¢wØpïîéãîïêáÅäâiogVgïxŒ≠∏»ƒ˚*~∞¯‚‡Ÿ˜˘—¯J˘?ÇëyuÉáwã˚e˚˚Ääâäàãâáçâëä˜É˜5Y˚.&O?;uÑé´^°l}êpr}~tb∑u›˜5˜ Ú˜.˜@˚ƒ˚)¶µ‡˜Xúéåíé˚ôív˘&û˜CÒ¯˘ü˚¥w⁄âô}C¸d\Äwq|Üë£Ñ≤|õqqutp_≤n∆˜ »”˜¯”ôô⁄ç-ãû˜»µb¥˜ì≤xûÓ˜î¢¥¢œ¯µ¯úà˜#¸¶w’áò~C¸QC~~Aáw˜´ü@é{ö“˜p˜&âﬂäñÅö7¢˜|t6|Å8˚&˜q∑®êêß˜˜û~0ùúãû˜¡§˜ÆØxûÒÒ˜}˜‹˘'üdçvóp¨˚b˜ë˜¢ƒ¿Ë˜/ ˚7˚ßw‘Üó~D¸D4ÖÑ=Éw˜®ü=íó“˜X√é˜Ç˚…N¯"Kc˚=ä˜äÏ®óíΩ˜≈]1”ïvñû˘û˜ ∏¯1∑x˘T˘ü˚~wÂÑëk4˚„â¸¯u˚?w∂åñÑµ[¸M%~y8Éw˜ü>éz£¯ç∏¯J¸πú¯§Ôöü⁄ë”ãû˜[¥¯4wö˘G¸5˜r˜X˜i˜œ˘ú}ôz|}Ñ||˚'˚)≥˜.Ïûóîôãú¸ì˝˘Vü^ç}òl”˚ç¯Ãw˚d¸O˚!}xYáw˜Zü\äuô™ïéïëõπ˜
˜ö¥*ïtîlãpzÉWwÜ˜ó˚{˜˜ß”ãûx∞¯·∞xûÚÒ¯˜ú˘?˜‚˜b˚)˜˚é˚†w’áò~C¸QC~~Aáw˜Ø˜Ç˜&˜˜cl˚Ö˚U#)˚a\~î´¯ê≠îë¡˜Q˜	˚˚Ldã±¯ﬂ±î¯ﬁ¯Á˜Dt˚hjq%˚ñ¯C¯ˆö¸°x˚>§Úü∞®˜˜q¸H¸ˆ|¯∆”}≥˜…û˜Æ≥´˜¯Î˘W˜„û˚íxŸáïÅ@˚4iOq?˚3'˜
˜O˜KÏ˜˜%Ù–U˚µ£É˜fuuÑ{ÄsÖÄçéÄ°Ejë\˚[˚"˚&˚b˚|˜A!˜K˜˜¬ù˜\≈ôö√é˚—ãû˘ûÈ˜r˚^Òå˜i ˜œ˘ú}ôz|}Ñ||˚'˚)≥˜.Ïûóîôãú˚–˝–˜Ãü8é~ó÷¯O÷òóﬁéü˚∫wﬁàò@¸O@~8àw”ãû˜[¥¯4wö˘G˘Vü^ç}òl”˚ç¯Ãw˚d¸O˚!}xYáw˜Zü\äuô™ïéïëõπ˜
˜ö¥*ïtîlãpzÉWwÜ˜ó˚{˜˜ß”}Ø¯˛Ø≠˜˜"˜r ˜˜X˜i˜œ˘ú}ôz|}Ñ||˚'˚)≥˜.Ïûóîôãú¸ì˝Ë˘C˜ﬁ˜_˚˜#˚S˚T˚˚#˚_˚]˜˚#˜T˜S˜˜#˜]˚å˚T:˚	˚˚:˜	˜T˜R›˜˜˜ﬁ˚˚R-~Ø¯¯¥—·˜~Ô¯~˜<€\ƒ˚’Q≠"º‹¿µ≤∆Â–L˚ ¶§u˜hvsÖÇÅzÑ|éê}üOwëq"?D)9≠a˜C˜>¨hNGZ\C0M¿˜Wu©˚h††çñóùØ´jÁ˜
„ÿÛ˚—ãû˘û˜Ò˜Ãü8é~ó÷¯O÷òóﬁéü˚∫wﬁàò@¸O@~8àw”ïvñû˘û˜ ∏¥˜›∂∑˜U˜h˜ﬁ˘mf{~r~tëì{tóvñsëuãUhiI}®™ìùößïòàÑô°ÄØy¢Ö¢ã¡©©÷†¸ü˝Êt˘T˘ü˚~wÂÑëk4˚„â¸¯u˚?w∂åñÑµ[¸M%~y8Éw˜ü>éz£¯ç¥¯J¸πú¯§Ôöü⁄ë”}Ø¯˛Ø≠˜¯?˜˘C˜ﬁ˜_˚˜#˚S˚T˚˚#˚_˚]˜˚#˜T˜S˜˜#˜]˚å˚T:˚	˚˚:˜	˜T˜R›˜˜˜ﬁ˚˚R˚*~•˘•£Î˜òÎ¯p˜ﬂ˜c˜E∆§ndò[[d~rnFPb˚˚˚≥˚—Or®≤~ªª≤ò§®—«≥˜˜+˚h`!44`ı˜h˜i∂ı‚‚∂!˚i”ãû˜º∑˜±ûıÒ˜√Ò˘PüAè~ò”¯Q”òò’èü˚®w’áò~C˚W˚√˜W”òò’èü˚®w’áò~C¸QC~~Aáw˜®üAè~ò”˜b˜√˚bC~~Aáw”ïv˘#ûõ˘;‡˘K˘ü˚`‡x∆ÜôÇm}Ñqm˚&¸˚,˜ÊmÕÅ©ãô§ñê èû˚ù‡wΩàú{±6˜ã¸∫ö˜p¯∆®’õõ∫ç˚*}ß¯∫˜Çö≠Á˜ë‰¯h˜m˜Bﬂ˚[wÑeL™˜1ÓÍ˜;´áö˚vá˚M˚;˚˚D‰˚˜˜·Í˜2j˚ cME4SÈ˜'≤ê≠îô°ò∑ù¥ÂæC˚˚*†v¯)¬åw⁄‹:ﬂ<˜›Bﬂﬁ˜ﬁ˘mf{~r~tëì{tóvñsëuãUhiI}®™ìùößïòàÑô°ÄØy¢Ö¢ã¡©©÷†¸1˝“¯xõ]}õº˜yË^ƒB[p|ID€™ÑçYxà@tyéôëåì¶ì{[˚ãS}z\â{˜göYê{ò≠˜≠ ª√õî¨ª£kJ˚eN}xZà{˚*âw˜ó∂¯ß©Á˜ÄÔ+ÎÙ¯^¯!˜5/˜
˚˚4'˚ ˚
‘:ˆ¿ªù±π¯åàm˚%˚˚>qçw˜Öõ˜3˜<ã˜Ù+bváÇÅuod}j>\’˜˜± œ‰∏4˚;˚*†v›ﬂ¯çõ`çi°dº˚.˜V®¶ÔËΩÆÃâô˚_}ìêäãè¢äîáå~åÅÉÉ{|˚˚âç¯3ÜéOxzÜ>w{åòïãíØîZ¸uUââBÄ{˜~õMç~î¥˜Iç˜˚LûrçáãÖÉÇÖy{5†v˜pŒHÕ˜çÕ–¯©˜pŒ˚n˜pI∞˚q˚oI˜o˚pÕ˜p¸ív˘FwÇ˜∫˜±˘8I˚x˝FŒ˚*~ß˘ß√÷F’˜o–T◊‘¯Q˜0ÿiª˚ÊÿÓ¡ÆµŒﬁC≈#!;H0J¢iÒ4‰˚<ulG&ÿI˜	˜
ÿÕÚÿ1¯PuiCVTØEø‘ƒ∏≥ œ∂_G‰ô¸-G__IAU«›Œû±…æ™tîÑãËE£rN”}∑¯˙ûÚÚ˜¸∂˘S˘ü˚{w÷âûr(˚¢=Å`slakTtJO\ùÆnnÆÇ∞€˜‘‘ññ⁄èü˚Æy⁄ÉïÅB˚À˚@›6˜:˜HŸ›˜P˜ôõ†Ÿè-ãû˜°≥˜Ω±xûÓÚ$Ò˜{˜⁄¯±¯w˜$—˚3˚öw’ÉìÇD¸FCäp9âw˜¨ü<å|ö’˜Hä§¢äû⁄≈ñ°≤»≠Æ«œ˚â!S\˚ÊzÅãçt˜ôßíë≠˜ÕY-”ãû˘û˜Ò‡˘eüXzñÎ2˚|˜é˜Q˜Q««£óŒêü˚òw«áíàtrxs4:tu∫∂˚@˚0˜W‡ﬁñóŸëû˚¨xŸÖñ8¸;8Ä=Öx˜¨û=ëÄóﬁ˜D•°ı!ÿ>¿Fãt‡yÇàOâw˜}∂¯nû˜µ±¬˜BÃJÀ˜Õ˜/¬˚˘d˜ﬁ˜U˚*˜.˚Q˚T˚+˚-˚V˚T˜+˚,˜T˜P˜+˜-˜STå˚:˚˚˚0˚2˚˜˜9˜;˜˜˜2˜/˜˚˚9%˚Fìq£r¶rÆSŸΩû®≤ª¡\∞G˚E{îäíãêä§âéáãb˚ÑbäânááÑääÉ|˜6ö˜Yëåä∂Óª®_åâ±K¢fö|ôãT˜°Srk`˚_˜=¥π§oV5†v˜Õ˜Õ©¯ã¯©˜’Õ¸ãI¯ã˚]Õ¸ãI˚Ë†v¯¨˜l¨ë”˜-”˜√¯≥⁄P¡31OR5;«P›ÂÃ…‚CgZol`H|Ë¿¥™®µ∫¨S;úã∞fû˜»≥c≤˜ó±xû˜Ò˜Ü;˜¶Ä¯Â˜D≈oΩ\ßröyíZôçg Ë°≤∂⁄˜.«˚<˚¨wﬁàòA¸QA~8àw˜‚¶Ä˜%Ï“Ùß ˚˜Ã<Yb)äõ -ä˜yßèç√˜»]0¶Ä†˚»*O]˚O|ì¨˜ç˜Vå–d˚˚é†v¯≠˜n≠ƒ≠˜n≠˜Î¯©⁄KÀ<<KK<<ÀK⁄⁄ÀÀ⁄iOZZOOZº««ºº««ºZO”ív°v¯dw†˘4p˘I¯Gõ˚{™àòÅy~áu~l0˚r<˜kt…çÑãò£ôì∂èõ˚^{µäôv≠%/˚\k‚H˜CãÜõäìíüòî¨çõ˚G{¢äîÄüX˜˚Èkòëíëëî©ô˜˜ÉÂ˚∞^úãåíìååªû˜˜Óúµêíûê˜∫ñv˘"ûê˙1˙6˘ü˚Zw¬ÜôÇl|ÑkÇs˚˚Ë˚˜Èp–ãäãó§°ï¬ü˚üw áèá≠:≠9 ˚Ø˚%¯É†àïãò°óë¿êü˚àw…Çéá“˚SÃ˚CçÜË˚°ö˜.¯;ëyë|éÇë|°U™;±*ú[™4ôŸ˜Éñ™Ã˜H¶‘ö≥ñ©öµõóªë˚—⁄˜ ˜o¯ﬁøh≤\jrskk¢wØîñèãìîåëÜäÅâhohVgïwŒ≠∏»≈¸
†v¯∫˜w˜1“˜°¯=úÇÉàÉÄâë©˜Ãi™DM^odyò~ûõòñöîàéãîñ¢ó¢¢ô{qm˚bjr[d©n¥ßÆú¶¶kíò¶üôí£¢˚Ωwu}mtzù§¶§ùŒ°˚—˚/§˘î§„ÿ˜¿˚/§1l}ô©˘<©ôô™Â§˚h˝∆˚—˚/§˘î§˜=ÿ˜ä˚/˘∆˚hrÂ™ô}m˝<m}}l1ru°¯Wñ˜\öíã˜öî¸}é¶
ﬂ
_˜é˘endstream
endobj
21 0 obj
<<
/XHeight 677
/StemV 84
/FontFile3 20 0 R
/StemH 0
/CapHeight 662
/Flags 34
/ItalicAngle 0
/Descent -215
/FontName/ETVMSD+Times-Roman
/Type/FontDescriptor
/Ascent 684
/FontBBox[-168 -218 1000 899]
>>
endobj
22 0 obj
<<
/BaseFont/ETVMSD+Times-Roman
/Name/F0
/Subtype/Type1
/Widths[250 0 0 0 0 0 0 0 333 333 0 564 250 333 250 278 500 500 500 500 500 500 500 500 500 500 278 278 0 564 0 0 0 722 667 667 722 611 556 722 722 333 389 722 611 889 722 722 556 0 667 556 611 722 722 944 722 0 611 333 0 333 0 0 0 444 500 444 500 444 333 500 500 278 278 500 278 778 500 500 500 500 333 389 278 500 500 722 500 500 444 0 0 0 0 0 0 0 0 0 722 0 0 444 0 0 0 0 0 0 444 0 0 0 278 0 0 0 500 500 0 0 0 0 500 0 0 0 0 400 0 0 0 0 0 0 760 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 276 310 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 722 0 0 333 0 0 0 722]
/LastChar 238
/Type/Font
/Encoding 19 0 R
/FirstChar 32
/FontDescriptor 21 0 R
>>
endobj
23 0 obj
<<
/Type/Encoding
/BaseEncoding/MacRomanEncoding
/Differences[32/space 58/colon 75/K 80/P 82/R/S 97/a/b/c/d/e 108/l/m/n/o 114/r/s 117/u/v/w 121/y]
>>
endobj
24 0 obj
<<
/Length 2977
/Subtype/Type1C
/Length1 2977
>>
stream
  FBMUXK+Souvenir-DemiItalic   J¯ ¯¯¯¯Å)¡˚˚™˙o
 ãã
 ãã   ˝   ˘  (ö  í Nfr}ITC Souvenir is a registered trademark of International Typeface Corporation.ITC Souvenir Demi ItalicITC SouvenirDemi Italic    3 F T V N O 1 B M C S  D W  4 Z , X P E    ≤$ó6î(†’RÆØv∑P›Ø	V	©
:˚ ˜ã≥˘À√˜∂˜¨˜Y˜‰˜»˜ú•V√*ãCUSüãbyóÑöà˜l¢Øç´ôÑíÄëoúàûÑ™vÊ}ª[ﬁ†Ï®ÿ˜˜/˚:Ç˚˚ŒqdàiñÉîÖõîáv=¸kNèÉ\iÉÇÉ}oßãü˜M£¨å´ôÅëÇí|ñÅëû”¯E‡öà¡˜ Àœv?PhVXpSlC~LÑE|‹˜˜œ’˜?˜j˜'˜â˜JÔò˜ô≠˜#±p©lù°fXîa48nQINW\=9˚˜I˜Õ‘†¨√üó¬Ø®ö}ñ|}w}ÉÄo]aqS@_¥÷âåœÃï”ı”©®yj9˚)iKá˚|Œ¯Ã˜˜8—˜A˜¶|«≈ô¨Ω∑ß≠∫¡˜'˚áp‡≥≥ù≠ÎX-ã›®•ü™Æo§põ£cZì\SS~l\cqm\[˚&˜~§8ZZxacqï≥¨ÅÅ®bjpqi`≥lÆ{v∂æÉª©|Ó¯≥˜/˜C˜˜VÜnÑnm?–^—Ëœ‘⁄∞äzÜJãsè]¨ãòîêèñøüüì¿üöóíëëíï¨Jw¿¢î∏è¶≠˜Jçïë•ãî†qÜ~F}véÄÅÑVà{<Z˚y(ãnãxüã©ãùí©éûõ‚í≤ù”Æ¢Ñ´oh@k}iyÑm~smøù[}átà}˜ﬁ|≥¯Í˜.˜+˜7˜,˜5˜5˙7˜∞ë≠ê¢®÷K∑E/H:>héúéõú–P≤J)J4<dê™ë´´¢âªjnKn}r{Çk|ulΩüYi~IÑhi˚Iã~íÖîá˜îåëåèçïëèòê¶òÃñ»ô…¶√õÆ≠Ã∏ã´ãñoãnãh|AÑfp˚âÉáwÉ}íÖïá˜ïìëïé¢ø˜kπõµÁ≈ßópsuÅbápÉai˚+kuóv£™’•ñ®ûìΩö¶¨Lv∫©|≥¯È˜(˜4˜?˜8¯M˜áwÇawsìrßÆ †ò´ûìæú•ÆMrº¥˜{ã›E∫Cã)KC<_í¶ëß®§ÖµjqCjr{Ñh~ue¿®OsÉ]Üsb˚aà}äwùã˜üè°§êú‰ô”∏˜OÍã≠öpkwÖkáv—ã≥˘Ã≈˜∏˜ï˜W˜ﬂ˜ØÌÓô≤‰Ïµ„€˜–Y¿M°ûVCãS˚¥slÜm~ïÑîÑúîáu>¸játÜayzÑÑ}ÇÉÖÄÉÇÑã|ãp´äüã˜U†•î§ôÇíÄí{ñÇìû‘¯uè£ë¢íïõ£¨ê•ã◊ã»lã9ãKYQVjZnRRáÅ|‡˜“’˜7˜b˜¯:ÆqòsßßÀ©ò¶úí¨ñ£±Ml√«±˜Põ ®íxõ|k[eusµq\ù[˚5˚˚,˚3#«2˜ﬂ ƒ‘∞˚^X~≈¥∆°œ®Ω©ù±µ≤∂úhdSx?sXgyhT]˚∂|≥˘H≥Ù®wís£¨⁄©ò´üì≤ó¶¨Po»Ù¯·ãùîzãi˚3_bp∑ìãfÅ|—˜ÈË˜x≥˜X˜H˜˜?ÈºâÅàÄÅwô~û´º±†°b©øyΩ›€Æ∆√Ωø±‹÷˜HÊ˚	IRjXd∆˜–ã§|ñsã};vÅkuÑjÄom≥ò`˜p˚t…ôQY@X˚2-Vwµª∫ûÿ°∂Æù≤º∑˚Rã≥˜›˜˜3˜1˜wµÜû±ìøïπ˜òÀ©Ñ[ºªûÀ≤≤x•b3X4Coê™í´™§Ü≥j˚a|Ñh|ãuyõÖôÑ¢Åå}tW˚ƒãq®êùã˚|›˜Ò‘÷˜?˜ËŒHp√«¿ö ß∑Æ°¨±∑◊R)Ë≠¨£∞™v§sú•fWñ_˚7˚+˚˚;˚Ò@˜	»«ú´ø¢öΩ±™õ~ñ|m\=ã,E|‰¯≥˜-˜DÒ˜0˜"˜°x*Üwàvãu3Ôg’‰ﬂ≈”ºπÃ©Ê€√{›FcledE—ôãM8H˚+gv¢∞∞öÀí±ïΩí±î≥ã≤®ÖüjlJpmvÇc~nlΩ†\ÄâÄäÅ˚ﬁ|˜5˜˜5⁄˜R˚%˜R†˜7|ºƒ≤¿πc¢aVTdRa∫t∞P∑˜©º≈≤¿πc¢aVTcSaπt∞©|⁄¯˙–˜˜R˜L˜R˜Û|˜3˜OÍ˜F˜l¸
Uã˜.ßù©°ú†¶Øì¨˜c4˚8€öôîôíîûèÀ°òãñÇïÅónó~êN¶DöHã?ã@wMaN`bLã?ã˚˜c˜i¬z⁄wãEãgsiowktbÑdãBM¶”v∞ÅÄ≥\^of_J√`¡sm…À–1˚W˜ŒÓ¯≥˜˜6˜+˜ ˜º¯S•Çõnw4rÖvzÖkÅtyôáöÖ£ÉãÄtâ/ãRã<°XX†∑i√®ß§†§au+-_u}¢lklwj`∂z∞˜˜˜+ﬂ≈ÀÁ‘˜'˜∏{¿Tdmhfpó|úxôzèÉuVC˚@LGá˜&∏˜ã≥˘ ≥¬˜≥˜/˜∞˜˜6~EèãXgÅÑÑÉããq¢àüã˜O£¨é´òÅíÅë}ñÄëû™˜PÊ¡¥H›˚7ãw|ÇàÄÑ~ÇÉ{g∂ê£˜0•Æé≠Æjyy«y»iœm√6˜˜s˜]óîìéöíüîûñ§•rèu˚"tqÑpzïÑòÉíÜêàÅ|zzÄÅ[`˚<˚$Fe™˜Pï≈âôπ©óîñíãöã¶révã˚LsjÖm~ñÑîÑöÅïÖx˜R|≥¯<≥˜+˜E¯˜!˜˜{ÑhQihóo¶ux£±|™ÔÃÁ·´áxàxw=”a—Í ∆Ÿ∑±À®ﬂ÷ºÄÍJbsbfDÃòãMKY˚';iz©´¢˜O°˜	å≥hÜyã]iuëbÑ~6ÄFp<}ce1WãlãÇ®ã§ã•ì≥è§ûËë´ó¡´´~ùklJn~myÉgrmªú]Å|“˜˛“ÿ˜?˜Ö˜?˜‰|€ﬂ¶ø…≈Ω≥’Ÿ˜(˚÷˚8:pTMRVd?<˚#˜D˜ê“Et«»„≤˜-˜Œ§RP4e˚3˚©|·˜Ï’˜x≥’˜?˜k˜¯z¯9ªndüQ˚2˚˚5˚+"Ÿ4Û——„ØÑ+ãtêd™ã§…§î†ùìºú§¥Gj…Î¯‡ã†}îwãg˚/n]|öÖñÖúÅêÇw˚Z¸µvtöúÄ{¢á®•¡°–©∏™†¨Æ¥¿ö_^V{Fs[fxi[\|ö¯uì˜á§˜Ë˘endstream
endobj
25 0 obj
<<
/XHeight 757
/StemV 190
/FontFile3 24 0 R
/StemH 0
/CapHeight 732
/Flags 262242
/ItalicAngle -10
/Descent -15
/FontName/FBMUXK+Souvenir-DemiItalic
/Type/FontDescriptor
/Ascent 732
/FontBBox[-123 -278 1296 987]
>>
endobj
26 0 obj
<<
/BaseFont/FBMUXK+Souvenir-DemiItalic
/Name/F1
/Subtype/Type1
/Widths[340 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 320 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 780 0 0 0 0 720 0 780 680 0 0 0 0 0 0 0 0 0 0 0 0 0 640 640 540 680 580 0 0 0 0 0 0 360 980 680 640 0 0 460 520 0 680 580 840 0 560]
/LastChar 121
/Type/Font
/Encoding 23 0 R
/FirstChar 32
/FontDescriptor 25 0 R
>>
endobj
27 0 obj
<<
/Type/Encoding
/BaseEncoding/MacRomanEncoding
/Differences[32/space 40/parenleft/parenright 44/comma/hyphen/period/slash/zero/one/two/three/four/five/six/seven/eight 65/A 67/C/D/E/F 72/H/I 76/L/M/N/O/P 82/R/S/T 86/V 97/a/b/c/d/e/f/g/h/i/j/k/l/m/n/o/p/q/r/s/t/u/v/w/x/y/z 135/aacute 142/eacute 146/iacute 151/oacute 161/degree 169/copyright 213/quoteright 231/Aacute]
>>
endobj
28 0 obj
<<
/Length 9389
/Subtype/Type1C
/Length1 9389
>>
stream
  SMDBXF+Souvenir-Light   G¯ ¯¯¯¯%º˚1˚aï˙_
 ãã
 ãã   „   ﬂ  hö  $û N`lITC Souvenir is a registered trademark of International Typeface Corporation.ITC Souvenir LightITC Souvenir  A  & M  N F U P S Y B E T J W » O D V Q R  - K [ ÿ I C  G H  ” Z œ 4 ) L    . * X "  $ 5        ' 3 0 1 ™ ´ / % 	 
 7 ° C   ∂ˇrÀëMÔw˘{˚ﬂÑÍ	Ö
.
Ω
ŸSœ\Ú∞0Uÿ_öEˆ´>¸∆)WÙ∞æYïÆB®*Ø7ª≥b–]ˆ ´!!!}!Ÿ"l"¨˚ÚYãø˜–ø˜òø„Â˜F¯˜Y•óãyüÖëíÑî¶â£üäöíƒpÄáÖÑÑxvxäp˚T˜J≈áûüΩ˜5∑∂li¶ÜèêàìïëëïåÉ»àüÉ°rë¸Ozxävyòàôá®Üéus¸§déÉe~áÄá{uûäõ¯f∏åáâîæéùí©ãúãîÖìÅã~ã|zÇÉhjhuXã˚*;É±›¸Bã≥˘9≥’÷’˜zêbz~yÇÇÜÉÜãÄwïâú˜†ëçüóÉèÅêÄëÄêäéàóÜõå†ú¯Êúé¢sx[uÇyÉÜáÉïÜëâûÖõÅs˜Rã≥¯¬⁄÷˜}÷˜}÷˘ñ˜¥ªÜ¬k∞Æm^ú^JMhVf√i_´HHSiUd°àÖÕlyxyÅ~ÇÉw~}Äôàîà∞Äádk˚ävxáÜÇáÑáÄwòà§Úúöç†òÇèÅèêwå°˜à”€∞¿‰ñBD˚eutâÇÜÇÜÑáÄvñâ°˜°ëç†óÉèÅêzìä†˜à”€∞ƒÆ´{kõòqãko˚ouxäÖÅÜÑáÄvóâ¢˜ üíç†óÉèÅêÄëÄêÑçãö˚*|ƒ¯º¶€˜°€˜˜Dœì“íÀ§«¢«µã”ãµp∞h°mûfíhã˚(ã˚	˚ã˚'ã˚Ù-˜ãøãºú∂®†ôµÆãßïÇìÅpi7ã˚;DΩ›|Ö∂˜ä≈Ò˜ª¥tV˚˚My9Éãº¯ª‚÷˜6¯=‹û£ä•ßrÜu>˜'ôã£vqäcyâârÄTÇuÅrwãwã|ãyàã{ãh©ëΩã¸oçw¨˜öõìú¨_ÇwQá¶Ω1|º¯!º™€˜Ê€˜≠¯t˚˚˚˚˚˜˚˜˜"˜˜ ˜#˜˚˜ ˚á¸R˚TÁÒÚøÔ˜˜∆0$ZYmdbl[sX˚∂ã≥˜ˇÿÊ÷˜:˜∂ï™û´£ô®±©ü£vúùê¢ô∞y£dSQ=[w®áÄÏd}luÉÄÄÉ|Ä|~ôáîáûÇ£sc˚ÑkràÇàÇáÉÜÄtùäõˆúõç°óÉèÅêÇévè©˚*ã≥¯≥ì˜˜d˜˜Y˜~˚˚+woååo}ÅáÉÖÄwëäö˜òôçõ§fÖã®©‘€¢£úyúy›8ãuzrÜãyzïâö˜ôôçûóÑêÅê~ëÅéÅï{ôvß~ú˚˜˜˜%õ¢éå°óîêíêñõÇå{/}ä|t™éãxmE=utv¢=€ßú£éùõÇå}˚	|Çä|{ëàóÑ®|ôsùq˚*|√˜y∏˜	ª§€˜ç÷¯A˜∞«{æ[±´bQöWb`Éye|Ér{xzòÉöùóïîöû´ùì≤“ ]AêNéLãJÄUhWjj^L+ﬁ\‚”ƒ≠«±rgáy¥∑õ£ä¢ôÅèÄéÅéÅèÖîÉöå¨ãõ@˜$:`Öhinrn_~eqqïùwxúÑ°§Û˜¨ﬂ˚|ƒ¯º˜Å≥ô€˜´÷¯	¯I¶`kõV˚!1˚˚˚€˚˜…øßº±^çzò ú†Ö®óÉèÇêëÅêÉìãõ˘úç¢sx[vÇyÇÜÄáÇîáíàùÖùáw¸ùrãxyqq_{f˚bÎÌÁæÚÙæ®ys∂˚é|ª¯$∫¥ ˜`—˜N˜∑fï^ö∏ΩΩ°∑‰£@ã®úáÆï°äóxñ°e`ï`acÇpjjqwda˚I˜ü‚˚TSo[stíïurñÖïyüÅñÄúzã}ãÄ{ã~ãm™o¢}Øu±ÄµãËãÁ«ãã¨yÆr†tübômì¸.ã≥¯$≥ÿ˜‰÷˜¯¡≠£°Æ©s°mlrukm†r™‘¸¡ùöçüôÅèÄèÇéÄéÜîÉöé¨ãõ˜\∞é∞Ö∞ùàãßrÄyÜÄ|Öf{ÅÅÜáäáãÖãóáïâ∫ÅÉqé_˚gbÖ{nÉÄàÉÜ~wùâõ˚R|≥¯,≥å˜
˜îÈ•¯m~Ñ|t•ìï_¨˚#™(·˚ï}ûnûã¶ã∏⁄ìö∂‘ÆŸ°‹ú…í¶ãíú†êíìîãîãûåzã@{äy}ëàïÉúêvgg'}fw[r]la[∆9˜Dã“ã¬∏ã¶ãóÇïã˚*|√˜y∏˜	ªª˜5§€∆˜Cö÷Â˜v˘ëëúòïñÉçÇeàÑãläÑáÖàÑ{âÜY1áÉÖÇÅÇìÖîñóôëí˚g¸∏Í¯A˜∞«{æ[±´bQöWb`Éye|Ér{xzòÉöùóïîöû´ùì≤“ ]AêNéLãJÄUhWjj^L+ﬁ\‚”ƒ≠«±rgáy¥∑õ£ä¢ôÅèÄéÅéÅèÖîÉöå¨ãõ@˜$:`Öhinrn_~eqqïùwxúÑ°§Û˜¨ﬂ1ã≥¯¬⁄÷˜ñ÷¯{˜±∫à»i∞ØkXô\;XoP\£áá i{tvÇÅÉ|Å|Äôáîà≠Äâpl˚ñtràÉàÅáÉÜÄm¢íú˜ôóîôòÇèÄèÇéuè†˜l≤çß©ß§ß≥úµË¢][˚óusáÉàÅáÑÜÄmüíù˜òóîôóÉèÅêÉèté†˚R|≈¯º®€˜Ì¯zôê~£ûö†ù•w°wò°kcñe˚$(˚
˚ ˚›#˜¡¿°Ø≥ôò§¶üñÑíÅ|Ç~ÅÉgm[x]*R·Â∫ó∆§≥∞°≤®∑ªûxh¶˚|¬¯$≥ ÷˜á÷ ˜D\êY©dg¶πx∏Ã…∞π∂eòmö—úîçüòÅèÄèÅéÅéÖîÉöå¨ãõ˜ª°è¥kzjÉÑ|ÄÜÜ~Åîáíá©zÜnl˚;gêupnjmWw_ijö™{~§å´ß˜í£á™k{D{xÄïÖìáóÑìáè~ízänãyE˚Xæ˜æ¯≈Í÷˜æ€˜>˜†∫îÆØ¨•®∞ò≥˜±+-\ÄWpdjt_rariëñtéÜÇèÑÄÑ~ÅfÂ|§Ãœ®Ω∂∂ºô À…{«b∫∏cS•OB\iW]´ÉÑ¡auJlq|ùãïâ∏Öà`h¸*jàfnÇÜÑávïãù˜úìçûòÇèÅèÇèÅéÜîÉöå¨ãõ˚˚Xæ˜ƒ¯ªö€˜∂÷¯`¯Móè¶xwslÄ|®d^òZ˚#,˚˚˚⁄˚˜…∆™ª∞˚2jàqoâÉÜÑàxïâú˜úêåüòÇèÅèÇèÅéÜîÉöå´ãú@˜Öeãvorqmb|d%YÂËÛ∏Ú˜
¨Æt£®oëheÉˆÎˆ˜)Éß•¢®™t£lnsuml°s™Yãæ˘≥ÁÂ˜J˘≥Üê∞ôòêñçú†xåz˚zxãuxôàöáòàüá|¸¿céÜf}~ÜÅà{uûäõ¯bü†â°ïèìòÀìñÜîz{ÖÉen{Ü[Ñ˚ÖUuå\äxô}ñè£ãõ¸B˚aÿ¯Ã≥ÿ˜Â÷˜ ¯¡≠£°Æ©s°mlrukmür´ƒ˚~∂å∑Ö∑ôâÖózzÄÜ}Ñf{ÄÇááâáãÖãóÜïâñâôàíÇï}ãrãz¸Yä_gÄ~ìã{tx{st§}†¡ª»πû£¬é◊«˚zãΩ¯	Ω°˜˜9ı˜‚ùüäûììûì¿°íàëÉ~Ä|ÇÑÅydk˚xÄéññìôíìÃﬁ˜˜+†•∫√ã≠™eÜv˚ÑÄzçÉÑÑÄÑ_à~äÇÑlùãóãíöëì¶±¢é∏ã›î£è|}}|ÉÅ˚˚%ng#˚ãcj∞ã£1|º¯!ºª˜5™€ﬁ˜C€€˜(˜v˘ëëúòïñÉçÇeàÑãläÑáÖàÑ{âÜY1áÉÖÇÅÇìÖîñóôëí˚Ö¸∏‘˜≠¯t˚˚˚˚˚˜˚˜˜"˜˜ ˜#˜˚˜ ˚á¸R˚TÁÒÚøÔ˜˜∆0$ZYmdbl[sX1ã≥¯¬˜Å≥ÿ÷˜ñ÷¯y˜≥øÜ∫g≥ØjZù\OPta_˜¡úé£rx[vÅyÇÜÄáÉîÜíâùÑùám¸¢|åfÇ}ÑÉÅàÅàÅáÉáããm†íúã˜	ôóìöòÅèÄèÇéÄéÜîÉöå¨ãõ˜Ç¥∂≥¢»‘¥^O˚YyåiÇ}ÇÅÜÇÜÑáãÄmüíú˜òòìöòÇèÄèÇéÅéÜîÉöå¨ãõ˚|∫¯!æ˜Å≥…÷˜®€…˜gUçIÆ_]Ø≈{ƒŒ–®Ω∏πøõÃŒ˜N˜˚KRk\d˜Œúå§sxZvÅyÇÜÄáÇîáíâûÑûáj÷˚≈π®≈µƒ∑Øigü†fñUa0a$!bdüÆtsÆäª¥†v˜ïƒ°˜î˜˜ï´ñàØßváu˚>kÄéhn†è°ã≥¯ª˜ÄŒÌ÷˜A¯=»ù¢ä£®wátP˜®ÜÈ∏ññÇÖìáëéáìüõùü´lümKcRSzzRçDäMqwlíml™ë°£˚¡wè`vÄ|ÑÅáÑÜãÄvìâù˜úõç†òÇèÄèÉèÄéÜìÉöé¨ãú˚˚`√˜>¡˜˘∫°€˜™€¯7¯9°ΩÉ¨•påqZDåëK˚-+˚˚‹,˜••êî§µx∏uU;$ÇOi!êºîçìãììáíÇoq^qE˜#ÇªÈ˜8¢˜ÀTµTü√∑¨Ã”Œq≈]π˚/˚Ì.eÁ€ﬂµÌÓ≤05-b5!ÉÛÁ˜˜(É†èÉtNH_ã~ÑíÑëëîïéé∏≤™À«∑x∫Ynqvm|ízñÄóÄòãõå¸.ã≥¯$≥ª˜5≠˜C˚÷c0˜v˘ëëúòïñÉçÇeàÑãläÑáÖàÑ{âÜY1áÉÖÇÅÇìÖîñóôëí:¸∏»˜JùöçüôÅèÄèÇéÄéÜîÉöé¨ãõ˜\∞é∞Ö∞ùàãßrÄyÜÄ|Öf{ÅÅÜáäáãÖãóáïâ∫ÅÉqé_˚gbÖ{nÉÄàÉÜ~wùâõ˚>˚a–˜/ø˜˛≥ã˜˜¢ﬂπ˜ﬂîIü:©P£\∫P≈ãõãöêöêyQ8 Jãyãxìzãxã{zãxãm®Ä•ãÙãÂ˜πﬁΩÊπ˜úÚô‡é°ëñïûçèåëãèãòÄåÄã3~Çä}fª¨ã2Ts3xWiÄsJ^vr†ôv¢y≠Äß|µsÚãµã…≤Çã•ãòéÄã!{Åâ{ÅïÜíÖû~åwéu˚*|ƒ¯ºª˜5¶€ƒ˜C∞€Â(˜v˘ëëúòïñÉçÇeàÑãläÑáÖàÑ{âÜY1áÉÖÇÅÇìÖîñóôëí˚g¸∏‘˜˜Dœì“íÀ§«¢«µã”ãµp∞h°mûfíhã˚(ã˚	˚ã˚'ã˚Ù-˜ãøãºú∂®†ôµÆãßïÇìÅpi7ã˚;DΩ›|Ö∂˜ä≈Ò˜ª¥tV˚˚My9ÉY|ø˘'æΩ·˜˛ÿ˜°¯PFúK™‹◊”∫“˜,±˚ãßùâ£ñòã¨àóáóÑëÄíW¨DõNãHãN}X_]enTãOã˚†¯T˜ã˚hã"'X.ãXãXó`ßf£x©v∞ôÉÇòzyÇ{{\æUÆqe¿Œ~Ã”—õπƒΩ¥¨…Õ≈r¬]∞d©Qõ\ñ˜*ã≥˜‡ø˜†≥ÂÂ¯EÂ˜H¯¯E˚ûdéÇdÄ~áá{uûäú˜!õûå°óéÅêÇêÄê}ëÜëãö¯∂≤àî≤ñôèñèú†xå{˚"{xävyôàôÜôàûá|˚Ç¸E˜^≥âí∞óòêñéú†xå{˚{vãuyöàôÜòáûà{¸ødéÇeÄ}áá{uüäõ˜úûå°ú~é}ê~êxéö˚*ã≥¯≥˜à≥ÿ÷˜ı˜ˆ¨Æõ¢∂ûóêñëãöãõ~ã~ã˚	ä}ÄëàìÖìÖíÖÄ_˚˚ dm¯xúç¢sw^wÅxÇÜáÇïáíà≥}Ürd¸|{éfÅ~ÖÇÅâÅàÅáÉÜããvúâúã˜ôóîôòÇèÇêÇéÅéÜîÉöå´ãúæ·—ÆlÌ˚ãavjèãsyôâô˜úìå†óÉëÅê{ìáêÇú]ŸS÷I…òòYã≥˘2≥˜´Â¯˘Yóå®w|~ÉÄ^j[zSázâhåãsãyùàöã¿ç†±äyöï}âs{¸5KâwBÑzâYãrv§âõ˜µ¢öç££_ãzåEèÜöŒ˚˚≥˘¶≥è¯´ñCÑãr´£îõûñ¯Y˘ØëõãümãsÇ~zÅYã’˘ª◊›˜∑Í¯^¥ïà∑ïéõëúíöèìî†ãïãïÑìÅã}ã~ÇÅ^Z|ãGã˚kºÍ›“‹Õ€ÃÓ‹ã˜ã∆oº]≠]¨\ïTãKãLzZ`chmZãUãe°d¥ã£ã£óã¶òÇîÖïÅöáëû™•´¢ù¢´∞ó≤”…VA-.6LN˚.˚;ytI-ãqq°åû˜fã≥˘ ≥Ì∆¯ì„¯:˜z˚P¯UÉùÉØrä˚|Ö{hÃ¨ãP¸ºjãÜl~ÜÄá{uùãù˜òôêöûzè|ê{ëyéàù¯œüYÌ˚Üˆ˚yëìyõãúô´óë÷˜/˜$˜‰¸†bìág}~ÜÅà{vûâõ˜úûå°û|ç|è}ètéõ¯∆∞íë≠îóéöèö¢Äçz˚tÑtxÑ*˚z¸ã≥˘ ≥·Â·ıdéÇeÄ}áá{uüäõ˜úûå°ú~é}ê~êxéö¯øå≥áí±óòêñéãúã†xå{ã˚{wãuyôàôÜòáûà|—|‰˜˚≥ç˜˜s”˜sÊ˜‡¯mÄväzqÆíãb'S˚"M<lπwø{¿|∫tŸã∫ã≥±~ã•ã°Ñåyã*}äxt§íí]ö+ß'≥3ïv∏&©ãºãË˜uõ∑ö_ﬁ˚uªãñãëèíìù¢ü©ô•≤“™È°⁄ô¿î¨åîù¶éêçéãëãõ{åã@}~äxq≤ñãX=N˚>ZJ[ÿJ˜0‰∂∞}®úÉç—ã≥˜lø¯(≥ã˜¯C˜)ﬁ˜Pg$ÉwÜÖyÇÖÑÖn∫ëù≈ùµÑ®©V|ã…ÆÆﬁñ≤˜Ÿíxïq∂˚	ãxkXñãlvüâõ˜ú¢ä¢óÑêÅêxïÉëÉüd˜ X˜5<˜R6˜%Ñóm√xã|ãu_~s;˚%<˚RS˚5˜˜˜$˜⁄˜˚¡ñr¸†v¯è˜Ñ‡˜˜˘qtxpj†{´åúêÜxNOgã~ÖëÖëêììéé¥Æ¶≈¬±z∂^—|ƒ˘"æØÒ˘A˘äôâôÇòÇòkú}ìO™KõHã˚rã˚=˚Uã˚lã˚a˜9˚(˜\ãÀã–ù¡≠§ö÷ƒã¨ãòÇñ~ãzÄzÅÅMMNh34=™‘Wa«wÂ”‡§‘¡Õœ¬ Ø„∫∑~p±¥mõm†`ëìqõãüãêúãúÅã≥˘æ˜¶Â¯ ¯˘∫â†√£≤ÜÑ¢∞Äò®tîÉñòãóãëïãñãìâïâìâôÉøÇïÜêÑãÑå¸øsàC}âäÑâÉÉëÄôóóôíì™•ùö¥î£ê≠ê§ãºãÜtãd¸ïdéÇeÄ}áá{vûâú˜úûå°ú~é|ê~èxèöY|∏˘4ª‡Â˜ëÍ˜…˜ˇÊÜ∆J1\yWikli[Ä^AL¨€Ü¶âÖûll{un˚˜#bÊŒÃòµ¡ø≥´»ÕÙ,—-ùŸ°Ÿ¡Â˜ Ã˚ PJxf]ptqiek£w™ù°î†óÜöãö«≈¢ø◊Œ\;b`nnefbáZá{â_çãrãvüáúäY|∏˘7∏øÍ˜ÃÍ˜√|˜R»˜z˜*€zÔe—’cI»1˚QM˚~˚+˚*…˚z˜Q∏Cd“∆xvÃÜ’ÕÃê‘ù…»û≤⁄÷”≥@PûüLê?HLÜAyNNxd?@Y|ª¯æ˜ó≥ºÍ˜“Í˜%˜˝ï˜=ı˜-˜E¢ôåØåã†ãû{ç|ã&ã˚SGD42d˚ã˚ã@ï:∫MºJ‘m‹ã˜%ãÚ˜ã˜"˜9‰˚>ChXSäQø∏√¥‘Ó∏73|ÉYá|NyVYHHU∏»twºÜ…å¿Yã≥˜/ƒ¯^≥ßœ˜îÂ¯N˜WÌüõç§®{år.¯Jßã´esÄÅ|y4:QMQ:a@s`U˚]k´è¢˜°2^èÄ\ÉÄâÖ~xùâö˜2öùçü†{åzè|èÉçÖôÜòä†ãô1˜˚î¿˜-‰˜ ˜˜Y|º˘1∫ª‘˜Ì‘¯¯+‘±·¡Êˆ˚¿0PQyf\^imUR.–VŸg6i)J%˚˜U˜ŒÀö≥¡æ±≠∆ ˆ4À/Ø˚P⁄h˜j!-!]9cdê¢ii£s≤¥Ê‘≈ÿ¨ÃÿG£˚≠‰›‡º÷‘ÿ]:DBZRlY|∫¯ª˜]Ÿº‚˜ÿÏ˜C˘'≈»∆éö∆°ë∆ù™ôÅèÇvàâÅ˚-É˚1òt¸	äyâu£ã∞≥‘ãıˆæ;(˚B?˚V@†Ãîéîãî¢vñvmyyn\≠c∞up∏¬Äæ”’û∫¬¿π´——˜% ◊˚UV|o\Yn≥˘‘¯_€¯_˘'˚ß˝
áÉàÇãÇt™Çû¿è¿µö˜r¯Îêóòßãñ†wÜ|¸}yéÅÇÅåX}â`ã{ât°ãùèööçÃì≤â¬1ã≥˜…ø˜´ø‰Â˜G˘!úõïµ˜8¬≤rq§Öëò|ïïéíîç…áùÉ¢kê¸OzxävyôàôÜòáûà|¸¿äcèÖe~~áÄáã{ãvûâúã˜úüå°ù}é|è~èyéõä˜™˜d©ïãw°Éìèáóüâßòåõï≈lÄáÜÑÉyuÄäo˚c©ã≥˘øÊÂ˜—Ò˜I˜Œ˜6®∏]˜˚8ãTfXñãlv§ãö˜(ôüãüõ}éêlôÑô}™`È]ÁGŸ›∞›«ãÔã¬oª\©^©XêVã˚Àzxäuyôàöáòáüà{¸øäcèÑe~Üàãzãvüäõã˜úüã°ù~ç~ë~êyçö¯´†äßûòòùºã¢‚˜|˚˚'˚fu z˜*|ø˘%¿∞Ò¯ôÒ¯|˜n˜,˜7˜kÒnÌC’”F-±(˚o˚˚B˚g%¶-“@EŒÂgÎêø;G¥À_^Ãz⁄ÿ÷õ◊¥ —∑“∫ﬂ⁄‘bKππKú2=@y<_NJ[Cb:mã≥˜ÖΩ˜Òø‰Â˜◊Ò˜G˜¨ÊåÏìﬁ¥‹≥‘‘ãÏã“g¬L´R©NèLã˚ò{xäuyôàôáòáûà|¸¿cèÖf~~ÜÄà{uûäú˜ õüå°ù|é|è}évèö¯©¶â¢ßôó¢¥å•ººáp∂≥q•_Z˚0˚[^˚é˜R|∑Ë∆¯¬‡∑ø∏˜‹¯Q∑¿¯˚f˜8˚?˜^˜_˜8˜?˜f˜f˚8˜?˚_˚^˚8˚?˚f˘E˚M˚%˚,˚F˚E˚%˜,˜M˜M˜%˜,˜E˜F˜%˚,˚M˚Y˚aooyW(bÏÂﬁ¶˜Ó˜z!ã≥©á®†âäùå≠{òg©Lõ^ã˚ã9˚ã˚ã˚Ÿ˚	˜ã√ã¬ü±πñóô†ãùãöò}ãzãÑÇ}—ã≥˜lø¯(≥Æ˜5ã˜˜$˜C˜˜)˜\˜ó˜v˘ëëúòïñÉçÇeàÑãläÑáÖàÑ{âÜY1áÉÖÇÅÇìÖîñóôëí˚’˝ªÍﬁ˜Pg$ÉwÜÖyÇÖÑÖn∫ëù≈ùµÑ®©V|ã…ÆÆﬁñ≤˜Ÿíxïq∂˚	ãxkXñãlvüâõ˜ú¢ä¢óÑêÅêxïÉëÉüd˜ X˜5<˜R6˜%Ñóm√xã|ãu_~s;˚%<˚RS˚5˜˜˜$˜⁄˜˚¡ñrÂ|≥˘/≥Ù∆¯@∆¯‰˜PU„V‡T‘Xœa√˚˜Coä˚~{à{yùâòà∑Çãje¸[ì}XÅ~àÄÜ{{ñÑö˜ôóíõ†}çyènìäò¶¯Ø˜
˚Ê˚&Ë˚#∏FøI∞AêÅîxôãßãÜ≠ãû¯’ïä®éïèòõèóêñèôèãöãú}ë|ã˚}~ÜzwõâõÜôáïàé{éäqã~Âãæ˘
æ‰Â¯?ÒÃ˘p{xâvzòàôÜòáûà|¸¿déÉe~áá{uûäú˜ó˜Â†⁄€—“ÆÈÓ˜bÚ)‘–.-è˚/˚.›í†ÊﬁÍ{N… N•-5˚Y˚˚˚W˚é°Ú¸.˚2≥˘◊≥∞Ÿ˜t˚&ì~•àíM˜l˜˜"˜#™˜…˜éíò•ìïzçÑwÉÑ{ÅtgpR{be+v'ã#ã˚&¥˚–˚òsìr´ãëãùçãï¸.˚2≥˘◊≥˜⁄ö˘}ÉóqèÑ»˚™˚˚#˚"l˚N˚áÉrÉÅúâíüìëúï¢Ø•ƒõ≥≤Ï†ÔãÛã˜&b˜F˜~£Ç§lãÑãzâãÅΩq≥˘:≥å˜'¯<˜¯¨˘p|}âykÃóãYMJ˚DsKi1f2W:W„cﬂgÂpœR˜3ãœã´ñè¶ôîèóìãñãù{è|ã˚#~xàzl∞ûöJ•˚≠˚¥ ≥#º"À.î~ñ|ùãüãû®ïôÁ˜Ï˜ï≤˜´˜êôëîóïìíïíãòãôÄë~ã˚é†v¯V∫˜b∫Ω∫˜b∫˜Ú¯Ï›Gœ98GG9å8ŒHﬁ›œŒﬁ˚ë√ä∫∫√ƒ∫\SQ\^SR]∏≈zú¯jó˜å≠˜¿˘endstream
endobj
29 0 obj
<<
/XHeight 764
/StemV 75
/FontFile3 28 0 R
/StemH 0
/CapHeight 730
/Flags 34
/ItalicAngle 0
/Descent -17
/FontName/SMDBXF+Souvenir-Light
/Type/FontDescriptor
/Ascent 730
/FontBBox[-157 -205 1173 971]
>>
endobj
30 0 obj
<<
/BaseFont/SMDBXF+Souvenir-Light
/Name/F2
/Subtype/Type1
/Widths[300 0 0 0 0 0 0 0 240 240 0 0 300 300 300 520 600 600 600 600 600 600 600 600 600 0 0 0 0 0 0 0 0 720 0 720 740 600 560 0 800 260 0 0 600 860 740 800 620 0 680 600 640 0 700 0 0 0 0 0 0 0 0 0 0 500 520 460 520 500 300 520 560 240 220 500 220 840 560 560 580 520 360 400 300 520 460 720 500 480 420 0 0 0 0 0 0 0 0 0 0 0 0 500 0 0 0 0 0 0 500 0 0 0 240 0 0 0 0 560 0 0 0 0 0 0 0 0 0 400 0 0 0 0 0 0 0 840 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 280 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 720]
/LastChar 231
/Type/Font
/Encoding 27 0 R
/FirstChar 32
/FontDescriptor 29 0 R
>>
endobj
31 0 obj
<<
/Type/Encoding
/BaseEncoding/MacRomanEncoding
/Differences[32/space 65/A/B/C/D/E 73/I 76/L/M/N/O 82/R/S/T/U 97/a/b 102/f/g 105/i 108/l 111/o 114/r 146/iacute 234/Iacute 238/Oacute]
>>
endobj
32 0 obj
<<
/Length 3952
/Subtype/Type1C
/Length1 3952
>>
stream
  JZCTWV+Souvenir-Demi   G¯ ¯¯¯¯)¡˚?˚Øa˙É
 ãã
 ãã   Ê   ‚  ö  a N_koITC Souvenir is a registered trademark of International Typeface Corporation.ITC Souvenir DemiITC SouvenirDemi    * / 5 3 0 % 6 $ ª . " & 4  - ∂ # J C M P H S B G ”    j&∞h∆<÷\˘Àdπ∫2ÿ	u	¯
s
›-∆Q÷d˚ ã≥˘ ≥◊˜J◊˜vètuÄÄÖ~ÉÄÖãyp¶Ñ°˜R°¶í¶ùÄë~ìÄëuñè¢ã†¯r†á¢°ññëòìñëãù¶píu˚RupÑpyñÖòÉñÖ°Äátãv˜ã≥˘ ≥‡¯4‡¯Ó˜®˚˜QW‘CÙO ¶rÖäf˚qläjsûÜûÖª|Ñfå`¸OäâàÇÑy|á{ÖzÑÉÑãxãi∏é¢ã‚¢∏à≠ûÉízí{ë|èÑùàîâóäó¯7˜Õ¸Cõs≤Mùy{öôã°»éõ¬¯≥åóçóéîíùöèõëúíìíãûã≠^àtã4t^éixìÑúÑõÖöáíyéÇçå©ã≥¯˛’˜ä˜J˜ä˜vètuÄÄÖ~ÉÄÖãyp¶Ñ°˜R°¶í¶ùÄë~ìÄëuñè¢ã†¯qØàù∂˜ç8ãπ£ôö¢ñàñâïàùÑæ|óÇísäã¸îsåÑÇ|ÑXàyâÅàÄãÄãtô|£ãπãçﬁ˜ã∂ãàyãgÂã≥˜ùÿ˜´“◊˜J˜~˜W˜ó˜≈Óõ≤_ﬂ˚ãXo`éãmiØå£˜Xû¨ç¶ùÄè~ìnõÖö~©i„c·J—€∞” ãÈã f√SßZ§LçUã˚¯äupÑpyñÖòÉñÖ°Äátãv¸qvètuÄÄÖ~ÉÄÖãyp¶Ñ°˜S°¶í¶ùÄë~ìÄëuñè¢ã†ä¯T†ã©ööõö±è†⁄Õg4˚	˚ f-â˜f|◊¯ˆ◊´˜W¯(˜W¯;|˜n˜M˜3˜t˜w˚H˜,˚p˚n˚D˚1˚r!∞+◊BF‘ÙdÔè◊˚1`˜N˜ÕîÀ©∆À¨¡∫÷˜3∑˚H˚˚_˚B˚4˜>ã“¯‚“÷˜J˜⁄˜W“˘pupÑpyñÖòÉñÖ°Äátãv¸rvètuÄÄÖ~ÉÄÖãyp¶Ñ°˜◊ÙÒ§◊◊—“™ÔÓ˜bÔ1—œ5+ñ"$˚1 ã¢“˜@ﬁ˚#˚2˚/9˚˚;?ä¶—˜|ÿ˘
≥»˜J˜Û‡˜á¯èµáë∞õôêïìãúã©lètã˚UupÑpyñÖòÉñÖ°Äátãv˚∂0î+—HR«Ôx”·Ú°—∆ƒœçÓﬂ˜ª®ïé£óôíóíù´iår4riäkyóÑôÑ£ïàn˚ UãDq[WoJqUMO§»mrºäÀ¡˜|„¯Ì‘´˜W˘¯∫wïól¶§úö£°à–ÖûÜö}ï}ìJ∑2°=ã˚mã˚X˚>ã˚tã˚r˜J˚&˜hã–ã‘ú∆Æ∞°Œæãªãû{õxãrãwq{{[]KmL@F™Õcj√y›Ã‘ö”µ»∆¥»Ø“∞≥~r´¨rórúg˜f|◊¯ˆ◊π˜N´˜W·˜tÈ˜W˜Ñ˜é(˜ù˘(öñúï†™lâvâ^däâÉxjW0ÜÉÅ}ÄñÉóôõôìñ¸˝√‘¯;|˜n˜M˜3˜t˜w˚H˜,˚p˚n˚D˚1˚r!∞+◊BF‘ÙdÔè◊˚1`˜N˜ÕîÀ©∆À¨¡∫÷˜3∑˚H˚˚_˚B˚4˜¢ã≥˘ ≥ﬁ‡¯z˜J¯c˜¬˚ ˜˚|≥Ü™[ã˚WqläjsûÜûÖ£Ññ~èzéÉãÇãá¸täâàÇÑy|á{ÖzÑÉÑãxãi∏é¢ã‚¢∏à≠ûÉízí{ë|èÑùàîâóäó¯=˜D¸0ùdòà∑ãæè†µù˜6¯&¸FvètuÄÄÖ~ÉÄÖãyp¶Ñ°˜R°¶í¶ùÄë~ìÄëuñè¢ã†¯w•çö¶ìûëüë§¢|òx˚N^áÄbzÂã≥˜Z›¯≥Ç˜,˜‘˜≠˜
§øÜ∞∞WÅã∑´ßŒïÆ˜¨ê{íu¨(ãzt`èãkk±ã¢˜=£¶ê®öÑíízïÜéÉûhÛ˚a¯tvºóSãfyâjyoXsYuYX˚W˚e˚g˚ÑyÑá{ÅÄÉÅÉã}ãd∏ê¶ã˜&˜”˜˜ûˆ˚éê{ïã‘¯‡“÷˜J˜ï˜¯˜+œÉhã≠≥Üƒ¶§ã∑hiñfãD˚+˜Nòïñöëíù∑å†©∑âÖ•ßÑõûuò{ñ}°ã•ãïüã¢ã†á≈~õôpâ{ã¸gupÑpyñÖòÉñÖ°Äátãv¸rvètuÄÄÖ~ÉÄÖãyp¶Ñ°¯}∏ìèµòî§ò≤¶ûyôyqtmy{\`dàO˚åíÚ©|⁄¯˘—º˜H˜å˜D˜˜¯nRôFü”Ãœ´ƒ˜8É˚"ã¡§óú£§ã¥Ñ£áôÄìíI≠:ùAãEãA}RaRadGãDãI≠R¡f∂nœyæÇØÑ«~´{´|ùoãh;6gF_\ó£fj°}§v´}†|õpãnãwpãoãO–UΩs∆pŒÄÃã‹ãÿûÃº»∏∞—ã◊ã≈p¡^∞d™Oû[ñYã”˘ ≥ÿ˜Jÿ˜vètuÄÄÖ~ÉÄÖãyp¶Ñ°¯U∏ìèµòî§ò≤¶ûyôyqtmy{\`dàOfRé}ã∆¯k†á¢°ññëòìñëãù¶píu˚RupÑpyñÖòÉñÖ°Äátãvã≥˘ ≥»˜N¿˜t˚]˜Jw˜é0˜ù˘(öñúï†™lâvâ^däâÉxjW0ÜÉÅ}ÄñÉóôõôìñ˚	˝√»◊˜vètuÄÄÖ~ÉÄÖãyp¶Ñ°˜R°¶í¶ùÄë~ìÄëuñè¢ã†¯r†á¢°ññëòìñëãù¶píu˚RupÑpyñÖòÉñÖ°ÄátãvÂã‘¯„œ÷˜J˜ù˜W¯^Ã ó≥¿º∞®¬…˜2Œ&ûœß‘≈‹ƒl∫Zß¶\TéW˚ˇupÑpyñÖòÉñÖ°Äátãv¸rvètuÄÄÖ~ÉÄÖãyp¶Ñ°˜N¯„úä§óòúõØå†…÷Ä<!˚X4y:˜*Ø»y¡UãH#0e1umãözzöç°†˚Úã≥¯-≥ƒ˜3Ÿ˜7˜#¯∂∏¬¶ø¡Z•Z[ZlVZæq∑J¸7~åpÜ~áÑÉÜÑÜÅÖÉÑã~ãtùÉüã˜=üùì¢òÉíÅëÑêÉêáíÜòå¶ãò˜ú©ëœ\lRxÅmxÜaÖp{òÜóÑúÅìÜèvéuãlãum|–˜˚◊˜x≥≈˜7˜W˜A˜q˘'©ëœ\lRxÅmxÜaÖp{òÜóÑúÅìÜèvéuãlãu˚ÙIëN≈ak∏Œ~¬˜6˜Ë˜@˜5Ô˚!V\xjbé˚)®å©ú§§úßõ™‹ú˚OHx 59ÜÍ»˚Úã≥˘9≥‘˜7‘˜}ãoÜ~áÇÅÜÉá~ÑÄÑã{ãk©ã£ã˜1£©ã´õÄí~íÉèÅêáîÜòãßãô¯†©ëœ\lRxÅmxÜaÖp{òÜóÑúÅìÜèvéuãlãum|–˜ˇ”•˜@˜u˜@˜…|˜%˜!Ì˜1˜*˚Ó˚!?BvXQX]iIEB´Gƒ\_¡“y–å–+{˜÷’¢ÒÊ‰°(C=~˚'Y˚Wﬁ˜”˜€ °˜@˜K˜@˜ø¯}GC~`TS_qFE˚#˜;˜••éí§¨}¨wcK:Ä[tAí≠ëçèéêçèçéê¢dé{\LtR1˜VÑ Ï˜K¢˜–PÆPôÕ∂Æ ⁄øxøg≤•£å∞å≠µhäkT/ê5¸>Åı√√û˜’‘ú%SM~ 8˚fã≥¯-≥Â˜7˜ë˜jÆçµú™ùîõû††ü~•Æù±™∂k™`QZTZs¨ÜÑ“^uMvÉvxÉmryóÉöÑ†ÅîÜëuëwãvãô˚K}ãoÜ~áÇÅÜÉá~ÑÄÑã{ãk©ã£ã˜1£©ã´õÄí~íÉèÅêáîÜòãßãôE|›˜O ÙŒ§˜<˜5˜6¯ò˜ª—xæMØßZMîSZ˚2~Eh¨~® îÀã»À®^Oi˚˚Hh˚"$·WÈ»«†√≠^éãzæÔ£©ã´úÄí}íÇèÉêÜïÖòåßãô˚6˜	kcåkuhpyqvjbu≠±€”Æ“˚∂ã≥¯ ÿ˜*˜Â˜7˜ë¯(´≠ØÜ∏∂`Ömn˜ìäªõì£nã©´¢•´ΩKùbDLlImqTãGåSxz}é|ÖÑàÅÇd§ã´ò˚°}ãoÜ~áÇÅÜÉá~ÑÄÑã{ãk©ã£ã˜1£©ã´õÄí~íÉèÅêáîÜòãßãô˚Úã≥¯-≥¡˜N¨˜t˚G˜7c0˜ù˘(öñúï†™lâvâ^däâÉxjW0ÜÉÅ}ÄñÉóôõôìñ*¸…»Ÿ˜~åmÑáÉÉáÉáÅÖÉÉã~ãtûÉüã˜9°£éßôÇíÅëmúë†™˜Ü¶ãº~£öÇÄêzd[ze{ÜjÅszôÜòÑúÇïàéwèuãlãt|ö¯uì˜á§˜Ë˘endstream
endobj
33 0 obj
<<
/XHeight 757
/StemV 163
/FontFile3 32 0 R
/StemH 0
/CapHeight 732
/Flags 262178
/ItalicAngle 0
/Descent -15
/FontName/JZCTWV+Souvenir-Demi
/Type/FontDescriptor
/Ascent 732
/FontBBox[-171 -283 1377 1007]
>>
endobj
34 0 obj
<<
/BaseFont/JZCTWV+Souvenir-Demi
/Name/F3
/Subtype/Type1
/Widths[340 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 740 740 760 820 660 0 0 0 340 0 0 600 920 760 860 0 0 740 680 680 760 0 0 0 0 0 0 0 0 0 0 0 580 620 0 0 0 360 600 0 300 0 0 300 0 0 620 0 0 440 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 300 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 340 0 0 0 860]
/LastChar 238
/Type/Font
/Encoding 31 0 R
/FirstChar 32
/FontDescriptor 33 0 R
>>
endobj
35 0 obj
<<
/Type/Encoding
/BaseEncoding/MacRomanEncoding
/Differences[32/space 58/colon 77/M 97/a 99/c/d/e 105/i/j 108/l/m/n/o/p 114/r/s/t/u 120/x 151/oacute]
>>
endobj
36 0 obj
<<
/Length 2235
/Subtype/Type1C
/Length1 2235
>>
stream
  GOUYOW+Times-Bold   @¯ ¯¯¯¯˚<˚n˙z˙:
 ãã
 ãã   ˘   ı  "∞  ñ }áå002.001Copyright © 1994-1997 Stream Technologies Inc. All Rights Reserved.
 Turku is a trademark of Stream Technologies Inc.Turku BoldTurku    . B O F K P  E M J U Y D ÿ Q S N  T V    t ˇdÃ*rs⁄	Rê_√<ù>uÓF˜∏ã§˘§s£Ûµ¯¶˜.¯˙+§<ïÅñ“¯O”ôö‘ê£˚è˚[¸l˚\¯l˚è¯r’ÉôÅW¸pOÄÇ<Är˜~§7ìyù‘¯fç˜é¸‚¶˜ç¯Òç¸çS}@Ñr˚+}“Zv¯[™§˜&˚˜˜˜¨¯z∂}†ÅÅààáäÜã~Ñîõ˜ô‡>ø˚˚>XBa£rµ≤ß¢´µlìãûû©ú≠ƒ§pMB¥1q˚E^˚	Nπ^ ≈πüΩ¬ÏXï°yøµ¶ôµ≥¥˚Vƒjn{Åqou®≤≈≤≤›£,ã§¯ŒÄw‘˜˜˜ÿ¯≠§h}ú¥˜ã„X¡8U`tU^¯Õ˚SrµÖïd˚ªcÄ~bÖr˜É§ié}õ∞˜ûÿí±æª≠ùoU˚ÜfÄ}gÜr˚c}”˜O∞˜4©§˜$˚$˜˜˜Ù¯<˜tôaXo{_ãBc ˜Ü˜è˜*ÑJÿ˚	˚6'˚ ˚&›'˜ﬁ¡≠Ê«Ï˚˜?˚˜†ªΩ•ü{líëuãÉé8˚“˚Jv˘,w˜éwR˜≈˜˜ô¯˙µiÆ`ahha`Æhµ∂≠Æ∂à¸¯¯_˚\ræáóÄ_¸mW|sjy~ìñõ†öã¶®q£jgrrgQƒa‹˜¬Ã˜ ˚+~©¯=©§˜'˜1˜&¯o˜y˜ ,Ú˚˚,$˚ ˚!È&˜˜È˜!˚&å˚3wUPQw¡˜3˜2ü¡≈∆üU˚2,}√¯
√˜H£§˜(˜6˜¯©û£_é|ô¥¯”˚lsŒÜïÑ]˚Lº\rò^˚:!˚$˚◊*˜ ºØùª∑J–û¶éÓï˚ZË{aUbUr≈˜˜¶«√≠™sfô¸	ã§˘wÕ˜˜ë§kå{ü±¯‰˚QrØáô{e¸ëezwjär¸	ã§¯Hw˜éwœ˜˜j¯˙µhÆa`hha`Æh∂µÆÆ∂≤¸˙§jè~õØ¯˚Ss∏ÄíÑa˚πbÉÉ_År˚“îv¯A∑”˜˜ﬂÓrósaÄÅvãq~û±˜¡Á∑/˜=r?&okMUqø˚ÿI∂d“ÃÆ•‡∏˚+†v¯H§ó¯k¯w§}åÉëÉó˚)˜wÒ˜û¢úï¨ë§˚<rΩäå}ááE/`«p∂óòïèØé§˚år®Ñéàûn˜˚Yogtn}xP>{fâr˜=£gå|ìöõ¨æ∫¬ûo∞RãöuéÇÇ}Éáhát˚c~Õ¯™§˜!¯AÊyùfbp|cã7R‰˜ı™ ¿´ìÄUåSåõu≤µ•§≤…Gª3˚)"˚&˚‰)˜◊ÕÆ–º˚+~v¯£v§¯V¯o˜y˚!-&˚˚-˜!˜ ÍÚ˜˜Í$˚ ˚&å˜2w¡PQwU˚2˚3üU≈∆ü¡˜3ÿ¯JvÅ}my˚"3T˜˜1õúûñüã§üws,˚Lv˜T¬¯
√Äw’˜ ˜5˜'Ï¯û˜á˜?Î!MfsUpà‹Œ˚Rr∑ÑîÅa¸âbÑÑ[Çs˜§†PéyüÕ˜!]∫•~∂˜ÿÚ˜-˚'w˚pQQjrü≥y˜áÏï¨»øø£N˚˚cã§˜¬˜%5·Äw›˜˚˜ ®¯E¯∫j©Y[anNcâ∏⁄˚Qr≥âò|b˚∫dÄaÉr˜ù§§NéÄò…˜Pø¶∂´‰©èPã¡±•¶¥˜Iã§¯ŒIÕw—˜˚˜˜˜˜˜´˘æ§dåÄòµ˜é·W√:QctKYÕml†FMdsNbäª‘˚RrµÜó~c˚∫bÇÅ_Ér˜Å§ßjé~õ±˜ùî¥æ∑∞úpR˚ÖaÅÄdár˜~§iç~õ±˜ûÁî¥ΩπÆörQ˚ÖaÄ~fâr˚“ìv¯yw›˜<˜é¯πf±]\ee]\±e∫π∞±∫˚—∫f±]\ee\]±e∫π∞±π˚ö}≠v¯Y¨äw§¶qÔ'•˜gÏ•˜¸˜˜?˚~rãÒ™™•¨ƒ¥f>§•µ˜&t|ÜÖÜ}•tk†ãX.IO8˚3˜Åíã.emp_£F]∑‰uÈp˚:§†îîíë•ûƒnã¿ÁÃ»„,~Ã¯§À˜˜˜¯™ü¢bç}öµ˜˚˚]røáïÅ^˚ÆifzÇod{üæ˜Ê˚Or¥ÉíÇa˚é2ºX‚≈µß∞µJ…¢ÃèÃëxû¯aó˜_õ˜pî˜üì¸ué§
§å
_˜é˘endstream
endobj
37 0 obj
<<
/XHeight 921
/StemV 25
/FontFile3 36 0 R
/StemH 0
/CapHeight 676
/Flags 262178
/ItalicAngle 0
/Descent -203
/FontName/GOUYOW+Times-Bold
/Type/FontDescriptor
/Ascent 912
/FontBBox[-168 -218 998 934]
>>
endobj
38 0 obj
<<
/BaseFont/GOUYOW+Times-Bold
/Name/F4
/Subtype/Type1
/Widths[250 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 499 0 443 555 443 0 0 0 277 332 0 277 831 555 499 555 0 443 388 332 555 0 0 499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 499]
/LastChar 151
/Type/Font
/Encoding 35 0 R
/FirstChar 32
/FontDescriptor 37 0 R
>>
endobj
39 0 obj
<<
/Type/Encoding
/BaseEncoding/MacRomanEncoding
/Differences[32/space 46/period 49/one/two 58/colon 65/A 67/C 70/F/G/H 76/L 79/O/P 82/R/S 85/U/V 97/a/b/c/d/e 103/g/h/i 107/k/l/m/n/o/p 114/r/s/t/u/v 121/y/z 146/iacute 151/oacute 168/registered]
>>
endobj
40 0 obj
<<
/Length 5001
/Subtype/Type1C
/Length1 5001
>>
stream
  TVYIHJ+Times-Italic   C¯ ¯¯¯¯Ä˚=˚m˙Ö˙
 ãã
 ãã      ¸  S¨  h }âé002.001Copyright © 1994-1997 Stream Technologies Inc. All Rights Reserved.
 Turku is a trademark of Stream Technologies Inc.Turku ItalicTurku  (  4 F S W J D P  E ' B N  ) T Q U M 7 H O - V [ $  ( ÿ  ” Z 0 6 3 C  " L 1 I • *   â ÈOæ'tπ∫Eæ8˝≤"£dπ]Ô	@	–
+
à
‹O≈ü,xÏn”xÒf˘Ω˚*yÆÄv˘¨åv˜‚˜„º¯è˘0tyÄ~Éyºfz§ã>˚DD*Pór˜˚¬Qõq]@SQB9K”Ëíãëçówå¸j˚sú£íóïûºµ¿fã∆˜‰·˜Õt≤/Á8ﬁ{•∏»∂µ „Æ^˚	èºúâ˚bÅ∏¯¢™·˜yÃ¯/¯
∏o¢T˚˚2˚9˚&3æV‡Œ’≤œ…óCQk{`ãSe∞¡ôéüí•®è˜,†Ú◊ã‚Jí7+G˚vù∑∞Êœ‘¿é†åö{t˚ô†v˜ËÒåv∏¯¯0¯™xünX@7(^Çwäçº˜[àéWÅWÇWÇ{éûìåì†òÅy~ÖiÅh:˚π◊∂˜ ö¥Æ–∞’µ¿†ã†fã∂®úû´˚bèv¯_v˜‡ËYΩ–¯=¯≠s•k‡u|~w–^∂çãh`J˚B@lkÜ˜Ç˜l˜
ïààãÖ~zÅ})}Øå¶ìö^õ[õ˚0ê˚+ånãäîãùãŒŸóò˜˜‘˜ã…¸ñv¯ƒı˜;Ï˜ú¯Ô©v¢povtmm†tß¶†¢©n¸à~ñj]jlyãÉÖëîíãèö¬‰˜÷àçH~sàFÇ{øäñáyÖà{Üyd˚$l˚äÖãreõx©π≥´‹¡˚bÄØ¯5w©‡¯<˜¸Ωa´H˚%˚ ˚'˚.)øUÎ‘…Æ‘¿{îcZSk[ãSh∏“˜$Ï˜Ò£öÉ{|Çãruõ|£¶ûû•˚*ïv¯Yv¶ﬂ˜¶ﬁ¯h˜πËU√2˚(˚*˚0˚-/¬WÎ˜ ˜*˜<˜8´)B˚m˚[k∞¬Ó›˜p˜∂ßfP˚*ìvçª¯¢ö·¯¢˘;ÜêPwâBÇyøñávÇÜrÅg_˚3ââÖ≥zöbã˚ ˚,˚`˚B≤^À–µ©ÏœçâÇeàvãumú{©∞æ¥‘¿ï]Vwy|ãÅÉîñìãåî≠{˜ê˚" ˚D4dt¶∑ÁÏ˜o˜´õuad†v˜€Æ˜ó¨ì˘˘˘"¸Ü{œÖïÜn}ÜpÖt˚¸O{RÉÑRÄ{˜êõQèyñ®ñåèì©…˜s≈ä¡äπéãYxâ|ÖsúÖ◊˜xëZ,ìè˚BàÃ˜}ë¢ïéÕã˜,™~M}ãÇâxüâ˚*Äº[ª¯°úﬁ¯pÔñ~~YSyãÑÜêìïê¶ñµÿ˜∆ÖéLÑÄ[äåÄÆoûdã˚˚1˚J˚-=ÆbŒ—≤©˜„çà{LÜqãwoò®±¨•ﬂÕ˚˜î3,˚z!drß∑ÂÈ˜q˜Æ¢qd”óv©v¯ø\∫ó˘Fx˘RÙ}óZOxyzäÉÜêïîåêí£ƒ˜gî≠ë©ãòØsßk24˚Haâç¶„ï±ãúØt£iO?D˚8àéƒ˜[àé$vååPÄ{¿äñázÉçë{M8˚ ÷™üﬂ…„x—º¬ª®òìÇ|Éåç|Tãâ;˚∫◊≤˜,†¬ªœ∫œ¡ª¶ãóãîÇã}ãÜåéÄ^Z˚Z}Qáz~¯oö{¶π∫∞ÿ¿Ä˜¶˜˜∑™r§mlrrlm§r™©§§©”†v˜⁄µ˜≤vÉ˘ô˘ë˘õ˚ä{ÀÇëÑp~ÜkÜz\˚9˚∞¿˜Xòª£ùÀìõ˚¶{óäîäëä±ÜòÄãsã}ápÖv˚¸O|TÑÖQ~{˜äõRí|î¶íåîçíŒ˜à˜±J˚Ä}Xw}HÇ{˜•õJë}íßíçîçî˜¯vöƒìí≈ï˚ôìv¢v¯A£åv˜ ‘πÿ|¯¯O}}ÇÑá~|nqúãcC[aJ-˜?ã@[nkaRl≥Ïz|¸w˚4öõíëêñ|≠™xã±ﬂ…¬÷Í˚Ÿã‘¨¢ü≠Ω´g=ï|õ˚*˚Mv˜Wû¯∂¯Â¯i˜…ﬂaºBL[l=TâéßÓáí˚0uéz©é≠àãpÑÜsÇj˚¸N~YÖÖ[Ü|˜bö\yî°©®ìÆ}¶òà®˜!˜0˜=˜+1ì˚(˚ ˚5'ltö°πª˜(ùπÃ§ƒºø≥°mW¸ñv¯+¨Ø˜ò˜º¯B;ßÚåçãçãçêàèÖÖääÄÇ\Sbib{mÄáàãÅãÇãîãÇ÷B˚ßt5åéãÇuä†y¶§£ñü¢ùõòú≥ƒ~ërlpj{}ãÅÖëñêåçèõﬂ˜“ﬂ¸ïv¥˜Ç˜´˘;ÜêQ{à9{§ç∑ärÑèñv>"¸v;à}ãziõy™¡ß¢Ò—îUCwxuãÅÜëïíéöì©dév˘4v◊¯¯˘D˘õ˚N{øÑñÖuy|hfK˚^˚ÛáI¯Jäëãëãê´öî…íõ˚Ö{¿ÑëÉô9Á¸√û¯¯˝õ¶ôï•ç˚*˚Lv˜¯°˜ã°ì¬¨⁄˜*»j⁄¸¯l¯≥OzvØã; 0=/U†n≈pPcyxt}íÄû|\gFoGHÕ]Î˜ﬁ√‰˜˚j{ã¿ñ£®òôöÜãô˙‚ËﬂÿòäéÉ±E}.R5NeußºÊƒ⁄ÕÆür`¸o¸MVQa?>X≤∆Øñ¢©§úüùòêì rÖö”oüxd˚*óv©v¯Nvô¯`¯nÛ|òUFÅÅyãÇÖíîíê†ï±∑˜4ó∑î¥ãö∞q§e,4˚&H^âçÀ˜eáç˚tëå[Ç{æâòÜx~ÇnÖvãÉl@˚ß÷¥˜$¢√º— „±¨ØãòãïãzãÄÖlÅf`˚7{PäÉ|lõ{´π©§„À-ãÆ¯ˇvÉ¯ ¯¬˜FwëN˚_s˚7ã>rîßèåíçë˜¯nôæ°õÃìõ˚¶{œÇïÜk}áwÑr˚¸O{SÄÅVÉ{¯ê˚*Ä¿mv¯Nv™v˜‡˜∏¯o˜ }î[Nyy|ãÑÖëïóçåòºãê†Ÿ˜ºAa˚rT`HP/XUnãqãç•çìÊ¯ ∏àéQ}zà@Ä}†â≤ílÉãäÇgY˚W\ÜpãzgùxØ–ææ˜O˜çh˚Éhw¯lúy©œØ–ªÆ˚ôêœ˜º«â¯¯¯6ñ˚∞l˚õá£øïí∫ã˜&˚…¸îÅúòñêûã»›5ã—æ∏Æ≥†|õwv}ysôÉã}ÇÑzyyñ°yHﬂäãHúúy∏¯ÚÆâvÕ˜˘E˘.vzÅÇÜvjf£ã4˚g˚V˚[˚l˚5ı˚˜0›πÛ‰zôWUEJ˚ ã˚M◊˜ ˜8˜˜v˜RÁ¿S!îûá˚*†vº˜¸¯-˘0ëâçáÑ2v{+{†çØãã£åòÄxÉãÖÖw˚¸ÇÄeÇá0}˜´ôtåKá∞íâÉ†÷˜#¯öèöçîãè”y±¯¯Æø˜¯Â˘e˜√ú˚ùz ÜöÑshf˚yolwe|S˚?”˜˜=˜Ö˜ZÙÕR!ìùàº˜Y|è~uyoãfK≠ã@˚g˚V˚Z˚k˚8˜˚ ˜E‹‹°≥–ª˜Oô¬õóŒê˚*ïv¯Yv˜Üv¶ﬂ˜.˜s$ﬁ‡Ë¯'˘†{öwÇÅáÖÖ˚6˚4Æ˜@ˆñíêîãñ¸|˝Ù¯h˜πËU√2˚(˚*˚0˚-/¬WÎ˜ ˜*˜<˜8´)B˚m˚[k∞¬Ó›˜p˜∂ßfP˚*ã÷¯•‘¯‡¯W¯éÌF‘-*?Q%güÑ≤Õµß…ã“¿WDP`C%˚˚e˚tz˜˜Ω˜zírXv~Uã˚Rê˜U˜U˜
˜
©∫ãœ¸ñv¯Xv˜Üvº˜N&˜s]Ë¯'˘†{öwÇÅáÖÖ˚6˚4Æ˜@ˆñíêîãñ˚˘˝˜Ú~ñj]jlyãÉÖëîíãèö¬‰˜÷àçH~sàFÇ{øäñáyÖà{Üyd˚$l˚äÖãreõx©π≥´‹¡˚b˚Lv˘v˜‡Èc≥–¯>¯≤u£h‡v{|w–Z¡óãdP,˚/p]w˜Ö¨N˜qyãvE}ÅVzéüìåî¡§Y˚lºöGïV~{Ñ|tmxqplwwÄÖÇãwã}®pãtãz{ãuãpüy™ã∞ãº≤–‡˜	˜#˜˜Éã⁄”y¨¯ˇ¨«Ù¯AÙ˘O¯=˜&/Î˚ ˚T˚k˚|˚d˚(Â*˜˜^˜g˜v˜m"¡˚0˚ ˚»˚S9[…Ù˜0˜˜º˜S⁄ºP+”yµ˘
vÒÊ˘ê˘õ˚Y{¬ÜöÅlÄázÄd?˚Øc˚*IG˚ ã9RªŒø®Èôæ ˜uö¡¢ú ëõ˚•{—ÖîápÖjÇlR˚`_w8ã`)ÊD˜˜ﬁ”˜*∑ﬂ˜±≤˜çè»òd†v˜‚ß˜õ®¯uÙ¯ﬁ¯îËCº˚˚ç{™Ü¥ébÜnÖw˚¸O{QÉÑTÇz˜áõTê~î©óéûì©ƒ˜eÀÜ˜˚Ÿ˜(õ_éxùwø.˜â˜®ÀƒÁ"ê&KU˚	sÑåêoÃ˜yë°òë∞ãÿµdF˚*Å°¯º¯‡¯n˜‘‘[ºD2V:J^äç¯ÜêUÇêã#|{†â∏ënyfá{˚¸äàr’n…˜)˜:˜B˜06~#˚˚S˚h|ó¶ÏÎ˜â˜µßiW˚—Ä˜˜|˜Ω˜Ä˜–˜ô¯™r§mlrrlm§r™©§§©‡'˚Î™r§mlrrlm§r™©§§©d†v˜vØ¯+vX¯˚¯»õSéÉï”,¯Ãq˚µ¸âA˚}{bÉ{˜Oõ\ê~í¢òì•ó¢≈˜˜pü˚åÅåÇãÅgx~Pä{æ˜ö˚V˜(˜òç˚bïv´v¯Bvô¯S¯a¯2õ˚K{∫âìà}h˚2˚	rwâç˜
¯ZÜêM}uàCÅ{ùΩènÖâÇÖu˚+¸◊÷ª˜Hµ´˚AÕ™Y∏∞¨≠÷±}ñhPÉÇzãry≠˜L?˜*˜¢õøëd†v˜≈∞˜Æ©¯âÚ¯¯äÓB¿˚˚åz´Ü±è`}áv`˚
¸={RÑÖPÄ{˜âõSíìßöéóî≠¿˜U∂Ö§â±ã˜,Û€˜	$ë˚OW˚xtçè{—˜ãë†óì®ãÊ¥g;˚*óv©v¯Ovû¯]¯pÙó_QvwzãÉÑíïñëôçìƒ˜eïÆë©ãò≤pßfKFM˚#-âç˜
¯KÖêL}wÜBÉz§åúå§âãtuj|P˚¸ã÷±˜)õµ≤∆¡‹Õ∆ÆãõãóÄã}ãÜåãÉnW˚S}WÇapú{ßæ∑Æ⁄ª˜}∂¯Îµ¥¡˜@À˜Õ˜.¡˘_˜€˜S˚)˜,˚N˚R˚)˚+˚T˚R˜*˚+˜Q˜N˜)˜,˜QU˚7˚˚˚.˚0˚˜˜7˜9˜˜˜1˜-˜˚˚8&˚Dìr¢s¶qÆSÿΩûß±∫¡]ØH˚C|äîíäè§âéÜc˚ÅcäânááÖääÉ|˜5öYëåä∂Ï∫£h∑Bã|ïûf°S˜ûTsk``˜;≥∏§oWxû¯Aô˜g¢íã˜°ç¸sé°
¢
_˜é˘endstream
endobj
41 0 obj
<<
/XHeight 677
/StemV 23
/FontFile3 40 0 R
/StemH 0
/CapHeight 654
/Flags 98
/ItalicAngle -11
/Descent -205
/FontName/TVYIHJ+Times-Italic
/Type/FontDescriptor
/Ascent 684
/FontBBox[-169 -217 1009 884]
>>
endobj
42 0 obj
<<
/BaseFont/TVYIHJ+Times-Italic
/Name/F5
/Subtype/Type1
/Widths[250 0 0 0 0 0 0 0 0 0 0 0 0 0 250 0 0 500 500 0 0 0 0 0 0 0 333 0 0 0 0 0 0 611 0 667 0 0 611 722 722 0 0 0 556 0 0 722 611 0 611 500 0 722 611 0 0 0 0 0 0 0 0 0 0 500 500 444 500 444 0 500 500 278 0 444 278 722 500 500 500 0 389 389 278 500 444 0 0 444 389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 278 0 0 0 0 500 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 760]
/LastChar 168
/Type/Font
/Encoding 39 0 R
/FirstChar 32
/FontDescriptor 41 0 R
>>
endobj
43 0 obj
<<
/Type/Encoding
/BaseEncoding/MacRomanEncoding
/Differences[32/space 97/alpha/beta 109/mu]
>>
endobj
44 0 obj
<<
/Length 745
/Subtype/Type1C
/Length1 745
>>
stream
  JTEEOH+Symbol   F¯ ¯¯¯¯)¡˚H˚∏˙÷˙Å
 ãã
 ãã   ˇ   ˚  ™    
àèbetaalpha002.001Copyright © 1994-1997 Stream Technologies Inc. All Rights Reserved.
 Simpele is a trademark of Stream Technologies Inc.Simpele    áà ò     •:¥&˚`v˜dª˘6≠»Ë>Ÿ˜fÎYÒÍ¯ï˜]ƒxÀo≤s´vú_†Ï ¡†Æ¿Á1’˚ZUujgklp^˝ ÚeÉOÉS·èßé£§é˜N∆a≤~»ã˜›Ê˜%|,\OAX_üµb¯â√º¬ΩÏ ºN?PpSoÑsíã|nx~wyùÄßõ§èãèÍøø˚ xyÆk”¯'≥}w≥ÒX¯ˇ˜xUÑypljp¥‘{˜˜œ3L˚Dà¯˜tP *VWt\_`_xI.˚*Ÿ,˜≥¿õ°≠´†û•®≈x&ØßdØ™Æ∫∫ç˚h˜%m:¯=n\[]qtôßus´|œ‹˜∏ÊÃ∂πoeûönûNèmAzΩY–¯Rw´ÓH‡˜b‚¨¯ÀÒw\ÄzurmuÆº¯4¸ÏXjcq_Uh∏—˜ﬂ6¸}rÜt|XÙÇoàzvf°m¶ß°©∞†àúÉß{æÜ¢§¢f∞§Ø¿¬≠ÃΩIï©jΩ«∫π‘ös£¯Üç˜?ò˜Åã˚véØ
¥
_˜é˘endstream
endobj
45 0 obj
<<
/XHeight 684
/StemV 41
/FontFile3 44 0 R
/StemH 0
/CapHeight 671
/Flags 4
/ItalicAngle 0
/Descent -223
/FontName/JTEEOH+Symbol
/Type/FontDescriptor
/Ascent 921
/FontBBox[-180 -292 1090 1005]
>>
endobj
46 0 obj
<<
/BaseFont/JTEEOH+Symbol
/Name/F16
/Subtype/Type1
/Widths[250 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 631 549 0 0 0 0 0 0 0 0 0 0 576]
/LastChar 109
/Type/Font
/Encoding 43 0 R
/FirstChar 32
/FontDescriptor 45 0 R
>>
endobj
47 0 obj
<<
/Type/Encoding
/BaseEncoding/MacRomanEncoding
/Differences[32/space 46/period 73/I 84/T 97/a/b 108/l]
>>
endobj
48 0 obj
<<
/Length 707
/Subtype/Type1C
/Length1 707
>>
stream
  FQBEJN+Frutiger-Bold   @¯ ¯¯¯¯˚:˚é˙|˙;
 ãã
 ãã      +√  ã ï•≠Copyright (c) 1988, 1990, 1994 Adobe Systems Incorporated.  All Rights Reserved.Frutiger is a trademark of Linotype-Hell AG and/or its subsidiaries.Frutiger 65 BoldFrutiger    5 B C M  *     $ ±%&:L¸-†v¯‡˜˜d˜ ˜d˜ ¯‡˜\˜¸∞˚˜\-Ì5·˜,€˜ÌØ˜˜c˜˚˜
|Î¯	≠∏ƒ°ƒ⁄∞o8ASIÜrXXrf^>ä)‰TÊ»Œ´ƒ™çBå{ãiêp\˜
à≥âØä≤ä±ä≤ãøÕ˜,JÃ˚1RE|sW¨”˚Á⁄‰ï«≈cÖfunovkyb[fû∑dÛ/Án®˜ﬂÛ˜sw–˜˜|˜ ñ˜`˜ó”≠Á·‚£,FDr+32nÈ‘D˚˚ó˜$ çûT≤…wƒ˜2≈˜˜!˜"Q˜˚2E\nZfâ˜¡˚†v˘Çw”˜”˜˘Ç˚†v˘Nw–˜ –˜ ˘N˚ ã˜ –˜ –˜ ˜ ˚ ó˘Nó˚Wó˜só˜®ëÒì¸˙óó˘Nó˚\ó˜xó˜®ëıì¸˛ó	Ì
˜ å˜™˘endstream
endobj
49 0 obj
<<
/XHeight 762
/StemV 140
/FontFile3 48 0 R
/StemH 0
/CapHeight 698
/Flags 262176
/ItalicAngle 0
/Descent -210
/FontName/FQBEJN+Frutiger-Bold
/Type/FontDescriptor
/Ascent 750
/FontBBox[-166 -250 1000 935]
>>
endobj
50 0 obj
<<
/BaseFont/FQBEJN+Frutiger-Bold
/Name/F17
/Subtype/Type1
/Widths[278 0 0 0 0 0 0 0 0 0 0 0 0 0 278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 278 0 0 0 0 0 0 0 0 0 0 556 0 0 0 0 0 0 0 0 0 0 0 0 556 611 0 0 0 0 0 0 0 0 0 278]
/LastChar 108
/Type/Font
/Encoding 47 0 R
/FirstChar 32
/FontDescriptor 49 0 R
>>
endobj
51 0 obj
<<
/Type/Encoding
/BaseEncoding/MacRomanEncoding
/Differences[32/space 37/percent 40/parenleft/parenright/asterisk/plus/comma/hyphen/period/slash/zero/one/two/three/four/five/six/seven/eight/nine 60/less 66/B/C/D/E/F 72/H 75/K 77/M 80/P 82/R/S/T 88/X 97/a/b/c/d/e/f/g/h/i 108/l/m/n/o/p/q/r/s/t/u/v 120/x/y/z 135/aacute 142/eacute 146/iacute 151/oacute 156/uacute]
>>
endobj
52 0 obj
<<
/Length 4841
/Subtype/Type1C
/Length1 4841
>>
stream
  IHQETH+Frutiger-Light   @¯ ¯¯¯¯˚,˚é˙|˙#
 ãã
 ãã      õ«  ≠ ï¶ÆCopyright (c) 1988, 1990, 1994 Adobe Systems Incorporated.  All Rights Reserved.Frutiger is a trademark of Linotype-Hell AG and/or its subsidiaries.Frutiger 45 LightFrutiger  =  1 M B O  U F S Q œ V J D P T H E N ÿ . 5 9 4       R C I &  $ , G  ”  Z  #   )   W 	 »  
 Y ﬁ 3   [  ' % ?   ? R ¡Cì—4£Á	Oôp–:§ﬂ˚1ç‚mï¢Òu–		-	e	Æ	⁄

d
ñ
¸@∞†∑›%NÉ&[íÛI_–ˆ1Rê¸˚*†v˜¬«˜®«·–˜é–·–˜¬Î˜Ìœ˜˜6Õ˚˚@–O˜„ΩY3˚)#[¸@†v˘Çw⁄ ⁄ ˘ÇL˚*¡aµ˜k¡˜1¡≥–˜ï |¯…ÜÆã™¥˜u˜Vƒ˚^I{xdN©∫Ωó¿‡™_4q˚˚JÉ˚?¨]¢)˜% “¨»ßçÖ˜$Tà˚˚(Q[§Œ˜˜ñ˜ù-†v¯hµa¡⁄ ˜§ ∏⁄ ˜Æ‡Ø˜‚≠M+˚  ˜⁄˜[ﬂ˚!eR]vâPÊNèbãcd˚—¡¯2¡˜ ˜ø¯í˚˜%Lu˚'UÔ˚æ.è>˜™™ìëöáøyÑ{ÜsãXz±π˜ﬁ˜˚*¡˜W¡˜E¡¥–˜¨–¯9€xmHx]˚Q‚˜ ˜Ò´˜P˜˚$˚5˚˚0˚- ˚˜=∫ƒïù∑˚À˜ßﬂƒËËÈØ32˚—†v¯\¡UÕ⁄ –⁄ ˜ê0Á¶˜ÔõúâáòÕéÄyé|J`VRtâPÌLèfãvS-˚Qv˜Z¡¯>µa¡‘ ˜¬–‹‘˚f ˜ΩçI™ªj€˜ —˜˜+˜/O˜˚*˚ d>o{â(èËL\¯˚ì(l˚˚˚d˜ËË≤˜˜˜™˚(˚*¡˜W¡˜E¡¥˜$¥–›˜@•–˜Ç¿¯–π˜˜$<˚±˝WÍ¯9€xmHx]˚Q‚˜ ˜Ò´˜P˜˚$˚5˚˚0˚- ˚˜=∫ƒïù∑˚À˜ßﬂƒËËÈØ32-¡aµ¯hw⁄ ˜§ ∏¯q¯íL˚Æ6g&˚4i…Î˜ L˚⁄˚ª7˜ı±ƒπ†çH0»á¥ã≥≤¸@†v¯íw˜0ﬂ⁄ ⁄ ¯íL0 ˜pL7 ˚b¡¯>¡¥–¯4¯äëy_ôN˚+&˚˚1˚"€˚˜8ª≥éö∂Ö∆e}fÇcã˚EÏ˜˜–‰˜≠¥Ä|≠-¡¯>¡≥–˜Ê–≥˜ì˚‘˚˜9˜9‘˜˜˜B˜˚9˚9B˚˚–˜
∆Í˜˜∆,˚
˚
P,˚˚PÍ˜
˚ô¡¯>¡t¢¥ ˜J–ÿ≠óy∏ºÖºÿ∞˜ ˜;˚èãÍÃ∏üÃÆ∏Ç|¨(ë¬ÿú^Uëp79e&˚(˜âûã˚QVjOZ]òûe-˚l¡p¶˜6¡¯2µa¡º–˜¬ Æ˜
˜ìÓ™˜˜˜Ø1˚.b˚ ˚ cÔ¯˜ìLÆQâ»\_îG˚*O˚˚/˚ø˚"˜7Ã√•’≠ç˚$}˚
˚6TSõüdDÜLÜÉ•»xŒ˜CÀ˜˜"-¡aµ¯>¡˜xwº–˜¬ º¯w˘ÇL˚⁄â§ÇY‘'˚*O˚˚/˚+—˚˜ ‘øßÃ≠çD: ¨¸˜ìÓ™˜˜˜≤˚..d˚˚˚l˜Ó˜K†v¯hµa¡⁄ ˜â ˜â º˘ä˜ÛÓQ”$;O[Otâ‰{Aû^˚mKhwâå‹·Nèbãcd¸ ˜Æº˜œ∆–‹¶RC˚Á ˜Æ˜œ∆–‹¶RC˚Á-¡¯>¡¥˜$≥–˜˜@¬–˜;Ç(¿¯–π˜˜$<˚Õ˝W‘≥˜ì˚‘˚˜9˜9‘˜˜˜B˜˚9˚9B˚˚–˜
∆Í˜˜∆,˚
˚
P,˚˚PÍ˜
˜É†vãﬂ¯µ–·–¯◊–∏·–˘	ç˜ö˝	∆˜í˘	ç˝	–˘N(p˚î¸˙˚ì¯˙ ˚*†v˘«˜l–˜l–˘˜b«¸uO˜bd†v˘Nwí¯Èí⁄˜q˜“˜i˚“ﬂ˚í¯˜˜ﬂ>˚Z˚Æ˚X˜Æ:˜~˚ﬂ˚*«¯Ó«t¢≈–˜è–ÿ«ù{∞¿}œ˜ ˜√˜!˜`˚‘åã˜ Â⁄©”∫ºÇz™(ñ ÿù[Têi˚)E˚˚K˜‘zã˚(D_5J[ö•b-Ñ«˜–«˜e«Ì–˜ë–¯^˘N˚˘Ñ˚Ûæö¥í∆ã˜
ƒY˚ ˚-Z0ZSó£_Dy∫øÑΩ˜)ÙŸ˜.˜7◊˚UnÑÉtê˜t˜µ˜ÚÑ¡˜û¡g¡˜û¡Ù ˜R ˜2 ˜R √¯◊˜H ∫;˜˜∫€ˆˆ\€˚˚\; √ …ü“÷÷üDMMwD@@w“…<¸≠˜Ê ∫;˜˜∫€ˆˆ\€˚˚\; < …ü“÷÷üDMMwD@@w“…îÎ¸∞≈¯1˘zQ-†v¯ùw˜Ÿãw˜¶–ÿ˜¯ ±^®˜Ó˝ –˘NMãﬂÌ‹Ì‹ﬂ:-Ñ«¯‰«º–˜‘–˜™˘˜%ö˚H˚˚|˚H˚%˚%|˜H˜˜ö˜H˜%«˚N`˚U˚7˚&©˚f˜[˜[©˜f˜&˜7`˜U˚NY†v˜o–˜ù–π˜o˜o˚o–˜o˜o–˚o˜oF˚o˚o-˚Qv˜Z¡¯>µa¡º–˜¬ $¯w¯íL‹8âùdÿ˚ ˚*O˚˚/˚+—˚˜ €ª¨Õ™ç˚Ω ¸¯eÓ™˜˜˜≤˚..d˚˚˚l˜Ó-¡aµ¯>¡˜xw‘ ˜¬–H‘ º‹çJ≠øo‘˜ —˜˜+˜/O˜˚*'YBrÇâ˜⁄L¯¸É(l˚˚˚d˜ËËØ˜˜˜™˚(-†v¯h¡˜xw⁄ ˜§ ⁄ ˜•‰≤ı˜Ûú?3˚ƒ ˜≈˜fÊ˚@RaSpâ˜⁄L˚*ã«˜°«˜ç«·–·˜ˆ«˚±˜°˜ó«˚ó˜ç˜•«˚Í-†v˜5«¯,–¢ ˜¢–˜¯˜q˚¢˜†¯,ç˚·¸h˜·˚5–˜5Ú«$¯q3˚Œ¸iú«¯Ó«ƒ–¯Õ˘@ûg8íb˚l˚˚)˚h˚l˜˚%˜p∑Ÿí¢±á«csEÖ]ã˚L(˜˜D˜AÒ˜˜Iº Ñt∑d†v˘NwÍ–Í–˜Ò˜Ê˚ÒÍ¸¯˜Ê˜›1˚Œ˚Õ˜ÕF˚—†v¯\¡˜Z¡Åï˜ Ë˜ ¯\˜¡˚∑»ÇË·ùûáÑòè¬hípéw˚á˚  f$UÚ-ã«¯›«Ω‡˜á÷Ω¯7«˚‚˜˜ÂÓÒ˜ãÛ˜2ƒ˚RGurXóL¬´Ωù ã–¡WA67#7.˚4˚E¸@†v¯íw‘˜$¿˜@˚& Ç0¿¯–π˜˜$<˚&˝W»⁄ ¯íL-Ñ«˜´«˜ë«¯)–˜*˜‡À÷˜˚!,b7YNí¶RÉI√v√Ñ«ã˜ ˜’˜ËW”.èç‡†«»‡˜ º˚QO~xXëJº¢øô¬ã÷‡h=˚˚"Å,y˚b˚l¡˘4wî¯>Ÿ¯íF˜I¸ò~^wIy^UãtèèÖU†Ü£à¢ã“Ø——£˜`¯ﬁI˚'¸=ä-Ñ«˜‹«˜`«{õ¬–˜Œ–Ï˜´Ñ˜#‡È˜˜A˚∏/JLpPgâ˜"√˜+˜Ià≥πÇ~®ëÕ,îffíe˚Ä<˚>˚gÏ˚8≤˚;˜Mñ¯ÏæN%-TD%$\‚·Á∆ Ô-ã«˜•«˜â«€–˜ç–[–Ù€˜˜%˜∫˜,ÁO≈3õçx·ú¥¿‰˜ ±˚˚:–¸»ÙÒˆ~˚˚"r.Cç¯÷Íx∆Ë}&˚*xB>-Ñ«˜¯v˜ï«π–\–˜≠–]–(œ¯≤/ŒV”ií0jE_ ˚˜Q˜˜˜º˜˜D≥,≠$ÕØÿƒ·˜'º˚(6˚]˚	í¯	˚˘+:g9;8ªŸÏ›ß‹¨ÀjÓl3l˚ƒ˜Û‘œØ‘Ã÷hAC>^LlRß7≥€îv˘fwl˜Ël–˜£˘fFú†v˜›«˜…w„–˜ı–„–˜›˜ı˚›–˘NF˚…˚ı˜…FYòv˜Õv˜zwπ¯è¯Ω¯ñ¸è˚zM¯è˚zÕ¸B˜W¯B˜W-†v˘«≈¯>˜◊˜¢˘«¸>O˜˙˚bã–¯Mwî¯>¯G¯íI˚(¸Mâ˚!¯MF˜A¸í’†v˘àwµ ˜ì˚ B˜ >˜&˜6˜6ÿ˜&‘˜ a4˚7˚#˚<˚<ﬂ˚#‚˚˚*¡aµ˜k¡˜1¡¥˜$≥–ﬁ˜@ç ˜Ç
¿¯–π˜˜$<˚±˝Wu¯…ÜÆã™¥˜u˜Vƒ˚^I{xdN©∫Ωó¿‡™_4q˚˚JÉ˚?•]¢)˜% “¨»ßçÖ˜$Tà˚˚(Q[§Œ˜˜ñ˜ù˚—†v˜–¥˜è¥˜˜è–˚è†v˘àw˜A ¢˘à‘˚ ÿ˚&˚6˚6>˚&B˚ µ‚˜ﬂ˜#˜<˜<7˜#4˜˚b†v¯íwì¯@ì‘˜#˜p˜˚pŸ˚C˜¢˜2˜ÑC˚˚R˚˜R=˜6˚Ñ-¡aµ¯hw‘˜$⁄ Ÿ˜@° ˜;Ç¿¯–π˜˜$<˚Õ˝W™¯q¯íL˚Æ6g&˚4i…Î˜ L˚⁄˚ª7˜ı±ƒπ†çB0»á¥ã≥≤-†v˜›«˜ç«„–˜ã–˜1˘“Í‹Ñ˚*.l:BF¸–˜›ƒÕ©à1≥˚Ä◊˚˜¢u∫©Síç·ñ–«Â˜:¿˚˚H˚˜n¡˜"¡˚ ⁄˜n7-Ñ«_∑˜`«˜‹«º–˜Œ–º˜©˘U˚#6-˚˚A˜^ÁÃ ¶∆Øç˚"S˚+˚Iéc]îònHÖIåÇ∞∞Ñ±˜Ä⁄˜>˜gº˜8d˜;˚MÄ¸*X»ÒÈ¬“ÒÚ∫45/PL'˚bã¡¯&¡´¯´¯¡˚«˜«¯&¡¸U˜ª˚«¸'-†v¯v˜ˆwÁ¯˜ç˘Ní˚-˚'√zQ˜'a-˚ºeﬂ˜·˚Ω±*˜˜'µx≈˚%Sí˜-˚b†v˜›«˜ç«ÿ–ÿ–˜›˜è«˚è˜ç˜õ«˚‡úã«¯÷«€–¯–˜)˘˜0˜D˚i˚j˚;˚ZRFO˜˜{˜=Ï˜ë˜`(˜$˚é˚Aó˘Nó˚\ó˜xó˜©íÛì¸¯ëó˘Nó˚\ó˜xó˜®ëıì¸˛ó	¡
 
yXO	˜™˘endstream
endobj
53 0 obj
<<
/XHeight 762
/StemV 63
/FontFile3 52 0 R
/StemH 0
/CapHeight 698
/Flags 32
/ItalicAngle 0
/Descent -210
/FontName/IHQETH+Frutiger-Light
/Type/FontDescriptor
/Ascent 750
/FontBBox[-152 -250 1000 911]
>>
endobj
6 0 obj
<<
/BaseFont/IHQETH+Frutiger-Light
/Name/F18
/Subtype/Type1
/Widths[278 0 0 0 0 1000 0 0 278 278 556 600 278 333 278 278 556 556 556 556 556 556 556 556 556 556 0 0 600 0 0 0 0 0 556 667 667 500 444 0 667 0 0 611 0 889 0 0 500 0 556 500 500 0 0 0 611 0 0 0 0 0 0 0 0 500 556 444 556 500 333 556 556 222 0 0 222 833 556 556 556 556 333 389 333 556 444 0 444 444 444 0 0 0 0 0 0 0 0 0 0 0 0 500 0 0 0 0 0 0 500 0 0 0 222 0 0 0 0 556 0 0 0 0 556]
/LastChar 156
/Type/Font
/Encoding 51 0 R
/FirstChar 32
/FontDescriptor 53 0 R
>>
endobj
54 0 obj
<<
/Type/Encoding
/BaseEncoding/MacRomanEncoding
/Differences[32/space 40/parenleft/parenright/asterisk 45/hyphen/period 67/C/D/E 72/H/I 77/M 82/R 84/T 88/X 97/a/b/c/d/e/f/g/h/i 108/l/m/n/o/p 114/r/s/t/u/v 120/x/y/z 135/aacute 142/eacute 146/iacute 151/oacute]
>>
endobj
55 0 obj
<<
/Length 3576
/Subtype/Type1C
/Length1 3576
>>
stream
  DAXJVE+Frutiger-LightItalic   C¯ ¯¯¯¯˚#˚é˙õ˙)
 ãã
 ãã  .  *  Å«  º ï≠µCopyright (c) 1988, 1990, 1994 Adobe Systems Incorporated.  All Rights Reserved.Frutiger is a trademark of Linotype-Hell AG and/or its subsidiaries.Frutiger 46 Light ItalicFrutiger  (  ) J Q F S I E B U D ÿ O  W H P T Z M [ V C 3 » G ” % œ * 5 N Y . &  $ 9 	 
   *   8 e ’1Õ>Àa…%&M÷m∏–˝[»Œ#Zò		,	U	‹

V
ã
õ
ÂTçß„¸ú†v˜›«˜…w∞˘∞œ—˜›˜˘D˚›œ˜*˘NGI˚…˚˘Ã˜…G¸@†v¯íw˜0ﬂß˜u.ËßÕ˜ ¯íI(˜	˜p@y7÷-˚Qv˜Z¡¯>µa¡˜ ˜ú–‹y˚fÕ…˜…çE†∆b”˜@‚˜>˜2˜PÁ˚FKiUiâhèûê•ç™LáeÉ`Ée\®˚O˜ ‘˜0˜„ØG7˚
P˚0˚h2d›€˚*¡˜W¡˜E¡≤ ˜“ ¯p˜Åé´è´™˜O’˚˚8'˚/˚?˚ÊD˜ﬁ≤õñ©ê»cz]zLã1J√Ìôåôçòñ¡Ëú”ﬂÌ›ÆT8â~ä}˚—†v¯\¡UÕß˜Û˚è –ßŒø˜è(Áû¥˜ÚùûäÑúöŒzézèvãI_dYkâHêùé¶é´LàkÜmÖn-†v¯h¡˜xw¯G–ßÕ¬˜é¢˜ ¬˜˜ãÀ≠eOiáuÑjQ˚≠Õƒ˜°ì≠íØãÆÎGø/:Ü]mgOâ◊˜◊I-¡aµ¯>¡˜xw≤–˜úÃòv∫¯‡˘ÇIE˚‚â—xLØA˚6.˚B˚"˚Ω$˜Ñ·æ±¬∞çDÑwÖjàoÃç£ëÆî¥™˚ÓÈ˜
«˜0˜„µD0˚9˚+˚3fŒ‡˚*¡aµ˜k¡˜1¡ö–˜á Å–∫¯H˜óî≥è∞üıQ«˚OQx|gÑK≠ú≈¶∆ã—≤cEvä|â|çwtçq˚˚<l˚)7ŒP⁄Ñ÷√¢À∂çDÜuâqàp çÆí∫ï≤®˚Ÿñ˜˜ò‡†üâã† }U!˚
X[´≈˚—¡¯2¡Ê–˜C¯í'}UÒZ˚vÜuy:ã_T≥c“•ûêîûë¡yÅzáxãfv°≥¨ì¨í≠¡˜ê˜ò¡˚™˜Cr˚b¡¯>¡≤–¯g¯äïqNïa˚Y%˚˚H˚“˚˜'ø≥íì£ì kÄe~eã,E⁄Ù˜Ÿı˜%≥∆~Åû-¡¯>¡√˜$≤–˜F˜8í–˜;(˜¯÷∫˜	˜$<¸˝f‘≤˜f˚Ÿ,˜˜Dˆ˜%˜>˜B‚˚˚A˚˚!˚?–Å˜Õ˜˜!Ó∂E+˚A˚ ˚2U—„-†v¯hµa¡˜ ˜à–∏ßÕΩ˜Ü£˜	∆˜˜ãÀ≠eOiáuÑjQ˚≠Õƒ˜°í´ì±ãÆÎGø/LKhUhâPêùé¶é´LâráuÖi˚bã–¯MwÃ¯A¯Ç¯íD˚¸MâR¯MKœ¸í◊-˚l¡˜6¡¯2µa¡≠–˜‹ß‹Ñ˚Jp»¿Ñ∆˜c∞È˜E±◊˜Û$ï∑î≤ê†LÅhÉhÖiâ‹ﬁ{F¨;˚>1˚-˚5˚»)˜œ≈£Ω∏çÉfm˚dC˚&ãTXñ¨YË˜⁄˜Õ˜(˜Ë∏D0˚	J˚˚-a–‡-¡¯>¡≤–˜Ò–≤˜f˚Ÿ,˜˜Dˆ˜%˜>˜B‚˚˚A˚˚!˚?–Å˜Õ˜˜!Ó∂E+˚A˚ ˚2U—„˚ô¡¯>¡–Õ˜–}õwºπÉ¿Óı∑˜˜˚`ñã‚“—õΩ±µÄx¨†∆aú`ì]ã9 b&˚˜]êã˚<8tN`aö°g˚b˚l¡c≥˘4wP¯ª∞¯Ä¯íG˚É¸KâW¯KI”¸ì`:xcic_ã||éñÄ@|UÄÄûüà°–∞±≈™¸@†v˘Çwß˜vßÕ˜4˘ÇI˚bã¡¯&¡w¯|w¯ï¡˚∆¯¯!ó∆¸	U˜µ¸¸"-¡aµ¯hwƒ–˜à ∏¯©¯íIY˚Üs˚	P˚˚ãKi±«≠è°í¨≈˜≠IR˚°ÑkÉeãh+œWÁ ÀÆ¡ÆçHÜyàpàk ç§è°ë≠-¡aµ¯>¡˜xw∑‰˜’–º˜å˘ÇI˚˝HÑhÅjÅgÃìØñ¨é†ç¨^ö∞RÙ˜?‰˜;˜5˜TÍ˚	7\k[fâ˜(•„∞H6˚
O˚0˚(l÷‚˜“˜+˜-†v˜›«˜ç«¯j–∞——˜›‹√£|Tõ»˚óœI˜†Å±Ñ∞Qïç˜ê‚œ˜˜:≤˚à˚2¡O“¬q<˚˚k.B˚*¡aµ˜k¡˜1¡√˜$ö–˜B˜8, Å–˜
 ˜¯÷∫˜	˜$<˚Î˝f¥Ä¯H˜óî≥è∞üıQ«˚OQx|gÑK≠ú≈¶∆ã—≤cEvä|â|çwtçq˚˚<l˚)7ŒP⁄Å ÷√¢À∂çA Üuâqàp çÆí∫ï≤§ ˚Ÿñ˜˜ò‡†üâã† }U!˚
X[´≈˚—†v¯\¡˜Z¡Äñ»¯Ë‘ÕÌ¯\˜ò¡˚ì±ú‹ù⁄÷ã©õÉâêö¿`îttçs˚l˚3xÄX˚~U˜¸@†v¯íw„˜$ß˜B8˜8ã(˜¯÷∫˜	˜$<˚`˝f–ßÕ˜ ¯íIúã«¯÷«¯◊–˜á˘‚˜)ÔK˚0˚v˚˚˚f˚9O˜g˜ì˜%˜=˜ç˜h˚,œ˚O˚˚*¡˜W¡˜E¡√˜$≤ ˜0˜8â ˜˜¯÷∫˜	˜$<˚Î˝fÍ¯p˜Åé´è´™˜O’˚˚8'˚/˚?˚ÊD˜ﬁ≤õñ©ê»cz]zLã1J√Ìôåôçòñ¡Ëú”ﬂÌ›ÆT8â~ä}¸@†v˘Nwß˜mß–˜(˘NF˚*†v˘«„¯é„˘˜h˚˝”˜˘˜hó«¸Å˜K†v¯hµa¡˜ ˜m«˜é–ºßÕ¿˜óûÁ¿˜	Ûã»£`SeÖmÑlR˚¢Õ¿˜óûÁ¿˜	Ûã»£`SeÖmÑlR˚¢Õ≈˜®ì∞í≤ãüËSƒ3:P`Djâ’àV≥CEcrK[âPèùè¶é´LâpÜiÖr˚b†v¯íwb¯õbÿ˜N˜lË˚l”˚˜°˜h˜Ö;˚6˚R2˜RF˜˚Ö˜É†vãﬂ¯Ø÷∞˘˜∞∞À˜˘ç˜˝ƒ¯"˘ç˚˝œ˜(˘N p¸¸˙˚¯˙+˚*ã«˜°«˜ç«∞¯|∞˜˙ï«˚≥√˜°˜öñ«˚ôæ˜ç˜©ñ«˚ÏãﬂªÓª›úﬂ9d«¯Ó«’–˘9˘6¶QTî@˚Ö˚B˚@˚à˚Q˜)˚	˜G’≠ôìßì»cÄu4ã˚' ˜˜˜^˜˜/˜_«ƒÑpæd†v˘Nw`˘l`‚˜≤˜–˜*˚–◊˚G¯˜»˜·7˚ò˚≥˚"˜≥@˜=˚ﬂ†v˘àwœ ˜ﬁ˘à˚˚4˚˚4˚l˚≤˚∫˚∏a˜ q˜˜˜p˜˜A˜˜7†v˘àw˜O ˚ ˜˜4˜˜4˜l˜d˜\˜^µ˚ •˚˚˚p˚˚A˚˚7˚—†v˜–≤˜û≤˜˜ìñ–˚ì-†v¯v˜ˆw˜¯	˜G¯πhÂ˜‹˚πÆ2˜˜*µz≈˚(Së˜-Rë˚-˚$√xQ˜(aó˘Nó˚\ó˜xó˜©íÛì¸¯ëó˘Nó˚\ó˜xó˜®ëıì¸˛ó	¡
–
yXO	˜™˘endstream
endobj
56 0 obj
<<
/XHeight 762
/StemV 69
/FontFile3 55 0 R
/StemH 0
/CapHeight 698
/Flags 96
/ItalicAngle -12
/Descent -210
/FontName/DAXJVE+Frutiger-LightItalic
/Type/FontDescriptor
/Ascent 750
/FontBBox[-143 -250 1031 917]
>>
endobj
57 0 obj
<<
/BaseFont/DAXJVE+Frutiger-LightItalic
/Name/F19
/Subtype/Type1
/Widths[278 0 0 0 0 0 0 0 278 278 556 0 0 333 278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 611 667 500 0 0 667 222 0 0 0 889 0 0 0 0 556 0 500 0 0 0 611 0 0 0 0 0 0 0 0 500 556 444 556 500 333 556 556 222 0 0 222 833 556 556 556 0 333 389 333 556 444 0 444 444 444 0 0 0 0 0 0 0 0 0 0 0 0 500 0 0 0 0 0 0 500 0 0 0 222 0 0 0 0 556]
/LastChar 151
/Type/Font
/Encoding 54 0 R
/FirstChar 32
/FontDescriptor 56 0 R
>>
endobj
58 0 obj
<<
/Type/Encoding
/BaseEncoding/MacRomanEncoding
/Differences[221/a168]
>>
endobj
59 0 obj
<<
/Length 188
/Subtype/Type1C
/Length1 188
>>
stream
  EZVNSW+ZapfDingbatsITC   6ã˚πœÉ
 à?ãã
 à?ãã   i   f   lë   ∂ a168    á %E¯
˙0˚π…˝Ã˘7˘Ã˝YV¯Á˙¸Á‰„bâ¸8˙‚J¸8¯Y¯Y¸Y¯X¯Õ˘endstream
endobj
60 0 obj
<<
/XHeight 0
/StemV 0
/FontFile3 59 0 R
/StemH 0
/CapHeight 1667
/Flags 4
/ItalicAngle 0
/Descent -293
/FontName/EZVNSW+ZapfDingbatsITC
/Type/FontDescriptor
/Ascent 1667
/FontBBox[0 -143 976 814]
>>
endobj
61 0 obj
<<
/BaseFont/EZVNSW+ZapfDingbatsITC
/Name/F20
/Subtype/Type1
/Widths[928]
/LastChar 221
/Type/Font
/Encoding 58 0 R
/FirstChar 221
/FontDescriptor 60 0 R
>>
endobj
62 0 obj
<<
/Type/Encoding
/BaseEncoding/MacRomanEncoding
/Differences[32/space 40/parenleft/parenright 44/comma 47/slash/zero/one/two/three/four/five/six 56/eight 67/C/D 97/a 99/c/d/e 103/g 105/i 108/l/m/n/o/p 114/r/s/t 135/aacute 146/iacute]
>>
endobj
63 0 obj
<<
/Length 2714
/Subtype/Type1C
/Length1 2714
>>
stream
  XVNGIU+Frutiger-Light   @¯ ¯¯¯¯˚,˚l˙|˙#
 ãã
 ãã      ]∞  
u ï¶ÆCopyright (c) 1988, 1990 Adobe Systems Incorporated.  All Rights Reserved.Frutiger is a registered trademark of Linotype AG and/or its subsidiaries.Frutiger 45 LightFrutiger             % ” B  E F J O H S T P $ U Q M N » D 	  
     S ô —AÕı[q∆6•¶Vxπ9wŒa°ÅSàü‘¸-Ñ«¯‰«º–˜‘–˜™˘˜%ö˚H˚˚|˚H˚%˚%|˜H˜˜ö˜H˜%«˚N`˚U˚7˚&©˚f˜[˜[©˜f˜&˜7`˜U˚N-ã«¯›«Ω‡˜á÷Ω¯7«˚‚˜˜ÂÓÒ˜ãÛ˜2ƒ˚RGurXóL¬´Ωù ã–¡WA67#7.˚4˚E-†v˜5«¯,–¢ ˜¢–˜¯˜q˚¢˜†¯,ç˚·¸h˜·˚5–˜5Ú«$¯q3˚Œ¸i-Ñ«˜‹«˜`«{õ¬–˜Œ–Ï˜´Ñ˜#‡È˜˜A˚∏/JLpPgâ˜"√˜+˜Ià≥πÇ~®ëÕ,îffíe˚Ä<˚>˚gÏ˚8≤˚;˜Mñ¯ÏæN%-TD%$\‚·Á∆ Ô-Ñ«˜¯v˜ï«π–\–˜≠–]–(œ¯≤/ŒV”ií0jE_ ˚˜Q˜˜˜º˜˜D≥,≠$ÕØÿƒ·˜'º˚(6˚]˚	í¯	˚˘+:g9;8ªŸÏ›ß‹¨ÀjÓl3l˚ƒ˜Û‘œØ‘Ã÷hAC>^LlRß7≥€-†v¯ùw˜Ÿãw˜¶–ÿ˜¯ ±^®˜Ó˝ –˘NM-Ñ«˜´«˜ë«¯)–˜*˜‡À÷˜˚!,b7YNí¶RÉI√v√Ñ«ã˜ ˜’˜ËW”.èç‡†«»‡˜ º˚QO~xXëJº¢øô¬ã÷‡h=˚˚"Å,y˚˜n¡˜"¡˚ ⁄˜n7-Ñ«˜–«˜e«Ì–˜ë–¯^˘N˚˘Ñ˚Ûæö¥í∆ã˜
ƒY˚ ˚-Z0ZSó£_Dy∫øÑΩ˜)ÙŸ˜.˜7◊˚UnÑÉtê˜t˜µúã«¯÷«€–¯–˜)˘˜0˜D˚i˚j˚;˚ZRFO˜˜{˜=Ï˜ë˜`(˜$˚é˚A¸@†v¯íw‘˜$¿˜@˚& Ç0¿¯–π˜˜$<˚&˝W»⁄ ¯íL˚*¡aµ˜k¡˜1¡≥–˜ï |¯…ÜÆã™¥˜u˜Vƒ˚^I{xdN©∫Ωó¿‡™_4q˚˚JÉ˚?¨]¢)˜% “¨»ßçÖ˜$Tà˚˚(Q[§Œ˜˜ñ˜ù-¡aµ¯>¡˜xwº–˜¬ º¯w˘ÇL˚⁄â§ÇY‘'˚*O˚˚/˚+—˚˜ ‘øßÃ≠çD: ¨¸˜ìÓ™˜˜˜≤˚..d˚˚˚l˜Ó˚*¡˜W¡˜E¡¥–˜¨–¯9€xmHx]˚Q‚˜ ˜Ò´˜P˜˚$˚5˚˚0˚- ˚˜=∫ƒïù∑˚À˜ßﬂƒËËÈØ32¸@†v¯íw˜0ﬂ⁄ ⁄ ¯íL0 ˜pL7 -†v¯hµa¡⁄ ˜§ ∏⁄ ˜Æ‡Ø˜‚≠M+˚  ˜⁄˜[ﬂ˚!eR]vâPÊNèbãcd-˚l¡p¶˜6¡¯2µa¡º–˜¬ Æ˜
˜ìÓ™˜˜˜Ø1˚.b˚ ˚ cÔ¯˜ìLÆQâ»\_îG˚*O˚˚/˚ø˚"˜7Ã√•’≠ç˚$}˚
˚6TSõüdDÜLÜÉ•»xŒ˜CÀ˜˜"˚—†v¯\¡UÕ⁄ –⁄ ˜ê0Á¶˜ÔõúâáòÕéÄyé|J`VRtâPÌLèfãvS˚ô¡¯>¡t¢¥ ˜J–ÿ≠óy∏ºÖºÿ∞˜ ˜;˚èãÍÃ∏üÃÆ∏Ç|¨(ë¬ÿú^Uëp79e&˚(˜âûã˚QVjOZ]òûe-¡¯>¡≥–˜Ê–≥˜ì˚‘˚˜9˜9‘˜˜˜B˜˚9˚9B˚˚–˜
∆Í˜˜∆,˚
˚
P,˚˚PÍ˜
ú«¯Ó«ƒ–¯Õ˘@ûg8íb˚l˚˚)˚h˚l˜˚%˜p∑Ÿí¢±á«csEÖ]ã˚L(˜˜D˜AÒ˜˜Iº Ñt∑˚—¡¯2¡˜ ˜ø¯í˚˜%Lu˚'UÔ˚æ.è>˜™™ìëöáøyÑ{ÜsãXz±π˜ﬁ˜-˚Qv˜Z¡¯>µa¡‘ ˜¬–‹‘˚f ˜ΩçI™ªj€˜ —˜˜+˜/O˜˚*˚ d>o{â(èËL\¯˚ì(l˚˚˚d˜ËË≤˜˜˜™˚(¸@†v˘Çw⁄ ⁄ ˘ÇL˜K†v¯hµa¡⁄ ˜â ˜â º˘ä˜ÛÓQ”$;O[Otâ‰{Aû^˚mKhwâå‹·Nèbãcd¸ ˜Æº˜œ∆–‹¶RC˚Á ˜Æ˜œ∆–‹¶RC˚Á˚*¡aµ˜k¡˜1¡¥˜$≥–ﬁ˜@ç ˜Ç
¿¯–π˜˜$<˚±˝Wu¯…ÜÆã™¥˜u˜Vƒ˚^I{xdN©∫Ωó¿‡™_4q˚˚JÉ˚?•]¢)˜% “¨»ßçÖ˜$Tà˚˚(Q[§Œ˜˜ñ˜ù˚b¡¯>¡¥–¯4¯äëy_ôN˚+&˚˚1˚"€˚˜8ª≥éö∂Ö∆e}fÇcã˚EÏ˜˜–‰˜≠¥Ä|≠†v˘àwµ ˜ì˚ B˜ >˜&˜6˜6ÿ˜&‘˜ a4˚7˚#˚<˚<ﬂ˚#‚˚îv˘fwl˜Ël–˜£˘fF†v˘àw˜A ¢˘à‘˚ ÿ˚&˚6˚6>˚&B˚ µ‚˜ﬂ˜#˜<˜<7˜#4˜ó˘Nó˚\ó˜xó˜©íÛì¸¯ë 
yXO	˜™˘endstream
endobj
64 0 obj
<<
/XHeight 762
/StemV 63
/FontFile3 63 0 R
/StemH 0
/CapHeight 698
/Flags 32
/ItalicAngle 0
/Descent -210
/FontName/XVNGIU+Frutiger-Light
/Type/FontDescriptor
/Ascent 750
/FontBBox[-152 -216 1000 911]
>>
endobj
12 0 obj
<<
/BaseFont/XVNGIU+Frutiger-Light
/Name/F21
/Subtype/Type1
/Widths[278 0 0 0 0 0 0 0 278 278 0 0 278 0 0 278 556 556 556 556 556 556 556 0 556 0 0 0 0 0 0 0 0 0 0 667 667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 500 0 444 556 500 0 556 0 222 0 0 222 833 556 556 556 0 333 389 333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 500 0 0 0 0 0 0 0 0 0 0 222]
/LastChar 146
/Type/Font
/Encoding 62 0 R
/FirstChar 32
/FontDescriptor 64 0 R
>>
endobj
65 0 obj
<<
/Count 4
/Type/Pages
/Kids[66 0 R 67 0 R 68 0 R 69 0 R]
>>
endobj
66 0 obj
<<
/Resources<</Font<</F1 26 0 R/F3 34 0 R/F4 38 0 R/F5 42 0 R/F2 30 0 R/F0 22 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS2 3 0 R/GS0 2 0 R>>>>
/MediaBox[0 0 595.276 793.70099]
/Parent 65 0 R
/Type/Page
/Contents 1 0 R
>>
endobj
67 0 obj
<<
/Resources<</Font<<
/F17 50 0 R
/F3 34 0 R
/F16 46 0 R
/F18 6 0 R
/F5 42 0 R
/F20 61 0 R
/F0 22 0 R
/F19 57 0 R
>>
/ProcSet[/PDF/Text]/ExtGState<</GS2 3 0 R/GS1 7 0 R/GS0 2 0 R>>/XObject<</Fm0 9 0 R>>>>
/MediaBox[0 0 595.276 793.70099]
/Parent 65 0 R
/Type/Page
/Contents 10 0 R
>>
endobj
68 0 obj
<<
/Resources<</Font<</F3 34 0 R/F16 46 0 R/F18 6 0 R/F0 22 0 R/F19 57 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS2 3 0 R/GS1 7 0 R/GS0 2 0 R>>/XObject<</Fm2 13 0 R/Fm4 15 0 R>>>>
/MediaBox[0 0 595.276 793.70099]
/Parent 65 0 R
/Type/Page
/Contents 16 0 R
>>
endobj
69 0 obj
<<
/Resources<</Font<</F3 34 0 R/F0 22 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS2 3 0 R/GS0 2 0 R>>>>
/MediaBox[0 0 595.276 793.70099]
/Parent 65 0 R
/Type/Page
/Contents 17 0 R
>>
endobj
70 0 obj
<<
/PageLabels 18 0 R
/Pages 65 0 R
/Type/Catalog
>>
endobj
71 0 obj
<<
/XPressPrivate(%%DocumentProcessColors: Black\n%%EndComments)
/CreationDate(20041118062933)
/Producer(QuarkXPress(tm) 6.1)
/Creator(QuarkXPress(tm) 6.1)
>>
endobj
xref
0 72
0000000000 65535 f 
0000000015 00000 n 
0000009089 00000 n 
0000009153 00000 n 
0000009216 00000 n 
0000009334 00000 n 
0000114711 00000 n 
0000030206 00000 n 
0000030269 00000 n 
0000018734 00000 n 
0000019284 00000 n 
0000030331 00000 n 
0000123933 00000 n 
0000036736 00000 n 
0000037287 00000 n 
0000042887 00000 n 
0000043437 00000 n 
0000055260 00000 n 
0000066092 00000 n 
0000066131 00000 n 
0000066671 00000 n 
0000076312 00000 n 
0000076530 00000 n 
0000077283 00000 n 
0000077449 00000 n 
0000080508 00000 n 
0000080740 00000 n 
0000081133 00000 n 
0000081522 00000 n 
0000090993 00000 n 
0000091213 00000 n 
0000091911 00000 n 
0000092114 00000 n 
0000096148 00000 n 
0000096373 00000 n 
0000097004 00000 n 
0000097174 00000 n 
0000099491 00000 n 
0000099711 00000 n 
0000100153 00000 n 
0000100417 00000 n 
0000105500 00000 n 
0000105721 00000 n 
0000106241 00000 n 
0000106353 00000 n 
0000107178 00000 n 
0000107391 00000 n 
0000107714 00000 n 
0000107838 00000 n 
0000108625 00000 n 
0000108850 00000 n 
0000109184 00000 n 
0000109567 00000 n 
0000114490 00000 n 
0000115252 00000 n 
0000115532 00000 n 
0000119190 00000 n 
0000119419 00000 n 
0000119914 00000 n 
0000120005 00000 n 
0000120273 00000 n 
0000120489 00000 n 
0000120662 00000 n 
0000120916 00000 n 
0000123712 00000 n 
0000124392 00000 n 
0000124470 00000 n 
0000124704 00000 n 
0000125005 00000 n 
0000125276 00000 n 
0000125471 00000 n 
0000125540 00000 n 
trailer
<<
/Size 72
/Root 70 0 R
/Info 71 0 R
/ID[<FE15B9BF73495AFB0951512504638828><FE15B9BF73495AFB0951512504638828>]
>>
startxref
125715
%%EOF
